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Abstract  
This thesis investigates the chemistry of 25 ascidian species collected from Algoa Bay, South 
Africa with a concerted focus on metal accumulation by these ascidians and the possible 
interaction of these metals with ascidian metabolites.  Chapter 2 details the screening 
techniques employed to establish the presence of nitrogenous metabolites (1H- 15N HMBC), 
hyper-accumulated metal ions (ICP-MS) and potential metal ion/ ascidian metabolite 
complexes (LC-ICP-MS/ESI-MS).  Unfortunately, exhaustive attempts to detect intact metal 
ion/ascidian metabolite complexes through the use of liquid chromatography with parallel 
inductively coupled plasma mass spectrometry/electrospray mass spectrometry (LC-ICP-
MS/ESI-MS) were unsuccessful.  However, the LC-ICP-MS/ESI-MS data obtained for the 
crude organic extracts of six of the Algoa Bay ascidian species, Distaplia skoogi, Aplidium 
monile, Aplidium sp., Didemnum sp., Leptoclindines sp. and Polycitor sp. enabled 
identification of a number of ten halogenated metabolites, namely the indoles 2.28-2.30, and 
the tyramine and tyrosine derivatives (2.31-2.33, 2.41, 2.43, 2.44 and 2.46), within the 
ascidian extracts.  This study confirmed that LC-ICP-MS/ESI-MS is a powerful tool for the 
dereplication of halogenated metabolites in complex mixtures especially where these 
compounds are present in very small amounts.  This study is also the first report of these 
compounds (eight of which are known) in African ascidians. Compounds 2.32 and 2.46 have 
not been reported before from a marine source.  Compounds 2.28-2.30 and 2.33 were 
present in sufficient amounts in the respective ascidian extracts to allow their isolation and 
structure elucidation using standard spectroscopic techniques 
 
Chapter 3 explores the ability of ascidians to accumulate a wide range of metal ions at 
concentrations which are often orders of magnitude higher than those of the surrounding sea 
water.  Inductively coupled plasma mass spectrometry (ICP-MS) was used to determine the 
total ion concentrations of 24 metals in 25 Algoa Bay ascidian species. To the best of our 
knowledge this is the largest and most extensive investigation of metal concentrations in a 
group of different ascidians occurring in the same area. Hypotheisizing that the metal ion 
concentrations for each ascidian specimen screened may represent a unique fingerprint for 
each specimen principal component analysis (PCA) was used in an attempt to establish 
whether there were spatial, temporal or phylogenetic relationships associated with the metal 
concentration fingerprints of the ascidians that formed part of this study.  The PCA results 
showed that there were no statistically significant relationships between ascidian metal ion 
concentrations and either the collection year or the collection site of the ascidians.  However, 
species from the family Didemnidae provided the clearest statistical evidence supporting a 
phylogenetic relationship between these ascidians and their hyperaccumulated metal ion 
profiles.  Furthermore, these results suggested that ascidian species are indeed actively 
concentrating metal ions from the surrounding sea water and are not simply sinks for 
passively accumulated metal ions.  Interestingly, the concentration of vanadium in the set of 
 iii 
ascidians studied did not appear to correlate with any of the other metals accumulated by 
these ascidians suggesting that there is possibly a unique method employed for the 
accumulation of vanadium by ascidians.  Chapter 4 investigated this possibility further after 
the nucleosides 4.10, 4.11, 4.13, 4.15, 4.17 and 4.40 were isolated from the vanadium 
accumulating ascidian Aplidium monile.   
 
Studies into the interactions between nucleosides and vanadyl are unfortunately rare and 
usually qualitative in nature with limited information provided about the stability or structures 
of the complexes formed.  The vanadyl accumulating aplousobranch ascidians e.g. Aplidium 
monile dominated our study of Algoa Bay ascidians therefore providing us with the rationale 
to investigate the relatively little studied binding ability and stability of vandyl-nucleoside 
complexes.  Potentiometric studies were conducted to determine the stability constants of 
complexes formed between the oxovanadium ion vanadyl (VO2+) and the commercially 
available nucleosides 4.10-4.14.  The data afforded by this analysis clearly confirmed the 
complexity of the vanadyl/nucleoside complexation and suggested that guanosine (4.12) 
formed the most stable complex with oxovanadium ions.  We were also able to establish a 
third protonation constant for the hydroxyl moiety in 4.12 with a logK 8.87 which has not been 
previously reported.   
 
Finally, Chapter 5 revisited the cytoxicity two Algoa Bay ascidians, Clavelina sp. and Atriolum 
marinense the extracts from which produced promising bioactivity results in previous studies 
against oesophageal cancer cells.  The HP-20 fractionated extracts of Clavelina sp. and 
Atriolum marinense proved to be similalrly cytotoxic to breast cancer cells.  With the exception 
for the 100% acetone(aq)fractions the NMR data for both species suggested that most active 
non polar fractions were dominated by what appeared to be structurally unremarkable fatty 
acid glycerides and as such were not pursued further.  Purification of the 100% 
acetone(aq)fraction of A. marinense resulted in the isolation of a styrene trimer, 5.1, common 
to both ascidian extracts.  The NMR simulation software WIN-DAISY was employed to 
confirm the structure of 5.1.  Attempts to establish if 5.1 was an isolation artefact or a product 
of marine pollution were inconclusive. 
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Chapter One: 
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1.1 Marine Natural Products and Modern Drug Discovery 
Secondary metabolites or natural products are metabolites which do not appear to be 
involved in the primary cellular functions of the organism in which they are produced.  This 
production of ‘non-essential’ metabolites is often energetically expensive and may be specific 
to a particular organism.  The production of secondary metabolites in the ocean is confined to 
a high proportion of marine invertebrates, plants, and microorganisms, and has not been 
reported from marine vertebrates.1,2  Generally, the biosynthesis of specific secondary 
metabolites is restricted to a single species, or a few very closely related species, usually 
within the same genus.1,2  The marine reef is a very competitive environment and the exact 
function of many marine natural products in the life of the marine organisms that produce 
them, is often unknown.  Some of the roles for marine natural products may include chemical 
defence against predators (antifeedants); inter-species growth inhibition to reduce competition 
for space and nutrients; and intra-species chemical communication cues.1,2 
 
Oceans cover over 70% of the earth’s surface, and comprise 95% of the earth’s biosphere 
(i.e. the total volume available to life on earth).1  The number of marine macro-organism 
species exceeds two million while the total species diversity of marine micro-organisms is 
completely unknown.3  The ocean possesses a significant variation in environmental 
conditions (i.e. light, temperature and pressure) along a vertical transect from the surface of 
the ocean to the ocean floor.  Not unexpectedly, the diversity and even the size of marine life 
changes with this vertical environmental differentiation.3  However, while the vertical transition 
in environmental conditions in the ocean is pronounced, the environmental conditions 
especially temperature, pressure and salinity at each defined depth have remained constant 
over a long period of time.1  Sponges (Phylum: Porifera) are the oldest known multicellular life 
forms on the planet, diverging from metazoans over 600 million years ago.4  Evolving in a 
stable marine, depth related, niche environment over hundreds of millions of years has 
enabled sponges and other marine invertebrates to divert metabolic energy from the day to 
day survival in a constantly changing environment, to the evolution of diverse enzyme 
mediated biosynthetic pathways for the production of a vast array of novel secondary 
metabolites.1  The structures of marine natural products are therefore generally more 
chemically diverse than those produced by terrestrial plants and this is regularly reflected in 
reviews of marine natural products published annually in Natural Product Reports.2  
 
Recently, Grabowski et al.5 explored the concept of chemical space as it pertains to natural 
products and known drug compounds.  They consequently showed that marine derived 
compounds have the broadest general coverage of this space, incorporating many drug 
relevant structural features.5  Bon and Waldmann6 went further to explore the link between 
natural products and protein space.  Small molecule modulators of protein function are one of 
the driving forces in chemical biology research and drug discovery.  Bon and Waldmann6  
draw attention to the fact that both protein folds and natural product scaffolds are highly 
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conserved in nature.  However, while changes in amino acid sequences may lead to changes 
in ligand binding sites in proteins, these binding sites will still conform to highly similar fold 
types.5  Conversely, differentially substituted natural products, even within the same general 
structural class, can exhibit diverse biological activities.  Therefore Bon and Waldmann6 
concluded that many natural products have evolved to interact with multiple proteins in order 
to elicit their biological functions.  For example, they suggest that natural products responsible 
for toxicity reflect an ability to bind with multiple protein receptors.  Similarly, Li and Vederas7 
have identified natural products as having privileged structures for drug discovery, through 
their production by enzymes to interact with a broad range of functional proteins.  They 
support their argument with evidence from the drug discovery process in which 7,000 
polyketide natural products have yielded over 20 commercial drugs (0.3% hit rate) whereas 
the hit rate from high throughput screening of synthetic compound libraries is only <0.001%.  
The link between marine natural products and new drug discovery is well established globally 
and has also been the driving force behind natural products research in South Africa for the 
last two and a half decades.8  Therefore, in order to set the scene for the South African 
marine ascidian chemistry research described in this thesis, it is deemed necessary in this 
introductory Chapter to provide firstly, an overview of contemporary marine derived 
pharmaceuticals either in, or about to enter, the market place and secondly, introduce the 
marine invertebrate Class Ascidiacea through a brief introduction to ascidian biology.  Further 
expansion of specific aspects of marine ascidian biology and chemistry are provided in the 
relevant chapters and sections that follow this Chapter.   
 
1.2 Current Marine Natural Products and Their Derivatives with Food and Drug 
Administration (FDA) Approval 
Currently there are two FDA or EU approved compounds whose chemical structures are the 
actual, unaltered, marine natural products isolated from their source organism, whilst a further 
five FDA approved drugs are synthetic compounds inspired by marine natural products.9  A 
summary of these approved chemotherapeutic agents as well as a further 13 marine natural 
product inspired drugs currently in various stages of clinical trials are shown in Table 1.1 
along with details relating to the original organism from which the compounds were isolated, 
the compounds chemical class and the disease areas for which these compounds provide a 
novel chemotherapeutic intervention.9  This section will briefly discuss the processes involved 
in bringing the seven approved drugs onto the market. 
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The first two natural product derived drugs currently on the market were inspired by the 
unusual nucleosides spongouridine (1.1) and spongothymidine (1.2) isolated from the 
Caribbean sponge Tectitethya crypta (previous synonym Cryptotethya crypta) in the early 
1950’s by Bergmann et al..9–11  The simple modification seen in 1.1 and 1.2, where the normal 
2-deoxyribose rings common to nucleosides are replaced by β-D-arabinofuranose rings, 
resulted in significant enhancement of biological activity.  Further exploration of the bioactivity 
mechanism revealed that the cytosine arabinoside (aytarabine, Ara-C, 1.3) was 
phosphoralyated in the cell and subsequently incorporated into the back bone of DNA where 
it served as a powerful inhibitor of DNA polymerase and DNA repair enzymes leading 
ultimately to cellular toxicity.9  In 1969 1.3 was granted FDA approval and entered the market 
under the trade name Cytosar-U® for the treatment of acute lymphocytic leukemia, acute 
myelocytic leukemia and blast crisis phase of chronic myelogenous leukemia and meningeal 
leukemia.11  The arabinoside derivative of adenosine, vidrabine, Ara-A (1.4), was found to 
have significant antiviral activity.9  Activation of 1.4 once again occurs with phosphorylation to 
give adenine arabinoside triphosphate which is a potent inhibitor of viral DNA polymerase and 
DNA synthesis in herpes, vaccinia and varicella zoster viruses.11  FDA approval of 1.4 under 
the trade name Vira-A® was granted in 1976.11  These early discoveries highlighted 
nucleoside biochemistry as an area for antiviral chemotherapy and more importantly provided 
the first clear examples of marine organisms’ value as a potential source of new 
pharmaceuticals.9 
 
The polypeptide, ω-conotoxin MVIIA (Ziconotide®, 1.5), isolated from the marine cone snail 
Conus magus, was approved for clinical use in 2004, and was the first marine natural product 
to enter the market in over 25 years.7,12  Compound 1.5 is used for the treatment of chronic 
pain caused by spinal cord injuries, and is injected directly into the spinal column as its 
peptide structure would be digested, and thus rendered ineffective, in the gastrointestinal tract 
if administered orally.  The polypeptide structure of 1.5 may appear complex, however the 
total synthesis of this compound is achieved relatively simply through a series of synthetic 
peptide bond formations, allowing for the industrial production of virtually unlimited amounts of 
this drug.13   
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1.5  
 
 
The hypertriglyceridemia reducing agent Lovaza® also received FDA approval in 2004.14  
Lovaza® contains synthetic esters (1.6 and 1.7) of ω-3 fatty acids originally obtained from oily 
fish species including anchovies, herring, mackerel and salmon.9  Combined with an improved 
diet and regular exercise, Lovaza® has significantly lowered levels of triglyceride and VLDL-
cholesteral in test patients.9 
 
 
O
O
O
O
1.6
1.7  
 
 
The synthetic production of compounds 1.3 – 1.7 is relatively easy which is fortunate as 
chemical synthesis is the ideal production method for natural product based pharmaceuticals 
as it eliminates the problem of supply and any possible adverse environmental impact.  
However, the remaining FDA approved marine natural products possess complex chemical 
structures, rich in chiral centers, requiring synthetic sequences involving numerous individual 
reaction steps which would often render total synthesis practically impossible and 
economically non feasible in an industrial context.15     
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Yondelis® (1.8), the second underivatised marine natural product currently in clinical use, was 
introduced in 2007 for the treatment of soft tissue sarcoma.9  Extracts from the ascidian 
Ecteinascidia turbinata were first found to have anti-tumor effects in 1969, but the active 
natural product, ecteinascidin-743 (ET-743, trabectedin, 1.8) was only successfully isolated in 
low yields (1 g per metric tonne of ascidian) in 1990.12  Mariculture of E. turbinata was used to 
obtain sufficient natural product for phase I and II clinical trials, however this method was not 
feasible for the production of larger quantities of 1.8 needed for phase III clinical trials, and 
eventual clinical use.12  Although the natural product 1.8 has a complex chemical structure 
containing eight chiral centers, Corey et al.,16 Endo et al.,17 and Chen et al.18 have all reported 
the total stereoselective synthesis of 1.8.  However, these syntheses all involved numerous 
synthetic steps and were thus deemed economically nonviable for the commercial production 
of sufficient quantities of 1.8.  Fortuitously, Cuevas et al.19 noted that the structural features of 
1.8 are very similar to cyanosafracin B (1.9) isolated from the bacterium Pseudomonas 
fluorescens, and suggested that the number of synthetic steps could be markedly reduced if 
1.9 was used as a starting point in a semi-synthesis of 1.8.13  Compound 1.9 was accordingly 
produced through the fermentation of P. fluorescens and then used as a precursor in the 
semi-synthesis of 1.8.19  This semi-synthetic approach was a much more realistic method 
than total synthesis for the production of the large quantities of 1.8 needed for phase III 
clinical trials, and eventual introduction into the market.9,12  
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Halichondrin B (1.10), an extremely potent tubulin inhibitor, was originally isolated in small 
quantities from numerous widely dispersed sponge species including Halichondria okadai 
(Japan), Axinella sp. (Western Pacific), Phakellia carteri (Eastern Indian Ocean) and 
Lissodendoryx sp. (New Zealand).10,15  In the case of the rare deep water (-80 to -100m) 
sponges Lissodendoryx sp. the yield of 1.10 was approximately 300 mg per metric tonne of 
sponge.15,20  The National Cancer Institute (NCI) commissioned a survey of the naturally 
occurring Lissodendoryx sp. populations of New Zealand and established that the estimated 
total biomass of Lissodendoryx sponge is approximately 289 tonnes, clearly indicating that 
wild harvest would never result in enough 1.10 for commercial use.20,21    Mariculture of the 
Lissodendoryx sp. was subsequently carried out in Beatrix Harbour, New Zealand by the New 
Zealand Institute of Water and Atmospheric Research (NIWA), in collaboration with the NCI.20  
Lissodendoryx sp. was successfully grown in mariculture, however, the overall yield of 
halichondrin B in the cultured sponge was not as high as that in the wild sponge.20  
Mariculture in general, requires a great deal of planning in terms of the positioning of the 
mariculture facility to ensure sustainability, as natural product production in marine organisms 
is very susceptible to environmental changes and even seasonal changes will affect the 
growth of the sponge and their production of secondary metabolites.20  Synthesis was once 
again believed to be the best option for the production of 1.10 for pre-clinical and clinical 
trials.  Compound 1.10 has a complex structure containing 32 stereocenters and the first total 
synthesis of 1.10 developed by Kishi and co-workers,22 required over 100 synthetic steps with 
an overall yield of less than 1%.  In general an economically feasible drug synthesis should 
not exceed 30 synthetic steps.15   
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The Japanese pharmaceutical company Eisai explored the possibility that smaller simpler 
analogs of 1.10 might still elicit the desired anti-tumour effect.15  This structure-activity 
relationship study involved the preparation of over 200 analogues of 1.10 and resulted in the 
discovery of eribulin (E7289, 1.11), a simplified analogue with 19 stereocenters, which 
exhibited improved cytotoxicity when compared with 1.10.15,21,23  The synthetic analogue 1.11 
was FDA approved in 2010 and is currently on the market under the trade name Halaven® for 
the treatment of metastatic breast cancer in phase III clinical trials for the treatment of 
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metastatic breast cancer.24  However, the synthesis of 1.11 still requires more than 30 steps 
which makes its production for clinical use by synthesis possibly problematic and other 
options for natural product semi-synthesis, as in the example of 1.8 described earlier, will 
possibly also need to be explored.15  
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The most recent FDA approve natural product derived drug is a derivative of dolastatin 10 
(1.12).  The cytotoxic peptide 1.12 was first isolated by Pettit and co-workers in 1987 from a 
Mauritian sea hare, Dolabella auricularia.9  In order to gain just 1 mg of 1.12 needed for 
structural elucidation an enormous number of sea hares, totalling approximately 2 tonnes, 
were required.25  Dolastatin 10 was found to have a novel peptide structure with four unusual 
amino acids, namely N,N-dimethylvaline, dolaisoleucine, dolaproine and dolaphenine.25  The 
absolute configuration of 1.12 was confirmed with the successful total sysnthesis of dolastatin 
10 by Pettit and coworkers in 1989.25  Later it was established the 1.12 was produced by the 
cyanobacteria (Symploca sp.) which form a major part of the sea hare’s diet.9  The powerful 
antimitotic properties of 1.12 saw it pass through phase I clinical trials.  However, when 1.12 
was entered into phase II clinical trials against a number of cancer cell lines it was not found 
to have significant clinical activity and was thus withdrawn from antitumor clinical trials.25  
Recently Katz et al.26 linked a chimeric antibody to a derivative of 1.12 namely 
monomethylauristatin E (MMAE) to produce Brentuximab vendotin (SGN-35, 1.13).  The 
antibody drug conjugate 1.13 acts in such a way that the antibody will target CD30, an 
antigen present on the surface of Hodgkin’s lymphoma cells, thus bringing the antimitotic 
agent, MMAE, into closer proximity to the cancer cells and vastly increasing its efficacy.26  
The success of 1.13 in phase I, II and III clinical trials against Hodgkin’s lymphoma resulted in 
the accelerated FDA approval of the drug in 2011.  Currently 1.13 is produced by Seattle 
Genetics and is on the market under the trade name Adcetris®.9   Table 1.1 reveals that within 
the 13 marine natural product derived drugs in the clinical pipeline three are anticancer 
agents which a similar antibody conjugated structure as 1.13. 
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As Table 1.1 and the above discussion shows, marine invertebrates are a relatively rich 
source of medicinal compounds.  Recently Schuhmann and co-workers27 developed a model 
to evaluate how valuable marine biodiversity is to the pharmaceutical industry especially in 
terms of anti-cancer drug development.  Schuhmann and co-workers27 estimated that an 
outstanding 250,000-590,000 novel compounds were awaiting discovery from marine 
organisms.  Their model predicted the pharmaceutical value of marine biodiversity to be as 
high as US$5.69 trillion and cautioned that a drop in biodiversity as small as 20% could 
equate to a market value loss of US$1.14 trillion.27  These figures encourage biodiscovery 
and exploratory research into marine natural product chemistry whilst reinforcing the need for 
sustainable methods of production of drugs from the marine environment.    In the context of 
this thesis which addresses our paucity of knowledge of the bioactive secondary metabolites 
produced by South African marine ascidians it is of interest to note that within their model, 
Schuhmann and co-workers predicted that secondary metabolites produced by marine 
chordates would be the more valuable from a pharmaceutical perspective over other 
organisms in the Kingdom Animalia.27  Interestingly, very few organisms within the phylum 
Chordata are capable of producing secondary metabolites.   One exception is the marine 
class of chordates, Ascidiacea, commonly known as ascidians, which have shown the 
potential to produce druggable compounds as indicated in Table 1.1 and from reports of other 
ascidian metabolites in preclinical trials.23,28,29 
 
Didemnin B (1.14) first isolated from the ascidian Trididemnum solidum was one of the first 
non-derivatised marine natural products to enter anti-cancer clinical trials.30  Promising in vitro 
testing results showed that 1.4 was active against lymphatic, colorectal and prostate cancers.  
Didemnin B performed well in phase I and II clinical trials against a range of tumours, 
however, trials were placed on hold due to undesirable side effects during treatment.25,28  
Aplidine (1.15) is closely related to 1.14 and was isolated form the ascidian Aplidium 
albicans.28  As can be expected, 1.15 also possesses potent anti-cancer activity however, 
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contrary to 1.14 there appear thus far in clinical trials to be no harmful side effects associated 
with treatments using 1.15.11,28,31  In the EU 1.15 has been given “orphan drug” status for 
acute lymphoblastic leukemia and is synthetically produced by PharmaMar under the trade 
name Aplidin®.10 
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Two exciting tubulin targeting compounds currently in preclinical trials are the cyclic peptide 
vitilevuamide (1.16), isolated form the ascidians Didemnum cuculiferum and Polysyncraton 
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lithostrotum, and diazonamide A (1.17) isolated from Diazona angulata (initially misidentified 
as Diazona chinensis).28,32  Although the exact mechanism of action for both 1.16 and 1.17 is 
still under investigations it appears that these two compounds not only interact with tubulin at 
different sites when compared to each other, but thus far seem to possess distinct bioactivity 
compared to any other tubulin targeting compounds in current studies.28  
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1.3 A brief introduction to ascidian biology 
Ascidians are believed to be the simplest chordates.  In the adult stage of life they are 
sedentary, soft bodied organisms which can either have solitary or colonial growth forms. 
Paradoxically, they produce swimming larvae which have a notochord, a quasi-equivalent of a 
vertebrate backbone hence their consideration by biologists as primitive chordates (Note: the 
notochord disappears in adult ascidians resulting in ascidians generally being referred to as 
invertebrates).  In traditional metazoan phylogeny the phylum Chordata consisted of three 
subphyla namely Vertebrata, Cephalochordata and Urochordata (Tunicata).33  Recent 
advances in phylogenetic research have however led Satoh et al. to recommend that 
Chordata be classified as a superphylum which is divided into three phyla due to distinctive 
characteristics of Vertebrata, Cephalochordata and Urochordata (Tunicata).33  Within the 
class Ascidiacea (Phylum/Subphylum Urochordata) there are two orders namely Enterogona, 
consisting of the suborders Aplousobranchia and Phlebobranchia, and Pleurogona containing 
the suborder Stolidobranchia.  Aplousobranch ascidians are all colonial and are believed to 
be the simplest ascidians in evolutionary terms.  The suborders Phlebobranchia and 
Stolidobranchia are considered more advanced and are made up of both colonial and solitary 
ascidians. 34 
1.3.1 Tunic 
The ascidian body is completely embedded in a thick covering known as the tunic, bringing 
about the common name tunicate.  The tunic is akin to a flexible exoskeleton and maintains 
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the animals shape, provides protection and anchors the ascidian to the substrate.33–36  The 
ascidian tunic is capable of rapid regeneration upon damage.37  The consistency, colour and 
thickness of the tunic is a variable feature across as well as within ascidian species thus it is 
often not a reliable feature for taxonomic identifications, often causing SCUBA divers to 
mistake ascidians for sponges or algae.34,35,38  The tunic is primarily made up of tunicin, a type 
of cellulose, which along with various proteins forms a matrix of fibres that give structure to 
the tunic.33–36  The biosynthesis of cellulose is brought about by a large multimeric protein 
complex in the plasma membrane.33   Cellulose synthase (CesA) and cellulase are two crucial 
enzymes involved in cellulose biosynthesis.  Investigation into the genome of Ciona species 
revealed that a single copy of CesA (Ci-CesA) was present.33   Through molecular phylogeny 
Ci-CesA was found to be within the same clade as Streptomyces CesA indicating that the 
bacterial CesA gene was likely transferred horizontally into the genome of a tunicate ancestor 
early in ascidian development.33  This ability of urochordates to biosynthesise cellulose is the 
key feature that Satoh et al.33 believe warrants the phylum-level classification of Urochordata. 
 
1.3.2 The branchial sac and digestion 
Ascidians are filter feeders and water enters though an oral siphon which is rimmed with oral 
tentacles (Figure 1.1) ensuring coarse filtration of larger particles.33–36  The water is taken into 
the branchial sac also known as the pharangeal basket which has dual functionality of 
gaseous exchange with the water as well as the uptake of food.  The branchial sac is a net 
like structure pierced with numerous stigmata each of which have a boarder of cilia which are 
responsible for the flow of water through the sac.34,36  The number of rows of stigmata as well 
as their shape are often characteristic and can be used as tools for taxonomic identification of 
ascidian species.  The overall shape of the walls of the branchial sac can also be a useful 
taxonomic identifier.34   
 
 
Figure 1.1:  Under water photograph of the solitary ascidian Microcosmus exasperatus 
clearly showing the ramified oral tentacle along the rim of the oral siphon. (Photo: Candice 
Bromley) 
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In the simplest forms of ascidians the surface of the branchial sac is flat with numerous 
stigmata whilst in more complex species the surface area of the branchial sac is further 
increase by the formation of pleats as seen in Figure 1.2.34  The beating cilia in the walls of 
the branchial sac push water from the sac into the peribranchial cavity.  The cilia are not, 
however, responsible for filtering the water and the uptake of planktonic food particles, this is 
achieved by a mucus net.34–36  The endostyle (Figure 1.3a) on the ventral side of the branchial 
sac is homologous to the vertebrate thyroid and produces hormones as well the mucus net.35  
The mucus produced by the endostyle sweeps over the walls of the sac, driven by the beating 
cilia and traps food particles contained in the sea water.  At the dorsal end of the branchial 
sac the mucus is rolled by the dorsal lamina to form a mucus chord (Figure 1.3 b) and moved 
towards the oesophagus for digestion.35   
 
Figure 1.2:  Microscope image of the pleated branchical sac of a Stolidobranch ascidian. 
(Photo: Candice Bromley) 
The filtered water is then expelled from the ascidian peribranchial cavity, along with digestive 
waste, via the atrial siphon.  Both the oral and the atrial siphons contain strong circular bands 
of muscle enabling the animal to close these openings.34,35  The rapid closing of siphons often 
result in a jet of water to be propelled out of the ascidian hence the affectionate name of sea 
squirt given to this group of marine organisms.  The filtration process is not selective and 
although the oral tentacles inhibit the entry of most of the larger particles, ascidians may have 
to periodically flush out the branchial sac by forcing the water back out the oral siphon in 
order to ensure that their respiratory and food filtration system does not become blocked by 
unwanted particles.34 
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a)   b)  
Figure 1.3:  Microscope images of the U-shaped endostyle (a) and the mucus cord formed by 
the dorsal lamina (b) of Phallusia nigra. (Photo: Candice Bromley) 
Mucus trapped food particles pass from the oesophagus to the stomach for digestion and the 
resultant faecal matter is expelled from the digestive tract through the anus into the 
peribranchial cavity.34,35  Filtered water flowing out of the branchial sac is pushed through the 
atrial siphon sweeping the faecal matter out with it.  In colonial ascidians the digestive tracts 
of zooids are found below the branchial sac whilst solitary ascidians have their digestive tracts 
situated alongside the branchial sac.34,35 
 
1.3.3 The Circulatory System 
Ascidians possess a complex network of channels, often loosely referred to as vessels, 
though which their blood flows transporting metabolites.34,38  Ascidian hearts are fascinating in 
that they completely reverse the flow of blood every few minutes.  The ascidian heart is a V-
shaped muscular tube which rhythmically contracts pushing blood through in one direction 
before pausing for a few seconds and when it begins to contract again it drives the blood in 
the opposite direction.34  Ascidian blood is isotonic to seawater and contains a number of 
circulatory cells.34  Further detail of these circulatory cells as well as the controversial belief 
that the blood of ascidians plays a role in respiration is discussed in Chapter 4. 
 
1.3.4 Reproduction 
All ascidians are hermaphrodites and the arrangement and shape of the sexual organs is 
once again a taxonomic indicator.34,35,39  Sperm is released into the peribranchial cavity where 
it is flushed out of the atrial siphon.  Eggs on the other hand are released from the ovary but 
are retained in the peribranchial cavity of the zooid for fertilisation.34  After fertilisation the 
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resultant ascidian larvae are brooded in the peribranchial cavity or in some species within a 
specialised brooding pouch.34   
 
 
Figure 1.4:  Microscope photograph of a brooding ascidian larva clearly showing the 
notochord-containing tail as well as three papillae at the front of the larval head which are 
characteristic of a didemnid species. (Photograph: Candice Bromley) 
As seen in Figure 1.4 the larvae of ascidians have a tadpole structure with the body divided in 
to a head and a tail.  The body is covered in a delicate tunic.35  The tail of the larvae contains 
a notochord which is homologous to that found in vertebrates.34  The muscle fibers in the tail 
propel the larvae and along with two sensory organs in the head namely the statocyst and 
ocellus, responsible for gravitropic and phototropic detection respectively, enable the larvae to 
swim.34,40  Ascidian larvae are not capable of feeding and rely on energy stored in yolk cells.  
Adhesive papillae located at the front of the larval head detect suitable substrates to settle on.  
Once settled the larvae metamorphosise into the adult tunicate.34  All ascidians reproduce 
sexually but colonial ascidians are also capable of asexual reproduction often meaning that all 
zooids in a colony, regardless of its size, are genetically identical.34 
 
Aside from being a consistent source of novel bioactive compounds, ascidians have also 
attracted the interest of researchers because of their ability to accumulate metal ions in 
remarkably high concentrations and further explanations of both the mechanisms of metal ion 
accumulation and the proposed role of metal ions in ascidian biology are described in 
Chapters 2, 3, and 4. 
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1.4 Aims of this thesis 
Exploring the interaction of hyper-accumulated metal ions and bioactive secondary 
metabolites in South African marine ascidians is the underlying theme that runs through this 
thesis.  The marine natural products chemistry of South African marine ascidians has largely 
been neglected over the last two decades when compared with natural product studies of 
South African sponges, soft corals, nudibranchs and marine algae.8,41–43  A focussed 
collection of specimens of 63 different ascidian species by SCUBA from  Algoa Bay, South 
Africa in 2004, as part of the NCI’s  National Cooperative Drug Development Groups 
(NCDDG)44 programme provided the initial unique source material for this thesis work (further 
collections of selected ascidians were made during this study from Algoa Bay).  With the 
support of a Royal Society grant in 2010 Davies-Coleman (Rhodes University) and Jaspars 
(University of Aberdeen) anticipated exploiting this unique collection of ascidians to ascertain 
if examples of metal ion/ secondary chelation, as originally discovered by Jaspars and co-
workers in the  Australian ascidians Lissoclinum patella45,46 and Eudistoma gilboviride47 
(described in detail in Chapter 2), were also evident in Algoa Bay ascidians containing similar 
nitrogenous metabolites.  The hypothesis that such chelation was not limited to these two 
ascidian species and may be more widespread amongst ascidians needed ratification.  The 
uniquely configured mass spectrometry infrastructure at the University of Aberdeen, designed 
to explore metal ion/secondary metabolite relationships, was unavailable in South Africa and 
the Royal Society grant provided the catalyst and the means to link state of the art chemical 
analysis infrastructure with a unique natural product resource. The results of this three year 
study are presented here. 
 
Although the primary aim of the thesis was to explore the occurrence of possible metal ion/ 
secondary chelation in Algoa Bay ascidians, we also realised that the in-depth analysis of 
ascidian metal ion concentration required for such a study would provide a unique opportunity 
to explore the existence of possible relationships between metal ion accumulation and the 
phylogenetic, spatial and temporal distribution of Algoa Bay ascidians (Chapter 3).   We also 
anticipated that the close scrutiny of the Algoa Bay ascidian extracts for nitrogenous and 
halogenated metabolites using contemporary nuclear magnetic resonance (NMR) techniques 
at Rhodes University and the mass spectrometry facilities at the University of Aberdeen 
respectively, would ultimately lead to the discovery of new and known natural products 
previously not encountered before in South African ascidians (Chapters 2 and 4)  In addition, 
if these metabolites were present in sufficient quantities, opportunities would be provided to 
study in detail selected metabolites’ potential chelation with ions regularly hyper-accumulated  
by ascidians e.g. vanadium (Chapter 4).  Finally, the discovery of new bioactive metabolites 
with pharmaceutical potential remains the mainstay of the majority of marine natural products 
research programmes.  Consequently, the source of the elusive potent cancer cell cytoxicity 
observed in extracts of two Algoa Bay ascidians Atriolum marinense Kott, 2001 and Clavelina 
sp. was pursued concurrently with the other research areas described above (Chapter 5).  
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Chapter Two: 
Screening of South African Ascidians 
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2.1 Introduction to South African ascidians taxonomy, zoogeography and chemical 
diversity 
2.1.1  Taxonomic diversity of South African ascidians 
The first taxonomic descriptions of ascidian species collected along the southern African 
coast were conducted by the early taxonomists Herdman (1882, 1886), Sluiter (1898),48 
Michaelsen (1904) and Hartmeyer (1912). The five collections that provided ascidian 
specimens for taxonomy, formed part of larger expeditions, conducted from the vessels HMS 
Challenger, Siboga, and Valdivia Deutschen Tiefsee, which were used to explore the 
biodiversity of the world’s oceans at the end of the 19th and early 20th centuries.36,40,49  The 
primary method of collection on these expeditions was dredging which resulted in the majority 
of ascidians assimilated into these biodiversity investigations being those preferring to settle 
on softer substrates such as sand.49  Some ascidian classifications made in these early 
studies are still considered ambiguous, or as in the case of Clavelina enormis Herdman 1882, 
incomplete as the initial short description was based on a single, immature specimen.49   
 
Michaelsen’s investigation of the ascidians of the Cape Province was the first concerted study 
of the ascidian population of South Africa.50  After these early taxonomic studies there was a 
hiatus in activity until Millar took an interest in the taxonomic wealth of the ascidians of 
southern Africa.  Millar’s numerous publications on the subject made significant strides in our 
understanding of the diversity and distribution of ascidians in South Africa. 36,39,51,52   
 
More recently, a comprehensive collection of South African ascidians from Sodwana Bay on 
the east coast to Saldanha Bay on the west coast was made by Griffiths (University of Cape 
Town) and Schleyer (Oceanographic Research Institute, Durban). The ascidians collected by 
Schleyer and Griffiths  were identified by the renowned French ascidian taxonomists, Claude 
and Francoise Monniot.49  Their seminal treatise documents the collection and description of 
82 South African ascidian species, 20 of which were new to science.  In addition Monniot and 
Monniot reviewed an additional 63 species previously recorded from South Africa, that were 
not part of the Schleyer/Griffiths collection.49   
 
Following shortly after the study by Monniot et.al. the South African ascidian taxonomist, 
Shirley Parker-Nance published her PhD thesis entitled ‘Aplousobranch ascidians (Tunicata: 
Ascidiacea) of southern Africa’ which included the description of 11 species of tunicates from 
Algoa Bay, South Africa, 5 of which were new to science.40   This work was the last of the 
taxonomic reports on ascidians of South Africa to appear in the taxonomy literature, apart 
from a few cursory ascidian descriptions, some of which were new species, recently 
published in the chemistry literature in support of marine natural product studies of these 
organisms.53–55 Details of the ascidian natural product chemical diversity emerging from these 
studies are reviewed in section 2.1.3 of this chapter.   
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The most recent estimation of the number of identified species of ascidian present in the 
waters off southern Africa is 168 species,  and includes those reported from along the 
coastlines of South Africa, Namibia and Mozambique, in addition to the West Wind Drift 
Islands of Tristan de Cunha, Vema Seamount and Amsterdam Saint Paul, but excludes those 
reported by Parker-Nance.56,57  Most taxonomists agree that even with a long history of 
ascidian taxonomic investigations along the South African coast, the sporadic nature of the 
sampling in terms of depths and locations, has created a fairly random inventory of species 
which grossly underestimates the ascidian diversity in South African coastal waters.40,49,58 
 
2.1.2 Biogeography of the South African coast 
The rich diversity of the marine flora and fauna in South African waters is noteworthy and has 
piqued the interest of many marine researchers for over a century.58,59  The reason for such 
biodiversity is due, in part, to the long contiguous coast line of South Africa, stretching 
approximately 3,000 km from the Mozambican border in the east to the Namibian border in 
the west.41,60  South Africa straddles the Indian and Atlantic oceans and the South African 
coastline is exposed to the two major oceanic currents that influence the biogeography of 
southern Africa.60  These two large ocean current systems, namely the Agulhas and the 
Benguela currents, are predominantly responsible for creating three distinct bio-geographical 
zones along the South African coastline (Figure 2.1).59,60  
 
The subtropical bio-geographical zone dominates the east coast of South Africa and is 
characterised by the presence of numerous circumtropical marine species.  The 
environmental features of this zone are dictated by the influence of the Agulhas current which 
sweeps down from the tropics delivering warm tropical water to the east coast (Figure 
2.1).41,59,60  The core of the powerful Agulhas current flows southward, following the edge of 
the continental shelf.  As the continental shelf widens off the southern Cape coast the 
Agulhas current is pushed further off shore, and the coastal waters along the southern coast 
become cooler.41,59  This drop in temperature results in a different set of flora and fauna, 
exhibiting a high degree of endemism, occurring along the south east coastline which is 
classified as the warm temperate bio-geographical zone (Figure 2.1). The Agulhas current 
finally turns back on itself and flows eastward as the return Agulhas current.59,60  The third bio-
geographical zone is the cool temperate west coast which is markedly different from the east 
coast.  The major current influencing this area is the Benguela current originating from a 
northerly deflection of the sub-Antarctic Western Drift current.59  The Benguela current flows 
north up the west coast of South Africa, bringing with it cold water (Figure 2.1).  Upwelling, 
another important phenomenon affecting the biogeography of the western coast, is caused by 
prevailing winds that blow the surface waters offshore, forcing water from the deep ocean to 
rise upwards and replace the retreating surface waters.  The waters from the deeper reaches 
of the ocean are devoid of light and therefore cannot sustain plant life, resulting in a nutrient 
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rich environment.59  The upwelling, bringing cold and nutrient rich water to the surface, 
creates an ideal environment for phytoplankton and seaweed populations, which in turn 
support food chains that culminate in productive fisheries.59,60    
 
 
 
Figure 2.1:  Map of the coastline of southern Africa depicting the ocean currents responsible 
of the three bio-geographical zones.  The sites indicated relate to the areas where ascidian 
collections have been made (A = Sodwana Bay, B = Aliwal Shoal, C = Algoa Bay and D = 
Tsitsikamma Marine Reserve).41 
 
2.1.2.1  Zoogeography of ascidians in South Africa 
In 1971, Millar comprehensively reviewed the biological and taxonomic literature published on 
ascidians worldwide.36  In his review, Millar estimated that 84 recognised species of ascidians 
occurred in the waters of South Africa.  Of this population, Millar approximated that as many 
as half could be considered endemic to the region, and further stated that 39% were found in 
the warm, subtropical waters of the east coast, 35% in the warm temperate south coast 
waters, 22% in the cold temperate west coast waters and only 4% were ubiquitous.36,39  The 
figures that Millar arrived at are in accordance with those obtained for other South African 
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marine fauna, however, the ascidian data reviewed was not collected with bio-geographical 
investigations in mind and as such the collection points along the coast were sporadic and for 
the most part focused on common ship routes.  Thus statements such as those made by 
Millar, alluding to the geographic distribution and endemism of South African ascidians must 
be viewed with caution given that our knowledge of the true extent of South African ascidian 
population remains uncertain.49  
 
Primo and Vasquez used modern statistical techniques to investigate the patterns of ascidian 
zoogeography of the southern African region.  Their work included distribution data obtained 
from the descriptive taxonomic reports on South African ascidians, previously discussed in 
this chapter, along with other literature reports allowing the region to be expanded to include 
the littoral zones of Namibia and Mozambique as well as the West Wind Drift Islands56  Due to 
the gaps in the knowledge of the ascidian diversity discussed previously the distribution of 
ascidians throughout the waters of southern Africa and because no new sampling was 
actively undertaken, it is once again with some caution that the results obtained by Primo and 
Vasquez  can be accepted.40,49,58  However, even with these factors in mind, some attention 
should still be given to the conclusions of Primo and Vasquez.  Firstly, they concluded that the 
ascidian populations on the West Wind Drift islands were markedly different from those seem 
along the coast of southern Africa, and so were not considered in further classifications of bio-
geographical zones.  They also stated that that the population found on the subtropical east 
coast was for the most part different from those of the cold temperate west coast. In addition 
they proposed that the warm temperate Agulhas region along the south coast acted as a 
transitional zone between the subtropical and cold temperate biogeographical regions as 
they, contained ascidian species found in the two other areas.56  They went on further to state 
that the southern African ascidian population exhibited 47% endemism, 25% Indo-Pacific and 
13% cosmopolitan and that the colonial species dominated the tropical regions and solitary 
ascidians the colder regions.56 
 
These conclusions, although more detailed, and with the added support of statistical proof, 
are by no means novel and at most simply add weight to classic observations on the general 
biogeography of the South African flora and fauna.  These original and general studies 
commonly state that there is a high level of biodiversity in the warm regions opposed to the 
higher biomass observed in the cold regions. The south east temperate region has been 
shown to incorporate aspects of the other two regions, and has a rich population of filter 
feeders.58,59 
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2.1.2.2 Study site: Algoa Bay 
The study site used for our investigation was Algoa Bay, situated in the south eastern warm 
temperate biogeographic coastal region of South Africa (shown as point C in Figure 2.1).  The 
characteristic crescent shape of Algoa Bay protects the subtidal reefs present in the western 
sector of the bay from rough surf conditions, which helps to facilitate accessibility and 
collection of specimens from these reefs by SCUBA.40   Algoa Bay is host to one of South 
Africa’s major harbours, Port Elizabeth, which along with the anthropogenic influence of the 
surrounding Nelson Mandela metropole ensure a steady supply of nutrients that enrich the 
waters of the western sector of the bay.  The nutrient rich warm temperate waters create an 
ideal habitat for filter feeders such as sponges and ascidians which are both abundant and 
ubiquitous in Algoa Bay.58,59  The majority of the ascidians in our investigation were collected 
from dive sites in western Algoa Bay in 2004 as part of the National Cancer Institute’s 
National Cooperative Drug Discovery Groups (NCDDG) program and had been kept 
continually frozen (-20 °C) since their collection.44  Further selective collections of individual 
ascidian species were made (2011-2014) in Algoa Bay as the research described in this 
thesis evolved. 
 
2.1.3 Previous investigations of the natural products chemistry of South African ascidians 
Kashman and co-workers were the first to report the isolation of novel, bioactive metabolites 
from a South African ascidian species.61  Polycitone A (2.1) and polycitrins A and B (2.2 and 
2.3) were isolated from the ascidian Polycitor sp. collected in Sodwana Bay, South Africa 
(indicated as point A in Figure 2.1). The chemical structures of 2.1-2.3 were elucidated using 
standard NMR experiments, and further analysis through single crystal X-ray diffraction was 
required to confirm the structure of the highly symmetrical 2.1.61  In a subsequent 
investigation, polycitone A (2.1) and polycitrin A (2.2), along with methylated derivatives of 
both compounds were assayed against retroviral reverse transcriptases and cellular DNA 
polymerases.  From this study the only compound with notable bioactivity was 2.1, which was 
found to be a potent inhibitor of retroviral reverse transcriptases (i.e. of human 
immunodeficiency virus type 1, murine leukaemia virus and mouse mammary tumour virus) 
as well as cellular DNA polymerases (i.e. Escherichia coli DNA polymerase 1 and both α and 
β DNA polymerases).62  This promising bioactivity provided the rationale for the total 
syntheses of 2.1 by Kreipl et. al..63    
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Patil et. al. conducted a bioassay guided fractionation of a methanol extract of the ascidian 
Lissoclinum sp. that was collected from Aliwal Shoal, South Africa (indicated as B in Figure 
2.1) as part of a collaborative marine invertebrate collection by Rhodes University and 
SmithKline Beecham (now Glaxo SmithKline).64  This investigation targeted marine secondary 
metabolites inhibiting interleukin-8 (IL-8) receptors, and resulted in the isolation of the new 
lissoclin disulfoxide 2.4.   
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The role of IL-8 as a neutrophil granulocyte attractant and activator, links it to a number of 
inflammatory disorders such as rheumatoid arthritis and psoriasis.64  Lissoclin disulfoxide 
(2.4) showed good inhibition activity against both IL-8 Rα and IL-8 Rβ receptors (IC50 = 0.6 
μM and 0.82 μM respectively) as well as inhibitory activity against protein kinase C with an 
IC50 value of 1.54 μM.64  In addition to the isolation of 2.4, this South African ascidian also 
yielded three known cyclic polysulfides, namely N,N-dimethyl-5-(methylthio)varacin (2.5), and 
3,4-dimethoxy-6-(2’-N,N-dimethylaminoethyl)-5-(methylthio)benzotrithiane (2.6) [both isolated 
previously from Lissoclinum japonicum65] and varacin (2.7) first isolated form Lissoclinum 
vareau.64–66  
 
A group of acyclic amino alcohols were isolated as their acetate esters 2.8 – 2.11 from the 
ascidian Pseudodistoma sp. collected from the Tsitsikamma Marine Reserve, South Africa 
(labelled as point D in Figure 2.1).  The detergent-like saponification products of 2.8 – 2.11  
were proposed as being responsible for the anti-microbial activity observed for the 
Pseudodistoma sp. extract.41,67 
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A second group of acyclic amines were isolated from another South African Pseudodistoma 
species, this time from Algoa Bay, South Africa.  This ascidian was collected as part of a 
collaborative survey of the marine invertebrates and algae from the warm temperate coast of 
southern Africa by the Coral Reef Research foundation, the National Cancer Institute (USA) 
and Rhodes University.41,68  Bioassay guided fractionation led to the isolation of four new 
nitrogenous metabolites, pseudodistamine (2.12), the unsaturated aliphatic amines 2.13 and 
2.14 as well as the β-carboline alkaloid 2.15.68  The chemical structures of these compounds 
were elucidated using standard spectroscopic techniques and the absolute configuration of 
the single chiral centre in 2.12 was determined through preparation and NMR analysis of the 
Mosher’s ester derivative of this compound.  The absolute configuration of the chiral C-2 in 
the amines 2.13 and 2.14 were established after ozonolysis degradation to produce alanines 
which were further derivatised with Marfey’s reagent and compared to derivatised D- and L- 
alanine standards using LC-MS.68  Compounds 2.12 – 2.15 were all screened against the 
human tumour cell lines LOX (melanoma), A549 (non-small cell lung), SNB-19 (CNS) and 
OVCAR-3 (ovarian), however only 2.13  showed any cytotoxicity with an approximate IC50 
value of 6.0 µM across all cancer lines.68 
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The two most recent studies into the chemistry of South African ascidians were both 
conducted  by McPhail and co-workers, and involved ascidians from the same 2004 Algoa 
Bay collection (SAF2004) which has provided the ascidian material for this thesis.53,54  The 
first of McPhail and co-worker’s53 investigations focused on a new species of Lissoclinum 
collected from Algoa Bay, South Africa.  An organic extract of Lissoclinum sp. was shown to 
have potent cytotoxicity against lung cancer cells.53  Through bioactivity guided fractionation 
of this extract a series of glycosylated polyketide macrolides, mandelalides A-D (2.16 – 2.19) 
were isolated.23,53  The absolute configurations of the mandelalides were initially proposed 
from exhaustive NMR, and chiral GC-MS sugar analyses.53  Mandelalides A and B (2.16 and 
2.17) were bioassayed against mouse Neuro-2a neuroblastoma cells revealing IC50 values of 
29 nM and 84 nM respectively and human NCI-H460 lung cancer cells yielding IC50 values of 
12 nM and 44 nM respectively.53  These potent cytotoxicity results against two different 
cancer cell lines highlighted the mandelalides as a promising family of compounds for further 
biological evaluation. However, the limited amounts of these compounds isolated in the 
preliminary study were a hindrance to further investigations of the mechanism of cytoxicity.  
As the most active member of the mandelalide series much interest has been paid to 
developing a total synthesis of 2.16 and its aglycone fragment.69–71  The total synthesis of 
mandelalide A (2.16) by Willwacher et al. revealed small yet notable discrepancies between 
the NMR data of the synthetic, and natural occurring mandelelide A, most noticeably in terms 
of the  13C  chemical shifts of the C11 and C25 methyl carbons.70  Willwacher et al. proposed 
that the flexible nature of the macrocycle may mean that the key ROESY correlations are 
observed even with configurations differing from those proposed for 2.16 by McPhail and co-
workers.70  In an attempt to clarify the configurational debate emerging around the structure of 
mandelalide A, a C11-epimer of mandelalide A was prepared, however noticeable differences 
in the spectral data between this epimer and the original published data for 2.16 prompted 
Willwacher et al. to conclude that there were further subtle but profound errors in the initial 
structure reported for mandelalide A.70   
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Just two months later, Ye and co-workers71 reported another total synthesis of mandelalide A, 
this time including a reassignment of the stereochemistry of the macrolide moiety.71 Similar 
inconsistencies in NMR data (esp. the chemical shifts of C11 stereo-center and the attached 
C25 methyl) were observed by Ye and coworkers, prompting the synthesis of a series of 
diastereomers of 2.16 and comparison of the NMR data of the synthetic diastereomers with 
those obtained for the naturally occurring secondary metabolite. From these investigations it 
was established that the correct structure of mandelalide A is 2.20 in which there is an 
inversion of the configuration not only at C23 but also C21 and at the oxymethine carbons 
(C17 and C20)  of the tetrahydrofuran moiety when compared to the structure initially 
proposed for mandelalide A (2.16).23,71  Interestingly, McPhail’s original C11 S assignment 
was retained.71  Ye and co-workers ended their investigation by submitting the synthetic 
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mandelalide A (2.20) into a panel of ten cancer cell lines and curiously reporting that no 
significant cytotoxicity was observed.71  In order to unequivocally confirm the structure of 
mandelalide A, Ye and co-workers sent a small portion of synthetic 2.20 to Mcphail and co-
workers.  McPhail’s group compared the synthetic mandelalide A with its naturally occurring 
counterpart using CD, NMR, and HPLC profiling (with and without co-elution with the natural 
product) and confirmed that the true structure of mandelalide A is 2.20.72  Interestingly, 
McPhail also noticed a minor contaminant in the synthetic sample of 2.20 and thus purified 
the synthetic 2.20 before submitting it into the original bioassay against human NCI-H460 
lung cancer cells.  Once again potent cytotoxicity was observed.  McPhail postulates that the 
differences observed in bioactivity when 2.20 was tested by Ye and co-workers may be due in 
part to the impurity of the sample, as well as the type of activity tested i.e. mandelalide A may 
not be antiproliferative but rather cytotoxic to confluent cancer cells.72 
 
Finally, the most recent Algoa Bay ascidian to be investigated by McPhail and co-workers 
was the new species Synoicum globosum Parker-Nance, 2012.54  Four new brominated 
rubrolides (2.21 – 2.24) and two known rubrolides (2.25 and 2.26) were isolated via NMR-
guided fractionation of a dichloromethane/methanol extract of S. globosum.54  The rubrolides 
2.21-2.26 were found to exhibit varying antibacterial activity in a range of pathogenic anti-
bacterial assays.54 
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2.2  Screening techniques employed to identify nitrogenous metabolites in South    
African marine ascidians 
The screens chosen to identify bioactive marine natural products will inevitably focus on a 
particular property whether biological, physical or chemical which the metabolites contained in 
the crude extract must possess to be regarded as being “of interest”.  Our interest in the 
chemistry of ascidians was focussed on the ability of ascidians to selectively concentrate 
metal ions by a phenomenon that is little understood.  The initial aims of this study were to 
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attempt to detect intact organometallic complexes between nitrogenous marine natural 
products and selected metal ions in crude ascidian extracts and to also establish if metal 
concentration by ascidians was specific to certain taxonomic clades as opposed to the 
environment in which they may occur.  With these aims in mind the following screens were 
sequentially employed; a literature survey to establish potential nitrogenous natural product 
chemical scaffolds that may be produced by South African ascidian genera; an NMR based 
screen to detect the presence of nitrogenous metabolites due to the prevalence of 
nitrogenous moieties in metal chelators;30,47,73–75 the total metal concentration of both the 
intact ascidian and the organic extract to determine which ascidian species harboured high 
concentrations of metals which by their presence may indicate possible chelation 
opportunities; and finally a targeted LC-ICP-MS/ESI-MS investigation of selected South 
ascidian extracts deemed most likely to exhibit marine natural product metal chelation as a 
final conclusion to the preliminary screens described above.  
  
2.2.1 MarinLit database survey 
One of the most common difficulties for a natural products chemist when faced, as we were, 
with a sizeable and unique collection of marine organisms (the Algoa Bay ascidian collection 
contained 63 different ascidian specimens) is to determine which species to investigate with 
the greatest potential to yield new bioactive natural products.  Since there is a paucity of 
studies of the chemical diversity of the South African ascidian populations, choosing ascidian 
species for study based on previous studies of ascidian chemistry from the southern African 
region would have been futile.  However, many species in the same genus or family as those 
found in South African waters have been shown elsewhere around the world to produce a 
plethora of bioactive natural products, and so having an inventory of Algoa Bay ascidians 
(identified to the genus level) in hand an investigation of the contemporary global ascidian 
marine natural product literature was deemed a good starting point towards determining 
South African species most likely to produce natural products of interest.2,31   
 
The marine natural products data base MarinLit76 was utilised as an aid in the review of 
compounds isolated from particular ascidian genera.  Care had to be taken during this survey 
as the taxonomy of ascidians is often changing with new techniques e.g. genomics being 
employed to add phylogenetic rigour to the more traditional taxonomic identification of 
ascidians based on consideration of morphological features only.  The ongoing evolution of 
taxonomic methodology ensures continual renaming and reclassification of species, genera, 
or even families of ascidians even after literature publication under their previously associated 
synonym.  In order to ensure a thorough analysis of the ascidian literature, all known 
synonyms obtained from the Ascidiacea World Database77 were investigated, and 
incorporated into the set of results obtained for the modern classification of the genera.  
Figure 2.2 is a summary of the results obtained from the MarinLit survey.  The ascidian 
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genera investigated are those reported to have species present in South Africa, these genera 
were grouped in to their parent suborders and families.  In the case of some very prominent 
and well documented families, the remaining genera which are common in other locations, 
but not represented in South Africa were grouped under the title “other”.  For each genus 
surveyed the total number of publications listed in MarinLit were accounted for, and presented 
as either “MNP isolation papers” (show in blue in Figure 2.2), which report on the initial 
isolation and elucidation of ascidian marine natural products (MNP), or “non-MNP isolation 
papers” (shown in red in Figure 2.2) which document subsequent studies or reviews on the 
clinical, biological, ecological, synthetic, or stereochemistry or absolute configurations of 
ascidian metabolites.  The second data set shown in Figure 2.2 depicts the number of 
isolated natural products contained in the MarinLit database that were related to each genus 
studied.  These isolated natural products were further classed into two subsets, namely 
“nitrogenous compounds” shown in green, and “non-nitrogenous compounds” shown in 
purple.  The reasoning behind this was because the initial aim of this thesis was to detect and 
isolate potential metal chelators from ascidians hence ascidians known to produce 
predominantly nitrogenous metabolites were of great interest due to the possible metal 
binding potential of their alkaloids.30,47,73–75   
 
On initial review of these data obtained from the MarinLit survey it was obvious that some 
ascidian genera had markedly larger counts of papers and compounds published.  Taken on 
face-value these results would imply that ascidians in these ‘popular’ genera are prolific 
producers of new secondary metabolites, however these high numbers should be treated with 
circumspection as they may rather reflect either a larger number of species in a particular 
genus or the accessibility, or even preferences, of different species to individual research 
groups which would bias their collection and further chemical investigations. Similarly, genera 
boasting a long history of study would also inevitably result in a larger publication output and 
thus record of isolated metabolites.  Most importantly, the interpretation of Figure 2.2 should 
not ignore other less ‘popular’ genera whose chemical diversity is yet to be fully explored.  In 
an attempt to account for the large discrepancies in the numbers recorded between well 
studied and less studied genera, Figure 2.2 contains two differently scaled axes.  The axis at 
the bottom of Figure 2.2, running from left to right, relates to genera with a larger number of 
publication and/or compounds associated with it in MarinLit, whilst the axis at the top of 
Figure 2.2, running from right to left, accounts for the genera with a publication or compound 
count that is lower than twenty and is scaled so that differences between these genera can be 
compared more readily.   
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The MarinLit survey results displayed in Figure 2.2 were used to determine which ascidians 
from the South African collection were more likely to afford nitrogenous secondary 
metabolites in the screening protocols that followed this initial literature survey.  Figure 2.2 
shows that the MarinLit ascidian results are dominated by the suborder Aplousobranchia 
which is also the most well represented ascidian suborder in the waters off South Africa.78  
Not surprisingly the majority of the species chosen for screening were members of this 
suborder.  The Aplousobranch genera that dominate the chemical literature (>100 
publications or isolated secondary metabolites) include Didemun, Lissoclinum, Eudistoma, 
and Aplidium.  These genera are well represented in South Africa and were an obvious 
choice to be included in our further screens.  Aplousobranch genera such as Clavelina, 
Trididemnum, Cystodytes, Synoicum and Pseudodistoma produced moderate results (> 30 
publications or isolated secondary metabolites), and because nitrogenous metabolites 
isolated dominated the secondary metabolite profiles of these genera they were also included 
in our further screens.  The genera Ritterella, Ascidia, Ecteinascidia, and Halocynthia were 
not well represented in Algoa Bay, and so were excluded from the screens. 
 
Conversely even though the genera Pycnoclavella, Atriolum, Distaplia, Hypodistoma, Sigillina, 
Aplidiopsis and Botryllus were the subject of only a few studies (<10) from the MarinLit survey 
(Figure 2.2), they are reasonably abundant in Algoa Bay and alkaloids dominate the 
secondary metabolites reported from these genera.  Finally, the ascidian genera Hypodistoma 
and Gynandrocarpa had no records in MarinLit, and so would normally have been overlooked 
however the species Hypodistoma vastum and Gynandrocarpa placenta are very common 
species in Algoa Bay, and so were also included on the off chance that they would prove to 
be new reservoirs of nitrogenous secondary metabolites.  The ascidian extracts subjected to 
further screening are listed in Table 2.1 together with the summarised screening results for 
these extracts.  
  
2.2.2 1H-15N HMBC NMR Screening 
The first screen that was carried out, to confirm the presence of nitrogenous metabolites, was 
a general 1H-15N gHMBC NMR screen of the 20 ascidians selected from the results of the 
MarinLit survey.  One of the aims of this thesis study was to detect and isolate potential metal 
chelators in ascidian extracts.  Since nitrogeneous metabolites have previously been shown 
to complex with metals, a screen focused on highlighting ascidians whose extracts were rich 
in these metabolites was deemed appropriate.30,47,73–75  The most efficient and cost effective 
method to detect nitrogen containing metabolites in a crude marine extract is LC-MS.79  
Unfortunately, the dearth of mass spectrometry facilities at Rhodes University was a 
significant challenge for our initial screening programme and was rectified later in the 
programme through collaboration with Professor Marcel Jaspars at the Marine Biodiscovery 
Centre at the University of Aberdeen. Fortuitously, in the period before being able to access 
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the MS facilities at the University of Aberdeen our research group had relatively unlimited 
access to the Rhodes University 600 MHz NMR, which was underutilised at the time when 
our screening programme was embarked upon, and hence a protocol was set up to employ 
this high powered analytical instrument for the detection of nitrogenous metabolites in crude 
ascidian extracts. 
Table 2.1: Results from the screening of South African ascidian crude extracts.  1H-15N 
HMBC values are the numbers of distinct correlations observed.  Tick marks indicate ascidian 
extracts where total metal analysis was conducted.  Elements that produced significant peaks 
in the LC-ICP-MS/ESI-MS analysis are recorded. (The presence of a “–“ indicates that the 
corresponding screen was not run on that particular ascidian sample)  
Algoa Bay Ascidians Hits in Screens 
Suborder Family Species name Sample Code 
1H-15N 
HMBC 
ICP-MS LC-ICP-MS/ESI-MS 
Aplousobranchia Clavelinidae Clavelina steenbrasensis TIC2011-036 -  - 
  
Pycnoclavella filamentosa SAF2004-058 1  51V, 75As, 79Br, 127I 
  
Pycnoclavella narcissus TIC2011-005 -  - 
 
Didemnidae Atriolum marinense SAF2004-043 3  127I 
  
Didemnum leopardi SAF2004-044 0  - 
  
Didemnum sp.1 SAF2004-065 5  63Cu, 75As, 79Br, 127I 
  
Didemnum sp.2 SAF2004-061 5  63Cu, 77Se, 79Br, 127I 
  
Didemnum sp.3  SAF2004-031 2 - - 
  Didemnum sp.4 SAF2004-071 4 - - 
  
Lissoclinum sp. nov. TIC2011-035 -  - 
  
Trididemnum cerebriforme TIC2011-018 -  - 
  
Leptoclinides sp.   SAF2004-015 2  51V, 75As, 79Br, 127I 
 
Holozoidae Distaplia skoogi SAF2004-030 2  51V, 75As, 79Br, 95Mo, 127I 
  
Hypodistoma vastum SAF2004-012 0  - 
  
Sigillina sp. SAF2004-051 2  51V, 63Cu, 75As, 79Br, 127I 
 
Polyclinidae Aplidiopsis tubiferus SAF2004-038 3  75As, 79Br, 95Mo 
  
Synoicum sp. TIC2011-027 -  63Cu, 75As, 79Br, 127I 
  
Aplidium sp.1 SAF2004-039 3  51V, 59Co, 63Cu, 75As, 79Br, 127I 
  
Aplidium monile TIC2011-032 -  51V, 75As, 79Br, 127I 
 
Polycitoridae Polycitor sp. nov. SAF2004-068 4  75As, 79Br, 127I 
  
Eudistoma sp.1  SAF2004-028 2  51V, 59Co, 63Cu, 75As, 79Br, 127I 
  
Eudistoma sp.2 SAF2004-037 3  - 
 
Pseudodistomid
ae 
Pseudodistoma sp.1 SAF2004-019 3  - 
  
Pseudodistoma sp.2  SAF2004-022 1  - 
  
Pseudodistoma sp.3 SAF2004-062 4  - 
Stolidobranchia Styelidae Botryllus sp. TIC2011-026 -  - 
 
Polyzoinae Gynandrocarpa placenta SAF2004-010 3  - 
 
Although both 14N and 15N exhibit nuclear magnetic moments (0.14 μ and -0.10 μ 
respectively), a crucial property for NMR analysis, the naturally abundant isotope, 14N 
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(99.6%), has a spin quantum number of I = 1 and is therefore susceptible to quadrupolar 
relaxation resulting in the generation of broad and mostly unhelpful NMR signals.80  However, 
the spin quantum number of 15N is I = ½ resulting in a symmetrical, spherical charge 
distribution which is a more desirable property for an NMR investigation.  However, the 
natural abundance of 15N is only 0.4% and this characteristic coupled with a low relative 
magnetic moment makes the detection of non-15N-enriched metabolites through conventional 
1D NMR experiments impractical.  Fortunately, the increase in sensitivity seen with the 
advent of inverse detection 2D NMR experiments i.e. indirect detection of a heteronucleus 
through the proton channel, has allowed the detection of 15N without isotope labelling.80  The 
2D NMR experiment chosen for this screen was the heteronuclear multiple bond correlation 
(HMBC) capable of detecting 2J and 3J correlations between 1H-15N.  Information obtained 
through analysis of HMBC data was believed to be more useful than that which would have 
resulted from analysis through the 1H-15N heteronuclear single quantum coherence (HSQC) 
experiments due to the potential of the HMBC experiment to detect primary, secondary and 
tertiary nitrogen moieties.  The pulse program used was the same as that which would be 
employed for a standard 1H-13C gHMBC experiment, i.e. Bruker Topspin hmbcgplpndqf,81 
except that the second acquisition constant (CNST2) was changed from 145 Hz to 90 Hz 
which corrects the differences in coupling constant for the heteronucleus changing from 
carbon to nitrogen.  The first and third gradient parameters were also corrected to 70% and 
50.1% respectively.81  Since the chemical shifts of the nitrogen resonances were unknown, a 
broad sweep width of 650 ppm was set and centred at O2= 200 ppm.        
The combined results of the 1H-15N HMBC NMR screens of all 20 ascidian extracts are 
presented in Figure 2.3 as a single HMBC plot with all the individual ascidian extract 1H-15N 
HMBC NMR experiments overlaying each other allowing common correlations to appear 
more intense.  The numbers of significant 15N HMBC correlations, determined through the use 
of Bruker’s Topspin oblique view,81 are recorded in Table 2.1.  Of the 20 ascidian extracts 
entered into this screen, only three extracts, namely SAF2004-044, SAF2004-012 and 
SAF2004-039, did not produce any significant 1H-15N HMBC correlations.  Interestingly, 
thirteen ascidian extracts produced a pattern of common correlations from the proton 
resonances at δH 2.73 and 3.16 ppm to the nitrogen chemical shifts 36.9 and 51.3 ppm 
respectively, and within this set of ascidians, eleven extracts produced a third common 
correlation between δH 4.27 and δN 196.3 (Figure 2.3).   
 
This pattern of correlations was initially proposed to be produced by a common guanidine 
[HNC(NH2)2] containing metabolite which would produce three distinct 15N resonances.  
Ascidians have been found to be fairly prevalent producers of guanidine metabolites82,83 
however all attempts to isolate and characterise a metabolite of this class from the ascidian 
extracts under investigation were unsuccessful.  The two common shielded correlations with 
proton resonances in the methylene window may also be attributed to aliphatic amines which 
are also fairly ubiquitous in the marine environment.67,68   
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Figure 2.3: A region (F1 = δ 0.0-9.0 ppm; F2 = δ 0-400 ppm) of the stacked 1H-15N gHMBC 
spectra (DMSO-d6, 600 MHz) obtained for the 20 crude extracts of South African ascidians. 
The accompanying circles highlight the common correlations detected in most extracts.  
2.2.3 Total Metal Ion Concentration Analysis 
Following analysis of the data generated through the 1H-15N gHMBC NMR screen a 
subsequent collection of ascidians belonging to our selected South African genera of interest 
was made.  The combined sample set from both collections was entered into the second 
investigation in which the total metal ion concentrations were established via ICP-MS.  The 
ascidians collected after the 1H-15N gHMBC NMR screen were distinguished by the sample 
code prefix TIC2011.  The results from the total metal concentration analyses are presented 
in depth in Chapter 3.  The ICP-MS total metal analysis results obtained after nitric acid 
digestion of the organic extracts of each ascidian are presented in Figure 2.4.  The metal 
concentrations are reported in mg of metal per kg of organic extract.  Based on these metal 
concentrations thirteen ascidian extracts were chosen for further speciation analysis. 
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2.2.4 Speciation Analysis 
Speciation studies were carried out on thirteen of the ascidian extracts which were flagged 
due to high levels of metals detected through total metal concentration analysis.  The 
assumption we made was that the opportunity of detecting chelated species was greater in 
ascidians with high concentrations of metal ions.  The speciation study utilised the unique 
arrangement of analytical equipment, present at the Marine Biodiscovery Centre (MBC) at the 
University of Aberdeen, which incorporated reversed-phase liquid chromatography (LC) with 
the parallel detection systems of inductively coupled plasma mass spectrometry (ICP-MS) 
and electrospray ionisation mass spectroscopy (ESI-MS).  Jaspars and co-workers at MBC 
have reported success in the detection of metal and metalloid complexes through the use of 
LC-ICP-MS/ESI-MS (Figure 2.5).45–47,75,84–90  The brief overview of this powerful analytical 
technique follows.  
 
a)  
b)  
Figure 2.5: Schematic diagram of the hyphenated LC-ICP-MS/ESI-MS technique (a) and the 
LC-ICP-MS/ESI-MS instrumentation used by the author in the Marine Biodiscovery Centre of 
Aberdeen University (b).  
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Inductively coupled plasma mass spectrometry (ICP-MS) is a popular analytical technique 
used to determine the elemental (metal ion) content of biological samples.  ICP-MS has the 
capacity to measure multiple elements concurrently to an impressive part-per-billion (ppb) 
level of sensitivity.75  However, this technique results in the complete destruction, atomisation 
and ionisation of the analytes making it an inherently elemental analysis technique and alone 
cannot give information regarding intact organic molecules for example incorporated in 
organo-metalic complexes. Liquid chromatography (LC) provides an opportunity to separate 
the organic components in complex matrices based on the varying retention times of different 
organic compounds on a particular chromatography column. If suitable standards are 
available the presence and concentrations of known compounds in biological samples can be 
determined directly from equivalent LC retention times.  However, when dealing with crude 
extracts containing unknown and possibly novel secondary metabolites, where standards are 
not available, no conclusive molecular identifications of organo-metallic complexes can be 
made by coupling LC to ICP  (LC-ICP-MS).75 
 
Obtaining molecular information is essential for the determination of organo-metallic 
complexes that may be present in crude biological extracts.  Electrospray ionisation mass 
spectrometry (ESI-MS) is a soft ionisation technique which is capable of ionising even 
unstable compounds and complexes without fragmentation.75  ESI-MS may also be coupled 
with HPLC which aids in the identification of metabolites through chromatographic separation.  
When working with crude biological extracts it is difficult to identify possible metal containing 
complexes, as often one is searching blind, without prior knowledge of the polarity or mass 
signature of the complex.75 
 
If these two powerful analytical techniques are used in parallel, invaluable elemental and 
molecular information is obtained.  Using one HPLC system whose eluent is split between the 
ICP-MS and the ESI-MS ensures that the separated metabolites are analysed by both 
techniques simultaneously and has the added benefit of modifying the chromatography 
system to suit the properties of the analytes.75  The LC-ICP-MS data pinpoints the retention 
times at which the elements of interest are found, whilst analysis of the ESI mass spectra 
produced at these retention times provides the crucial molecular information necessary in 
determining the structure of the compounds that may be associated with these elements i.e. 
as metal containing complexes.75      
 
A common chromatography system used in the ESI-MS analyses of natural crude extracts is 
reversed-phase HPLC using methanolic solvent systems which offer effective solubility of a 
wide range of secondary metabolites and provide the solvent volatilty necessary for ESI-MS 
analysis.75  The successful use of reversed-phase chromatography in parallel with ICP-MS 
and ESI-MS has been reported by the University of Aberdeen group in a number of studies in 
which arsenic containing biomolecules have been identified from a variety of sources 
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including cabbage, whelks, capelin fish and brown alga.84–87  The covalent C-As  bonds within 
these organo-arsenic compounds add stability and so they are not as likely to dissociate 
when exposed to reversed-phase (RP) chromatography as do metal chelates.75  The 
detection of intact plant phytochelatin complexes with arsenic and mercury exposed to 
reversed-phase LC-ICP-MS/ESI-MS is a promising result showing that at least some 
biological metalloid and metal complexes are stable enough for detection through harsh 
reversed-phase chromatography.88,89   
 
The first ascidian extract to be investigated by the Jaspars group using LC-ICP-MS/ESI-MS 
was Lissoclinum patella.  L. patella afforded the cyclic peptides patellamides which have been 
shown through circular dichroism studies to complex copper.45,46,73,90  In order to ensure that 
the copper complexes did not dissociate on chromatography Jaspars and co-workers ustilised 
a poly(methyl methacrylate) size-exclusion chromatography (SEC) column which reduced 
dissociation because there is little interaction between the analyte and the stationary phase.75   
Copper-patellamide complexes were successfully observed using SEC-ICP-MS/ESI-MS in an 
extract of L. patella that was spiked with copper however when the extract on its own, without 
the copper doping, was analysed no complexes were detected implying that these 
patellamides are not in fact complexed with copper in the ascidian.75  Since this investigation 
involved previously established metal complexes it was a good starting point for the method 
development of SEC-ICP-MS/ESI-MS analyses of crude ascidian extracts.   
 
Jaspars and co-workers subsequently used SEC-ICP-MS/ESI-MS to investigate a crude 
extract of the ascidian Eudistoma gilboviride which was found, through total metal 
concentration data, to contain high levels of iron.  The data produced through SEC-ICP-
MS/ESI-MS analysis revealed peaks at the same retention times in both the iron and bromine 
ICP-MS traces.  Analysis of the ESI mass spectra recorded at these retention times identified 
a series of complexes involving Fe(II) and eudistomin H (2.27) and its analogues.47  The 
authors state that although detection of intact iron complexes in the crude extract of E. 
gilboviride was successful, it is still not definitive proof that these complexes occur in the living 
ascidian, as there is a possibility that these complexes formed during the extraction process.47  
The successful SEC-ICP-MS/ESI-MS analysis of extracts of L. patella and E. gilboviride 
without dissociation of the metal complexes is a testament to the capabilities of SEC 
chromatography over RP chromatography.  However, the negative aspect of using this SEC 
column is that without a customised buffered solvent system hydrophilic sites along the 
stationary phase result in chelate dissociation and prolonged retention of analytes.75  The 
solvent system that was employed for the L. patella and E. gilboviride studies was accordingly 
50 nM trimethylamine carbonate buffer at pH 8.8, which successfully eluted the majority of the 
metal complexes intact.  The metal complexes that were retained on the column were 
subsequently eluted with a formic acid and methanol solvent system fortunately with marginal 
observed dissociation.47,75 
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The trimethylamine buffer used by Wright et al. is unfortunately very unpleasant to work with 
due to a distasteful odour reminiscent of rotting fish.  This property, along with the need for 
two separate solvent systems to ensure the complete elution of all metabolites, means that 
the use of a SEC column for the speciation of more than one ascidian extract is not practical, 
and to this end our investigation comprised of reversed-phase LC-ICP-MS/ESI-MS analysis.  
Any promising extract data obtained through this speciation analysis would be considered for 
subsequent SEC-ICP-MS/ESI-MS analysis. 
 
For the speciation of the thirteen South African ascidian extracts the ICP-MS analyses 
focused specifically on the detection of V (m/z 51), Mn (m/z 55) Fe (m/z 57), Co (m/z 59), Cu 
(m/z 63), Zn (m/z 66), As (m/z 75), Se (m/z 77), Br (m/z 79), Mo (m/z 95) and I (m/z 127), 
whilst the ESI-MS simultaneously obtained mass data to aid in the identification of organic 
substituents.  Ascidian crude extracts were prepared at Rhodes University following an 
established procedure (documented in Chapter 6) developed by Jaspars and co-workers in 
order to minimise metal contamination.  Table 2.1 summarises the elements which were 
detected and produced peaks in the ICP-MS traces obtained from each ascidian extract.  
Unfortunately, although metals were detected in the LC-ICP-MS traces of a number of 
ascidian extracts the peaks produced were of low intensity, and were often insufficiently 
resolved to be considered for SEC-ICP-MS/ESI-MS analysis.  Attempts were made to identify 
possible metal containing complexes at the retention times where metal ions detected by ICP-
MS were coincident with the retention times of metabolites revealed by ESI-MS. However, 
because enhanced dissociation was increasingly likely following exposure to reversed-phase 
chromatography conditions, any organometallic complexes that had survived were potentially 
at very low concentrations thus resulting in small MS peaks which are always difficult to 
detect due to higher noise levels at low concentrations.  During the LC-ICP-MS/ESI-MS 
analyses it soon became evident that this parallel mass analysis technique was particularly 
useful for identifying halogen (Br, I) containing secondary metabolites in the crude ascidian 
mixtures.  Examples of these analyses are documented in the following section of this 
chapter. 
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2.3 Further analysis of selected ascidian extracts containing halogenated    
nitrogenous secondary metabolites 
The following ascidian extracts produced promising results in the preliminary 1H-15N gHMBC 
NMR and LC-ICP-MS/ESI-MS screens, and were worked up accordingly when sufficient 
ascidian material was available to isolate the halogenated compounds.  Where insufficient  
ascidian material was available to isolate the halogenated metabolites the screening results 
are noted, and potential ascidian extracts for further study are highlighted.  
 
2.3.1 Distaplia skoogi - SAF2004-030 
Specimen SAF2004-030 was a colony of the cream colour morph of Distaplia skoogi 
Michaelsen, 1934,49,50 Aplousobranchia: Holozoidae,49 (Figure 2.6). The ascidian Distaplia 
skoogi was collected using SCUBA at a depth of 25 m in White Sands, Algoa Bay, South 
Africa, in July 2004, and kept frozen until extraction.   
 
          
Figure 2.6: Distaplia skoogi, collection specimen SAF2004-030 (left) and photographed at 
White Sands, Algoa Bay, South Africa (right, photograph by Dr. A. Oosthuizen). 
 
2.3.1.1  Results from the 15N HMBC screen 
The ascidians SAF2004-030 (Distaplia skoogi) and SAF2004-051 (Sigillina sp.) are both from 
the family Holozoidae and their crude extracts both revealed distinct correlations from 
aromatic proton resonances (δH 7.25- 7.55) to nitrogenous functionalities (δN 20- 35) in the 
15N HMBC screen.  Figure 2.7 depicts a region (F1 = δ 0.0-9.0 ppm; F2 = δ 0-200 ppm) of the 
15N HMBC spectrum obtained for the crude extract of D.skoogi clearly showing the 
correlations that flagged this extract for further study.   
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Figure 2.7: A region (F1 = δ 0.0-9.0 ppm; F2 = δ 0-200 ppm) of the 15N HMBC spectrum 
(DMSO d-6, 600 MHz) obtained for the crude extract of D. skoogi. 
 
2.3.1.2  Results from the LC-ICP-MS/ES-MS screen 
Inspection of the LC-ICP-MS/ESI-MS data obtained for the crude extract of D. skoogi 
indicated the presence of relatively high levels of iodine, molybdenum, bromine, arsenic and 
vanadium in the extract (Figure 2.8).  The intensities of the peaks found in the bromine (m/z 
79) ICP-MS trace were markedly stronger that those observed for the other elements 
detected, suggesting the presence of significant amounts of one or more brominated 
metabolites and provided the rationale to continue and isolate and identify these brominated 
metabolites from the extract. 
 
Figure 2.9 is a summary of the analysis of the LC-ICP-MS/ESI-MS data obtained for the crude 
extract of D. skoogi and reveals how this analysis was utilised to detect the presence of 
brominated metabolites.  The bromine (m/z 79) ICP-MS trace is depicted in red, and the ESI-
MS extracted ion chromatograms (EIC) of the brominated metabolites detected at selected 
retention times are shown in black [Figure 2.9(a)].  The ESI-MS spectra observed at selected 
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retention times coincident with the retention times of bromine peaks in the ICP-MS mass 
spectra are displayed in Figure 2.9(b).   
 
Figure 2.8: Selected LC-ICP-MS traces obtained for SAF04-030 (127I blue trace, 95Mo purple 
trace, 79Br red trace, 75As green trace and 51V orange trace).  Traces are vertically offset for 
clarity 
The peak at retention time (TR) 14.40 min in the bromine ICP-MS trace strongly overlaps with 
the ESI-MS EIC for m/z 211.9707 indicative of a brominated metabolite with this TR in LC-
ESI-MS.  The ESI-MS mass spectrum at this TR [14.40 min, Figure 2.9b)(i)] contained the ion 
cluster m/z 211.9706, 213.9686 in a 1:1 ratio which is characteristic of a monobrominated 
compound.  The best fit simulation91 resulted in the potential molecular formula of 
C8H7ON79Br [(M+H)+ ∆ 0.2 mmu] which was confirmed after isolation and structure elucidation 
(Section 2.3.1.3) to correspond to the bromo-oxindole 2.28. 
 
The major peak observed at TR 17.13 min in the LC-Br-ICP-MS trace overlapped perfectly 
with the peak occurring at equivalent TR in the LC-ESI-MS chromatogram which afforded a 
dominant ion cluster of m/z 589.9687, 591.9662, 593.9640 in a 1:2:1 ratio indicative of a 
dibrominated compound [Figure 2.9(b)(ii)].  Unfortunately attempts to isolate and identify this 
compound were unsuccessful.  A point to note for possible further study is that at this TR 
(17.13 min) peaks were observed in both the iodine (m/z 127) and molybdenum (m/z 95) ICP-
MS traces obtained for D.skoogi (Figure 2.9).  The intensities of these peaks were lower than 
that detected for bromine (m/z 79), however they may still imply a compound or number of 
compounds containing iodine, molybdenum and bromine.   
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Figure 2.9: Halogenated metabolites detected in SAF04-030 extract by LC-ICP-MS/ESI-MS. 
a) Selected ICP-MS and ESI-MS EICs; b) ESI mass spectra and structures for (i) 2.28 at TR 
14.40 min, (ii) unidentified dibrominated compound at TR 17.13 min, and (iii) 2.29 at TR 19.50 
min detected in ESIMS negative ion mode. 
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The third peak investigated in the Br-ICP-MS trace of D. skoogi had a TR of 19.50 min.  
Attempts to obtain an extracted ion chromatogram (EIC) which overlapped with the Br-ICP-
MS chromatogram were only successful in ESI in the negative ion mode.  The negative ion 
ESI-MS EIC for m/z 272, was a good fit, and related to the ESI mass spectrum containing the 
1:2:1 ratio isotope pattern at m/z 271.8735, 273.8715, 275.8694 suggesting the presence of a 
dibrominated metabolite [Figure 2.9(b)(iii)].  The [(M-H)-] ion simulation91 calculated for 
C8H4N79Br2 (∆ 3.0 mmu) resulted in the closest fit to the experimental data.  The structure of 
this compound was later confirmed after isolation and structure elucidation to be 3,6-
dibromoindole (2.29, Section 2.3.1.3).  
 
2.3.1.3  Isolation and structure elucidation of 2.28, 2.29 and 2.30 
Due to the promising screening results, a larger portion of D. skoogi (SAF2004-030) was 
lyophilised and sequentially extracted with methanol followed by dichloromethane.  The 
combined organic extracts were concentrated under reduced pressure before being subjected 
to a liquid-liquid partitioning between ethyl acetate and water.  The nonpolar ethyl acetate 
partition was subjected to extensive normal phase DIOL HPLC, shown in Scheme 2.1, to yield 
the known compounds 6-bromo-2-oxindole (2.28), 3,6-dibromoindole (2.29), and 6-bromo-3-
chloroindole (2.30). 
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The oxindole 2.28 was isolated as colourless needles with a melting point range of 216 - 219 
°C.  The molecular formula of 2.28 was established as C8H6NO79Br from HRESIMS, m/z 
211.9710 (∆ 0.4 mmu) which implied six degrees of unsaturation.  The IR spectrum contained 
a characteristic carbonyl band at 1643 cm-1, as well as a strong band at 3435 cm-1, indicating 
the possible presence of an amide.80  The presence of a carbonyl moiety was further 
supported by a deshielded 13C NMR resonance (δC 176.4) and thus accounted for one of the 
six double bond equivalents required by the molecular formula.  The 13C NMR spectrum also 
showed the presence of three aromatic methines (δC 126.0, 125.3 and 112.9), three aromatic 
quaternary carbon signals (δC 143.4, 124.0, 121.3) as well as a methylene carbon (δC 35.6), 
suggesting a monosubstituted bromo-oxindole chemical structure for 2.28 (Figure 2.10).  
Correlations observed in a 2-dimentional COSY NMR experiment between the aromatic 
protons δH 7.16 and 7.08 (J = 7.9 Hz) and the long range correlation between δH 7.16 and 
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7.03 (J = 1.5 Hz) suggested that the oxindole system was brominated at position 6 (Figure 
2.11).  
Distaplia skoogi 
methanol/dichloromethane extract
Liquid-liquid partitioning between
EtOAc and H2O.
EtOAc fraction
DIOL HLPC 
(40% EtOAc/Hexane)
Fn 1 Fn 2 Fn 3 Fn 4
Fn 6 Fn 7-10
DIOL HPLC 
(60% CH2Cl2/Hexane)
H2O fraction
Fn 5
DIOL HPLC 
(20% CH2Cl2/Hexane)
Fn 11 Fn 14
DIOL plug
(10% EtOAc/Hexane)
recrystalised from hexane
2.28
2.292.30
Scheme 2.1: Chromatography protocol used to isolate 2.28-2.30 from Distaplia skoogi
  
 
 
The distinctive, approximately 1:1 protonated molecular ion [(M+H)+] isotope pattern [(m/z 214 
(100), 212 (97)] in the ESI mass spectrum confirmed this substituent to be bromine.  The 2J 
and 3J gHMBC correlations acquired for 2.28 (Table 2.2) unequivocally supported the 
proposed structure for 2.28. 
 
The oxindole 2.28 is commercially available92 and has also been detected, using GC/MS, in 
extracts of the marine murex molluscs Plicopurpura patula and Plicopurpura columellaris 
(Mollusca: Gastropoda).93  The presence of the same secondary metabolite in marine 
organisms from different phyla may indicate a common symbiotic microbial source  for 
2.28.94–96 
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Figure 2.10: 1H (600 MHz, CDCl3) and 13C (150 MHz, CDCl3) NMR spectra obtained for the 
oxindole 2.28. 
 
 
Figure 2.11: A region of the COSY spectra (F1 = 6.7 – 7.5 ppm) obtained for 2.28.  The 
accompanying structure illustrates the 3J and 4J COSY correlations used to determine the 
position of the bromine substituent.  
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Table 2.2: 1H (CDCl3, 600 MHz), 13C (CDCl3, 150 MHz) and 2D NMR data obtained for 2.28 
Position   δC ppm 
δH ppm 
(int., mult., J/Hz) COSY HMBCa 
1 - 7.76 (1H, br. s) 
2 176.4 - 
3 35.6 3.48 (2H, s) H-4, H-5, H-7 C-2, C-3a, C-4, C-6, C-7, C-7a
3a 124.0 - 
4 126.0 7.08 (1H, d, 7.9) H2-3, H-5 C-3, C-6, C-7a 
5 125.3 7.16 (1H, dd, 7.9, 1.5) H2-3, H-4, H-7 C-3a, C-7 
6 121.3 - 
7 112.9 7.03 (1H, d, 1.5) H2-3, H-5 C-3a, C-5, C-6 
7a   143.4 -     
a HMBC correlations are from the proton(s) stated to the indicated carbon. 
 
 
Spectroscopic data (MS, NMR and IR) obtained for 2.29 were consistent with data reported 
for this compound, isolated from the ascidian Distaplia regina collected in Malakal Harbour, 
Palau.97 The molecular formula of 6-bromo-3-chloroindole (2.30) was established as 
C8H5N79Br35Cl from the appearance the deprotonated molecular ion [(M-H)-] at m/z 227.9215 
(∆ 0.1 mmu) in the negative ion HRESIMS.  A strong band at 3445 cm-1 in the IR spectrum 
was characteristic of a N-H stretching absorption.80  The 13C NMR and DEPT 135 spectra 
showed the presence of four aromatic methines (δC 123.9, 121.4, 119.7 and 114.4) and four 
quaternary carbons (δC 135.7, 124.4, 116.8, and 107.0) with typical heteroaromatic shifts, 
suggestive of a disubstituted indole system, which would account for the six degrees of 
unsaturation implied by the molecular formula.  The IR spectrum also showed a band at 737 
cm-1 suggesting that the indole ring was halogenated.80  That this halogenation comprised 
both bromine and chlorine substituents was further supported by the presence of 
characteristic isotope peaks at m/z 228, 230, 232 [(M-H)-] in a 3:4:1 ratio in the ESI mass 
spectrum of 2.30.  Assignment of the 13C chemical shifts of the two halogenated carbons in 3 
was provided from a combination of gHMBC, HSQC and COSY NMR experiments.  The 
position of the bromine and chlorine substituents at C-6 and C-3 on the indole ring in 2.30 
was determined by initially comparing the 13C chemical shift data of 2.30 with those of 2.29 
(Table 2.3).  The chemical shift of C-6 in 3 (δC 116.8) was consistent with that of C-6 in 2.29 
(δC 116.8), while the downfield shift of C-3 (δC 107.0) in 3 compared to that of C-3 in 2.29 (δC 
91.9) placed the chlorine substituent at this position in 2.30. 
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Table 2.3: 1H (600 MHz, CDCl3) and 13C (150 MHz, CDCl3) NMR data obtained for 
compounds 2.29 and 2.30. 
  2.29  2.30 
Position 
 
δC ppm 
δH ppm  
(int., mult., J/Hz) 
 
δC ppm 
δH ppm 
(int., mult., J/Hz) 
1  - 8.20 (1H, br. s)  - 8.08 (1H, br. s) 
2  123.9 7.21 (1H, d, 2.6)  121.4 7.16 (1H, d, 2.6) 
3  91.9  107.0 
3a  125.9  124.4 
4  120.5 7.44 (1H, d, 8.3)  119.7 7.50 (1H, d, 8.3) 
5  124.0 7.31 (1H, dd, 8.3, 1.5)  123.9 7.30 (1H, dd, 8.3, 1.5) 
6  116.8  116.8 
7  114.3 7.54 (1H, d, 1.5)  114.4 7.53 (1H, d, 1.5) 
7a  136.0  135.7 
 
3-Chloro-6-bromoindole has not previously been isolated from an ascidian species, however, 
it has been shown to be produced, along with compound 2.29, by the marine acorn worms 
Ptychodera flava laysanica and Ptychodera flavaI.98,99 Ascidians (Urochordata: Ascidiacea) 
and acorn worms (Hemichordata: Enteropneusta) are both marine detritus filter feeders, but 
phylogenetic analyses of the deuterostome phyla supported by cladistics analysis of 
morphological data confirms that these groups belong to two different clades.100,101  Therefore 
the occurrence of compounds 2.29 and 2.30 in marine organisms from different phyla would 
again possibly suggest a common symbiotic marine microbial source for 2.29 and 2.30.94–96  
 
As part of our on-going investigation of the cytotoxicity of South African marine invertebrate 
and algal natural products to various cancer cell lines, 2.28-2.30 were screened against the 
metastatic MDA-MB-231 breast cancer cell line.102,103  The IC50 values observed for 2.28-2.30 
were 74.4 µM, 117.7 µM, 72.5 µM and respectively, indicating that these compounds are 
marginally cytotoxic to MDA-MB-231 breast cancer cells.55  Compound 2.28 was previously 
found to be active against Bacillus subtilis, Esherichia coli, and Staphylococcus aureus.97 
 
2.3.2 Aplidium monile - TIC2011-032  
The ascidian Aplidium monile Monniot, F., 200149 Aplousobranchia: Polyclinidae, (Figure 
2.12) was collected by SCUBA from a depth of 12 - 15 m at Bell Buoy dive site (33° 58.998’ S 
25° 41.622’ E), Algoa Bay, South Africa, in November 2011 and given the voucher code 
TIC2011-032,.   
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Figure 2.12: Aplidium monile (TIC2011-032) collected from Bell Bouy dive site in Algoa Bay, 
South Africa.  Photograph provided by Dr Shirley Parker-Nance. 
2.3.2.1  Results from the LC-ICP-MS/ES-MS screen 
The LC-ICP-MS/ES-MS data obtained for an extract of the ascidian Aplidium monile prepared 
using the extraction protocols adopted for preparing extracts for LC-ICP-MS/ES-MS screening 
revealed the possible presence of iodine, bromine, arsenic and vanadium containing 
compounds (Figure 2.13).  
 
 
Figure 2.13: Selected LC-ICP-MS traces obtained for Aplidium monile (TIC2011-032) (127I 
blue trace, 79Br red trace, 75As green trace and 51V orange trace).  Traces are vertically offset 
for clarity.  
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The bromine (m/z 79) ICP-MS trace aquired for the extract of Aplidium monile contained two 
major peaks at TR 7.06 min and 7.46 min (Figures 2.13 and 2.14).  The ESI-MS relating to TR 
7.06 min [Figure 2.14 (b)(i)] contains a major peak at m/z 309.9258 which had a distinct 1:2:1 
(m/z 307.9283, 309.9258, 311.9235) isotope pattern indicating the presence of two bromine 
substituents.  The best fit simulation91 produced for this mass related to a [(M+H)+] molecular 
formula of C9H12ONBr2 (∆ 0.2 mmu).  Interestingly, even though a soft ionisation technique 
was used to acquire these data, evidence of some fragmentation was observed in the ESI-MS 
mass spectrum.  The first fragment, with a dibromo- isotope pattern at m/z 290.9016 (relative 
intensity of 1), 292.8994 (2), and 294.8972 (1), correlated to a compound with a molecular 
formula of C9H9OBr2 implying the loss of an ammonia ([M+H-NH3]+, ∆ -17 amu) from the 
parent ion, a further loss of bromine ([M+H-NH3-Br]+, ∆ -96 amu) resulted in the second 
fragment cluster at m/z 211.9831 (1) and 213.9810 (1) indicative of a monobrominated 
fragment.  From these data it was believed the the compound detected at TR 7.06 min was 
the tyramine analogue, 3,5-dibromo-4-methoxyphenethylamine (2.31).   
 
The ESI-MS mass spectrum of the second major 79Br-ICP-MS peak with the TR 7.46 min 
[Figure 2.14 (b)(ii)] contained the major peaks m/z 355.9144 (1) and 357.9118 (1) suggesting 
a single bromine substituted metabolite.  Once again there were secondary peaks, with the 
conserved bromine isotope patterns, at m/z 338.8879 (1) and 340.8855 (1) relating the the 
loss of ammonia ([M+H-NH3]+, ∆ -17 amu) from the parent ion, and at m/z 211.9833 (1) and 
213.9811 (1) suggestive of a similar structure to 2.31.  However the mass difference between 
the first and second fragment clusters was found to be -127 amu, characteristic of the loss of 
a labile iodine, which tentatively suggested that this tyramine derivative was 3-bromo-5-iodo-
4-methoxyphenethylamine (2.32).  The presence of iodine in this metabolite was further 
confirmed by the appearance of a small shoulder (almost completely obscured by a more 
dominant iodine containing metabolite) at TR 7.46 min in the iodine (m/z 127) ICP-MS trace of 
this extract. 
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Figure 2.14: Halogenated tyramines detected in TIC2011-032 extract by LC-ICP-MS/ESI-MS. 
a) Selected ICP-MS and ESI-MS EICs; b) ESI mass spectra and structures for (i) 2.31 at TR 
7.06 min, (ii) 2.32 at TR 7.46 min, and (iii) 2.33 TR at 8.09 min. 
 
m/z m/z m/z
0
1
2
3
4
200 250 300
In
te
ns
ity
309.9258
292.8994
211.9831
0
2
4
6
200 250 300 350
In
te
ns
ity
211.9833
338.8879
355.9144
0
10
20
30
240 290 340 390
In
te
ns
ity
259.9695
386.8742
403.9003
b)
3 5 7 9 11 13 15 17 19
In
te
ns
ity
 [c
ps
]
Time [minutes]
ICP-MS: m/z 127 (127I)
ESI-MS: m/z 309.9
ESI-MS: m/z 403.9
ICP-MS: m/z 79 (79Br)
ESI-MS: m/z 355.9
(i) (ii) (iii)
a)
I
Br
O
NH2
m/z 211.9831
m/z 338.8876
2.32
[M+H]+ m/z 355.9141
Br
Br
O
NH2
m/z 211.9831
m/z 292.8994
2.31
[M+H]+ m/z 309.9260
I
I
O
NH2
m/z 259.9693
m/z 386.8737
2.33
[M+H]+ m/z 403.9003
Chapter 2 
53 
The extract of Aplidium monile produced an iodine (m/z 127) ICP-MS trace with a peak 
between TR 7.5 - 9.5 min that was of such magnitude that it saturated the detector resulting in 
the unusually shapped peak (TR 7.5 - 9.5  min) observed in Figures 2.12 and 2.13.  The ESI-
MS relating to this retention time was dominated by a peak at m/z 403.9003 (Figure 2.14 
b)(iii)).  The EIC of m/z 403.9003 was a very good match to the iodine ICP-MS trace 
indicating that the compound with TR 7.8 min is iodinated (Figure 2.14 a).  As was observed 
with the brominated tyramine metabolites the ESI-MS for this dominant iodine containing 
compound had further peaks at m/z 386.8742 ([M+H-NH3]+, ∆ -17 amu) and m/z 259.9695 
([M+H-NH3-I]+, ∆ -144 amu), suggesting the presence of another halogentated tyramine, 3,5-
diido-4-methoxyphenethylamine (2.33).  The dominance of 2.33 in the extract of A. monile 
swamped the detection of potential vanandium or arsenic containing chelation complexes, 
and no further analysis of vanadium and arsenic data was pursued. 
2.3.1.3  Isolation and structure elucidation of 2.33 
To establish the structures of the halogenated tyramines in A. monile the remaining crude 
extract from the LC-ICP-MS/ESI-MS screen was partitioned between dichloromethane and 
aqueous methanol (70% aq. methanol).  The 1H NMR data acquired for the polar methanol 
partition contained, as expected, the resonances relating to the halogenated tyramine 
derivatives, as well as other prominent aromatic, and methylene signals of metabolites not 
detected in the initial analysis of the LC-ICP-MS/ESI-MS data.  The investigation of the 
compounds giving rise to these latter resonances will be discussed further in Chapter 4.4. 
 
Continuing with the attempted isolation of the halogenated tyramine derivatives, detected in 
the speciation analysis, the methanol partition fraction was fractionated using a C-18 Sep-
Pak® cartridge (Waters,10 g).  Seven fractions were collected based on the polarity of the 
solvents used to flush the cartridge (water, 10% acetonitrileaq, 20% acetonitrileaq, 40% 
acetonitrileaq, 60% acetonitrileaq, 80% acetonitrileaq, and 100% acetonitrile).  The fourth 
fraction produced a very simple 1H NMR spectrum (Figure 2.15) with two methylene triplets at 
δH 3.14 (2H, J = 7.6 Hz) and 2.86 (2H, J = 7.6 Hz), a singlet at δH 3.81 (3H) indicative of a 
methoxy moiety, and an aromatic singlet at δH 7.77 relating to two chemically equivalent 
protons.  These 1H HMR data suggested either the presence of the dibromo- or diiodo-
tyramine (either 2.31 or 2.33 respectively).  The 13C NMR spectrum supported the presence 
of an iodine substituent on an aromatic ring with the presence of a shielded resonance at δC 
91.5 (Figure 2.15).  That this compound was the anticipated diiodo-tyramine 2.33 and not 
2.31 was confirmed from HRESIMS analysis which yielded the molecular formula C9H11NOI2 
(m/z 403.9000, [(M+H)+], ∆ -0.3 mmu).   
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Figure 2.15: 1H (600 MHz, MeOD) and 13C (150 MHz, MeOD) NMR spectra obtained for the 
diiodo-tyramine 2.33. 
Table 2.4: 1H (600 MHz, MeOD), 13C (150 MHz, MeOD), COSY and gHMBC NMR data 
obtained for 2.33. 
  3,5-diiodo-4-methoxyphenethylamine (2.33) 
Position δC ppm 
δH ppm 
(int., mult., J/Hz)  COSY HMBCa 
1 138.1 -    
2 141.5 7.77 (1H, s)   C-3, C-4, C-5, C-6, C-7 
3 91.5 -    
4 159.8 -    
5 91.5 -    
6 141.5 7.77 (1H, s)   C-2, C-4, C-5, C-7 
7 32.7 2.86 (2H, t, 7.6)  H2-8 C-1, C-2, C-6, C-8 
8 41.6 3.14 (2H, t, 7.6)  H2-7 C-1, C-7 
9 61.1 3.81 (3H, s)   C-4 
a HMBC correlations are from the proton(s) stated to the indicated carbon. 
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Standard 2D NMR experiments were carried out to confirm the arrangement of substituents 
on the benzene ring and unequivocally confirm the structure of 2.33 (Table 2.4).  The key 
gHMBC correlations are displayed in Figure 2.16.  The 3J HMBC correlations from the 
methoxy protons (δH 3.81, H3-9) and the aromatic protons (δH 7.77, 2H-2/6) both to the 
quaternary carbon resonance at 159.8 ppm established the position of the methoxy at C-4.  
The three bond HMBC correlation observed between the methylene protons at 2.86 ppm (H2-
7) and the aromatic methine at 141.5 ppm placed the amine chain at C-1.  The 1H and 13C 
NMR shifts and key COSY and gHMBC correlations used to elucidate compound 2.33 are 
reported in Table 2.4.     
  
                       
Figure 2.16: A region (F1 = δ 2.0-8.5 ppm; F2 = 20-170 ppm) of the gHMBC spectrum 
(MeOD, 600 MHz) of diiodotyramine 2.33. The accompanying structure shows the key 3J 
gHMBC correlatios used to elucidate the structure of 2.33. 
The 1H NMR data obtained for the Sep-Pak® fractions five to seven were very similar to those 
observed for 2.33 however slight differences were seen when the chemical shifts of the 
aromatic proton singlets observed in the individual factions were compared (Figure 2.17).  
These slight shifts in chemical equivalence were believed to be due to the presence of 
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bromine substituents on the aromatic ring.  However, when 13C NMR data was acquired from 
fractions five to seven there were no observable shift in the resonance assigned to C-3 and 
C-5 (δC 91.5).  In an attempt to isolate and elucidate the brominated derivatives detected 
during speciation analysis a larger scale extraction of TIC2011-032 was carried out.  
Unfortunately, the dominant iodinated compound 2.33 appeared to hinder the isolation of the 
other minor halogenated metabolites in the mixture due to major streaking of 2.33 during 
exhaustive attempts at HPLC purification of the different fractions.   
 
 
Figure 2.17: A stack plot of the 1H NMR (MeOD, 600MHz) spectra obtained for 2.33 (bottom) 
and fractions five to seven produced from intial reversed-phase fractionation of the extract of 
Aplidium monile.  Slight differences in the chemical shifts of resonances are believed to be 
due to differing halogenated substituents on the tyramine scaffold. 
The first report on the isolation of 3,5-diiodo-4-methoxyphenethylamine (2.33) from a natural 
source was by Ireland and Sesin104 who reported the isolation of 2.33 together with its urea 
derivative 2.34 from an unidentified species of Didemnum ascidian three decades ago.104    
Compound 2.33 was later isolated as the major compound in the Indonesian Didemnum sp. 
and the Palauan Didemnum rubeum.105,106  More recently the ascidian D. rubeum was 
revisited and a series of iodinated tyramine derivatives were isolated including 2.33 and 2.34  
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as well as seven new analogues 2.35-2.40.107  This is the first report of 2.33 from an African 
ascidian. 
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The dibrominated tyramine 2.31 appears to be less common, in the marine environment, than 
its iodo counterpart.  The only reported isolation of 2.31 was by Ireland and co-workers108 
from the indonesian ascidian Eudistoma sp. however, related analogues of 2.31 such as the 
tetramethylated tyrosine derivative 2.41 and the monobromo-tyramine 2.42 have been 
isolated from the sponge Verongula sp. and the ascidian Cnemidocarpa bicornuta 
respectively.108–110    In a synthetic and biolgical evaluation of a series of bromotyramines 
Schoenfeld et al. found 2.31 to exibit potent antifouling and cytotoxic properties.111  
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The C3 monohalogenation and C3, C5 dihalogenation pattern appears thus far to be 
ubiquitous in halogenated marine tyramines without exception and the C3, C5 dihalogenation 
pattern tentatively proposed for 2.30 and 2.31 would appear to be vindicated.  Interestingly, 
albeit speculative, from high resolution mass data this appears to be the first case of an 
asicidian found to produce both the dibrominated (2.31) and diiodinated (2.33) tyramines, as 
well as the previously unreported bromo-iodo-tyramine 2.32 and is the first report of these 
compounds co-occurring in an African ascidian. 
  
2.4   Parallel ICP-MS and ESI-MS as a tool to de-replicate known and discover new    
halogenated tyramines and tyrosines in South African marine ascidian extracts   
In depth analysis of the LC-ICP-MS/ESI-MS data obtained from the screening of the 13 Algoa 
Bay ascidians resulted in the detection of halogenated tyramine metabolites from two 
additional ascidian extracts and suspected halogenated tyrosine metabolites from a further 
two ascidians.  The use of LC-ICP-MS/ESI-MS analysis as a rapid dereplication technique for 
halogentated metabolites is further documented below. 
2.4.1 Polycitor sp. nov. - SAF2004-068 
The ascidian specimen SAF2004-068 (Figure 2.18) was an unknown species of Polycitor 
(Suborder: Aplusobranchia, Family: Polycitoridae) collected by SCUBA at a depth of 21 m 
from Haarlem Reef dive site, Algoa Bay, South Africa in July 2004.  This colonial ascidian had 
a growth form consisting of multiple round lobes and was pale blue in colour with red orange 
zooids resulting in the common name of lucid polycitor ascidian.  Organic extracts of Polycitor 
sp. nov. were entered into the 1H-15N HMBC screen, total metal concentration profile analysis, 
and LC-ICP-MS/ESI-MS analysis.  The results of each screen are summarised in Table 2.1.  
 
        
Figure 2.18: Polycitor sp. nov. collection specimen SAF2004-068 (left) and photographed at 
Algoa Bay, South Africa (right).  Photograph credited to Coral Reef Research Foundation 
under contract to the National Cancer Institute (no. N02-CM-77249). 
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2.4.1.2  Results from the 1H-15N HMBC screen 
The organic extract of Polycitor sp. nov. (SAF2004-068) was one of the eleven ascidian 
extracts that produced a common pattern of three correlations from the proton chemical shifts 
at δH 2.73, 3.16 and 4.27 ppm to the nitrogen resonances at δN 36.9, 51.3 and 196.3 
respectively (Figure 2.3).  In addition to these three common correlations a fourth clear 
correlation was seen from an aromatic proton resonance at δH 7.86 ppm to the downfield 
resonance at δN 196.3.  The deshielded nature of these resonances found in the fourth 
correlation suggested the presence of an aromatic alkaloid in the extract of Polycitor sp. nov. 
which may have metal chelation potential. 
2.4.1.3  Results from the LC-ICP-MS/ESI-MS screen 
Analysis of the LC-ICP-MS/ESI-MS data obtained for the crude extract of the ascidian 
Polycitor sp. nov. (voucher code: SAF04-068) indicated the presence of iodine, bromine, 
arsenic and vanadium containing compounds (Figure 2.19).  Attempts were made to establish 
the organic metabolites associated with these elemental data by investigation of the ESI-MS 
spectra obtained at the relevant retention times.  Analysis of the bromine and iodine 
metabolites yielded the results presented below.  Unfortunately, attempts to detect potential 
arsenic or vanadium containing metabolites were not successful.   
 
Figure 2.19: Selected LC-ICP-MS traces obtained for Polycitor sp. nov. (SAF2004-068); 127I 
blue trace, 79Br red trace, 75As green trace and 51V orange trace.  Traces are vertically offset 
for clarity.  
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Figure 2.20:  LC-ICP-MS/ESI-MS analysis of the extract of SAF2004-068 (Polycitor sp. nov.). 
a) Selected ICP-MS and ESI-MS EICs; b) ESI mass spectra for retention times of interest (i) 
9.5 min, (ii) 15.4 min, and (iii) 15.9 min. 
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On inspection of the iodine (m/z 127) ICP-MS trace (Figure 2.19 and 2.19 a)), acquired for the 
organic extract of Polycitor sp. nov. the peaks at TR 9.5 min and 15.9 min indicated the 
presence of iodinated metabolites at these retention times.  The extracted ion chromatogram 
(EIC) of m/z 403.9003 (Figure 2.20 a) contained a peak at TR  9.5 min, which correlates both 
in terms of mass and TR to the diiodinated tyramine 2.33, was also, as expected, congruent 
with a peak appearing at the same TR in the 127I ICP-MS trace.  These data therefore suggest 
that 2.33 occurs in different species from both the Polycitoridae and Polyclinidae families 
occurring in Algoa Bay, South Africa.  
 
The second peak in the 127I ICP-MS of SAF2004-068 appeared at TR 15.9 minutes and the 
ESI-MS produced at this retention time was dominated by the mono-isotope peak at m/z 
480.3572.  Unfortunately, the EIC produced for m/z 480.3572 was not a strong match and 
produced a peak apex that was shifted slightly to the right when compared to that in the I127 
ICP-MS trace.  Attempts to match EICs for the other ESI-MS peaks produced at this retention 
time were also unsuccessful.   Therefore there was insufficient mass spectral evidence to 
speculate further on the structure of the iodine containing metabolite at TR 15.9 mins.  
The Polycitor sp. nov. 79Br-ICP-MS contained a major peak at TR 15.4 minutes which 
correlated with a similar TR in the ESI-MS EIC for m/z 612.7304 (Figure 2.19 and 2.19 a).  
Inspection of the ESI-MS obtained at this retention time (Figure 2.20 b)(ii)) revealed an 
isotopic peak pattern at m/z 608.7347(1), 610.7328(4), 612.7304(6), 614.7285(4) and 
616.7260(1) indicative of a tetra-brominated metabolite.  The EIC for m/z 612.7304 was 
overlaid onto the bromine ICP-MS trace and giving a reasonable match (Figure 2.20 a).  The 
molecular formula simulations91 generated for the lowest isoptopic mass of m/z 608.7347 
gave reasonablely similar m/z values for two molecular formulae; C8H7O4N9Br4 ([(M+H)+] ∆ -
0.2 mmu) and C9H13O9N2Br4 ([(M+H)+] ∆ -0.7 mmu).  Unfortunately, attempts at dereplication 
by matching these two molecular formulae to known formulae in available resources such as 
SciFinder and MarinLit yeilded no readily interpretable results and this species of Polycitor 
should be earmarked for further investigation.  Regrettably, only a very limited amount of 
extract was available from the 2004 collection of SAF2004-068 and time and other resource 
constraints prevented further recollection and secondary metabolite isolation and structure 
elucidation investigations as part of this thesis study  
 
 
2.4.2 Leptoclinides sp. - SAF2004-015  
The ascidian with the sample code SAF2004-015 was a thin, upright, fan shaped colonial 
Leptoclinides species which was predominantly white with orange zooids (Figure 2.21).  
SAF2004-015 was collected by SCUBA from the White Sands dive site in Algoa Bay, South 
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Africa, from a depth of 21 m, in July 2004 and kept frozen until extraction for the 
aforementioned screens, the results of which will now be discussed. 
 
      
Figure 2.21:  Leptoclinides sp. collection specimen SAF2004-015 (left) and photographed 
underwater at Algoa Bay, South Africa (right, photograph supplied by Dr Shirley Parker-
Nance.  
2.4.2.1   Results from the 1H-15N HMBC screen 
The results obtained for the crude organic extract of Leptoclinides sp. were unremarkable, 
with only two significant correlations produced from both the proton multiplets at δH 2.73 and 
2.78 to the same nitrogen resonance at δN 36.9 ppm.  The shielded nature of both the proton 
and nitrogen resonances involved in these correlations were indicative of resonances 
expected from an aliphatic amine.80  
2.4.2.2  Results from the LC-ICP-MS/ESI-MS screen 
Preliminary analysis of the LC-ICP-MS data obtained for the crude organic extract of the 
ascidian Leptoclinides sp. (Suborder: Aplousobranchia, Family: Didemnidae, voucher code: 
SAF04-015) revealed the presence of iodine, bromine, arsenic and vanadium containing 
compounds (Figure 2.22).  Investigation of the corresponding LC-ESI-MS data was carried 
out in an attempt to identify the metabolites responsible for these elemental results. 
The iodine (m/z 127) ICP-MS trace (Figures 2.22 and 2.23) obtained for Leptoclinides sp. had 
two major peaks appearing at TR 9.5 and 16.0 min.  The retention times of these peaks were 
very similar to those produced in the iodine ICP-MS trace of Polycitor sp. nov. (Figures 2.19 
and 2.20), which tentatively implied common metabolites. Arising from similarities in TR values 
the m/z values obtained at these retention times for the iodine elemental analysis of Polycitor 
sp. nov. were used as a starting point.  The EIC for m/z 403.9003 was overlaid onto the I127 
ICP-trace and the peak at TR 9.5 min resulting in a reasonable match (Figure 2.23 a).  The 
corresponding ESI-MS generated at this retention time did indeed display m/z 403.9003 as 
the major peak (Figure 2.23 b)(ii)).  Once again the elemental and molecular information 
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would suggest that the tyramine, 2-(3,5-diiodo-4-methoxyphenyl)ethanamine (2.33), which 
had been isolated from a number of ascidians in the Didemnidae family,104–107 was also 
present in this crude extract of Leptoclindies sp..  The use of an ion trap allowed for the 
analysis of the MSMS data for m/z 403.9003 which revealed one dominant peak at m/z 
259.9695 and corresponded to the [M+H-NH3-I]+ (∆ -144 amu) fragmentation product as 
described previously.  
 
Figure 2.22: Selected LC-ICP-MS traces obtained for Leptoclinides sp. (SAF2004-015); 127I 
blue trace, 79Br red trace, 75As green trace and 51V orange trace.  Traces are vertically offset 
for clarity.  
 
Our initial analysis of the LC-ICP-MS/ESI-MS data generated at TR 15.9 min from the extract 
of Polycitor sp. nov. (documented in the previous section) also did not yield any readily 
interpretable results.   However, the successful identification of 2.33 at TR 9.5 min in both the 
Leptoclinides sp. and Polycitor sp. nov. extracts motivated us to investigate the second 
common iodinated metabolite in the Leptoclinides sp. extract with TR 15.9 min.  The 
Leptoclinides sp. ESI-MS mass spectrum between TR 15.9 and 16.1 mins was accordingly 
investigated.   
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Figure 2.23:  LC-ICP-MS/ESI-MS results obtained for the extract of Leptoclinides sp. 
(SAF2004-015).  a) Selected ICP-MS and ESI-MS EICs; b) ESI mass spectra for retention 
times of interest (i) 9.1 min, (ii) 9.5 min, and (iii) 17.7 min. 
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No distinct major mass peak was observed in this TR time frame and only a series of m/z 
peaks of moderate intensity were present.  The EICs corresponding to each of these m/z 
values were consecutively extracted and overlaid onto the 127I LC-ICP-MS trace.  
Unfortunately, none of the EICs where strong matches, and so the m/z value that might 
correspond to the elemental data produced could not be interpreted with any confidence.  The 
failure to obtain even a suggested m/z value in either of the data sets obtained may also 
suggest that the unknown iodinated metabolite with TR 15.9-16.1 min is not successfully 
ionised by the soft ES ionisation technique. 
The Leptoclinides sp. LC-ICP-MS bromine (m/z 79) trace contained an intense and broad 
peak with a retention time ranging from 16.9 – 18.7 minutes as well as a minor peak at TR 9.1 
min (Figures 2.22 and 2.23 a).  The ESI-MS spectrum corresponding to TR 9.1 min contained 
the intense peaks as m/z 466.0352 and 468.0331 with a distinct 1:1 isotope ratio indicative of 
a mono-brominated compound.  It was therefore not surprising that the EIC generated for m/z 
466.0355 overlaid perfectly with the peak observed at the same retention time in the bromine 
ICP-MS trace for Leptoclinides sp. (Figure 2.23).  The two simulations generated with the 
smallest ∆mmu afforded molecular formulas C31H15Br ([(M+H)+] ∆ -0.3 mmu) and 
C17H17O6N5Br ([(M+H)+] ∆ 0.2 mmu), the former is far less probable.  Searches of the marine 
natural product literature (MarinLit) and general chemical literature (SciFinder) did not yield 
any known compounds with molecular formula consistent with the predicted formulae and no 
chemical structure could  proposed from these limited mass data. 
The ESI-MS for the TR range 16.9-18.7 min (Figure 2.23) contained a series of peaks with 
distinctive bromine isotope patterns at m/z 575.9517(1), 577.9494(2), 579.9471(1) and m/z 
597.9333(1), 599.9310(2), 601.9290(1) indicating the presence of possibly a dibromo- 
metabolite.  The EIC of the major peak (m/z 577.9494) matched the bromine ICP-MS trace 
excellently (Figure 2.23). Attempts, through molecular ion simulations and database 
searches, were made to identify the di-brominated metabolite assuming that the m/z 
577.9494 value related to the [(M+H)+] ion, however no known marine natural products with 
molecular masses consistent with these data were found.  Interestingly, when the negative 
ion channel of the ESI-MS of TR 16.9-18.7 min was utilised, as a routine check in these 
analyses, a wealth of molecular ion adducts were observed (Figure 2.23).  Regrettably, 
because of a paucity of material in hand no further attempts were made to isolate these 
individual brominated compounds. 
 
As a final note on the LC-ICP-MS/ESI-MS data obtained for the extract of Leptoclinides sp..  
We were continually cognisant of the aim of the project to find nitrogenous ascidian 
metabolites chelating to metal ions and our attempts at proposing a structure for the chemical 
structure of the metabolite responsible for the distinct peak at TR 10.38 min in the elemental 
LC-ICP-MS analysis of vanadium (m/z 51, Figure 2.22) will be discussed briefly.  The ESI-MS 
generated at this retention time revealed two major peaks at m/z 211.14 and 333.21, 
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however, the EICs for these mass values were not exactly coincident with the peak observed 
in the 51V ICP-MS trace thus it was deemed unlikely that these two peaks represent vanadium 
containing organometallic complexes.112   
 
2.4.3 Didemnum sp.2 - SAF2004-061 
The ascidian specimen collected by SCUBA at a depth of 18 m at White Sands reef, Algoa 
Bay, under the voucher code SAF2004-61 was a colony of the purple encrusting ascidian 
Didemnum sp.2 (Family: Didemnidae, Suborder: Aplusobranchia, Figure 2.24).  
 
       
Figure 2.24:  Didemnum sp.2 collection specimen SAF2004-061 (left) and photographed 
underwater at Algoa Bay, South Africa (right).  Photograph credited to Dr Shirley Parker-
Nance.  
2.4.3.1  Results from the 15N HMBC screen 
The extract of Didemnum sp.2 (SAF2004-061) also gave the common pattern of correlations 
from the protons at δH 2.73, 3.16 and 4.27 to the nitrogen resonances at δN 36.9, 51.3 and 
196.3 respectively (Figure 2.3).  The 1H-15N HMBC spectra obtained for Didemnum sp.2 
further revealed two more correlations from δH 3.09 and 4.12 ppm to δN 53.6 and 374.4 ppm 
respectively. 
2.4.3.2  Results from the LC-ICP-MS/ESI-MS 
Analysis of the LC-ICP-MS/ESI-MS data obtained for the crude organic extract of the ascidian 
Didemnum sp.2 (SAF04-061) indicated the presence of iodine, bromine, selenium and copper 
containing compounds (Figure 2.25).  Unfortunately, the peaks observed in the selenium and 
copper LC-ICP-MS traces were of low intensity, and none of the attempts to extract molecular 
information from the corresponding ESI-MS data were possible.  The detection and tentative 
structure elucidation from mass data of two halogenated metabolites within this extract is 
discussed here. 
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Figure 2.25:  Selected LC-ICP-MS traces obtained for Didemnum sp.2 (SAF04-061); 127I blue 
trace, 79Br red trace, 77Se green trace and 63 Cu brown trace.  Traces are vertically offset for 
clarity. 
The iodine (m/z 127) ICP-MS trace (Figure 2.25 and 2.26) obtained for Didemnum sp.2 
revealed two major peaks appearing at TR 8.64 and 13.99 min.  Unfortunately, none of the 
major peaks seen in the ESI-MS obtained at 13.99 min had EIC retention times that matched 
the iodine ICP-MS trace, therefore no further analysis was carried out. 
The correlating ESI-MS obtained at 8.64 min (Figure 2.26) contained two major peaks at m/z 
364.0401 and 237.0949 (Figure 2.26 b) (i)).  Although the major peak at this retention time 
was m/z 237.0949 the extracted ion chromatograph for this mass did not match that obtained 
for the elemental 127I ICP-MS suggesting that this was not an iodinated metabolite.  The EIC 
for the less intense peak at m/z 364.0401 was however a perfect match to the 127I ICP-MS 
trace (Figure 2.26 a)).  The mass difference of 126.9452 amu between these two major peaks 
is indicative of the loss of labile iodine adding further support for the presence of iodine in the 
compound with a molecular ion at m/z 364.0401.  The closest fit simulation91 generated 
corresponded to the molecular ion formula C13H19O3NI (∆ -0.3 mmu).  Submitting these mass 
data in to the MarinLit data base did not yield any iodinated metabolites.  In an attempt to 
extract more information from these data the MSMS for m/z 364.0401 was analysed and 
showed three major peaks at m/z 304.9661, 258.9609, and 178.0620 (Figure 2.26 b) (ii)).   
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Figure 2.26: LC-ICP-MS/ESI-MS results obtained for the extract of Didemnum sp.2 a) 
Selected ICP-MS and ESI-MS EICs; b) ESI mass spectra for retention times of interest (i) 8.6 
min (ii) the MS2 spectrum acquired for m/z 364.04 and (iii) ESI-MS for TR 10.6 min. 
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The mass difference between the parent ion (m/z 364.0401) and the fragment peak at m/z 
304.9661 (∆ 59.0740 amu) in the MSMS suggested the loss of a trimethylamine [N(CH3)3] 
moiety.  The remaining fragment peaks observed in the MSMS are also both indicative of the 
loss of this trimethylamine, along with a further loss of carboxylic acid group in the case of m/z 
258.9609 (∆ 105.0792 amu), and an iodine rather in the case of m/z 178.0620 (∆ 185.9781).  
The formation of similar fragments, albeit through the loss of differing functional groups, was 
seen with the tyramine derivatives 2.31-2.33 detected in TIC2011-032 (Aplidium monile).  The 
structure of the iodinated compound with in this current extract (SAF2004-061, Didemnum 
sp.2) was therefore tentatively proposed to be that of the tetramethylatedtyrosine derivative 
2.43 ([M+] m/z 364.0404, ∆ 0.3 mmu). 
The Didemnum sp.2 ICP-MS trace relating to the occurrence of bromine (m/z 79) (Figures 
2.25 and 2.26) generated one major peak appearing at the retention time of 10.64 minutes.  
The ESI-MS for this retention time (Figure 2.26 b) (iii)) clearly showed a major compound with 
an isotope pattern at m/z 393.9650 (1); 395.9629 (2); 397.9607 (1) that implied the presence 
of a molecular ion with two bromine functionalities.  The EIC of m/z 395.9629 was a good 
match to bromine ICP-MS trace (Figure 2.26). The simulation generated, for this isotope 
pattern, which produced smallest mass difference corresponded to the molecular ion formula 
C13H18O3NBr2 (∆ 0.2 mmu), indicating a brominated metabolite with a similar scaffold to that 
detected in the iodine analysis.  A MarinLit search relating to these data yielded one dibromo- 
metabolite, 2.41 ([M+] m/z 393.9627, ∆ -0.2 mmu), whose mass data matched the dibromo 
compound detected in the extract of Didemnum sp.2.  Compound 2.41 was first isolated by 
Albrizio et al. from the Caribbean Verongida sponge Aiolochroia crassa (reported under the 
synonymised name of Pseudoceratina crassa).109  The anti-fouling and anti-parasitic 
properties of compound 2.41 were subsequently investigated and 2.41 was found to be 
inactive in both cases.113,114  The structure of 2.41 is consistent with the structure predicted 
through MSMS fragmentation data for the iodinated compound 2.43.  Unfortunately, due to 
the small quantity of Didemnum sp.2 obtained in the original collection made in 2004, no 
attempt at the isolation and elucidation of these halogenated metabolites were carried out.   
 
2.4.4  Aplidium sp. - SAF2004-039 
The ascidian specimen with the collection code SAF2004-039 was an undescribed Aplidium 
sp. (family: Polyclinidae, suborder: Aplousobranchia) collected from a depth of 12 m at 
Roman Rock dive site in Algoa Bay, South Africa in July 2004.  This colonial ascidian had an 
irregular cushion like growth form and was tan in colour with purple zooids creating a mottled 
appearance throughout (Figure 2.27).  
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Figure 2.27:  Aplidium sp. collected by SCUBA from Roman Rock reef, Algoa Bay, South 
Africa.  Collection specimen SAF2004-039 (left) and photographed underwater at Algoa Bay, 
South Africa (right).  Photograph credited to Dr Shirley Parker-Nance.  
2.3.6.1  Results from the 1H-15N HMBC screen 
The 1H-15N HMBC data obtained for the crude organic extract of Aplidium sp. (SAF2004-039) 
revealed only the three correlations from the protons at δH 2.73, 3.16 and 4.27 ppm to the 
nitrogen resonances at δN 36.9, 51.3 and 196.3 respectively which were common to eleven of 
the extracts screened (Figure 2.3).   
2.3.6.2  Results from the LC-ICP-MS/ESI-MS analysis 
The elemental LC-ICP-MS data obtained for the crude extract of Aplidium sp. (SAF2004-039) 
indicated the presence of the elements iodine, bromine, arsenic, copper, cobalt and vanadium 
(Figure 2.28).  The traces for arsenic (m/z 75) and copper (m/z 63) although weak, appear at 
a similar retention time.  The two major isotopes of copper (63Cu [~70%] and 65Cu [~30%]) 
would create a molecular ion isotope pattern in the ESI-MS that would be fairly recognisable, 
and would help with the identification of a copper-natural product complex if such a complex 
existed in the extract. However, no such pattern was observed in the LC-ESI-MS 
chromatogram at the equivalent retention time in the LC-ICP-MS chromatogram. 
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Figure 2.28:  Selected LC-ICP-MS traces obtained for Aplidium sp.(SAF2004-039); 127I blue 
trace, 79Br red trace, 75As green trace; 63Cu brown trace; 59Co pink trace; 51V orange trace.  
Traces are vertically offset for clarity. 
 
The iodine (m/z 127) LC-ICP-MS trace obtained for Aplidium sp. revealed major peaks at TR 
6.73, 11.45 and 13.00 minutes (Figures 2.28 and 2.29).  The peaks with TR of 6.74 min in the 
ESI-MS chromatogram (Figure 2.29 b)(i)) afforded dominant mass peak at m/z 307.9780.  
The closest fit simulation generated for m/z 307.9780 corresponded to the molecular ion 
formula of C9H11O3NI (∆ 0.4 mmu; [M+H]+).  MSMS analysis of this molecular ion yielded a 
fragment ion (m/z 261.9716), which represents a mass difference of 46.006 amu with the 
parent ion.  These MSMS data would imply that the major fragment observed at m/z 261.9716 
corresponds to the loss of a carboxylic acid group [M+H-CHOOH]+ supporting the presence of 
a carboxylic acid moiety in 2.44 and accounting for one of the five degrees of unsaturation 
implied by the molecular formula.  A tri-substituted benzene ring would account for the 
remaining four degrees of unsaturation and accommodate an iodine, hydroxyl and a 2-amino-
propanoic acid substituent consistent with 2-iodo-tyrosine (2.44).    
  
 
5 7 9 11 13 15 17 19 21 23 25
In
te
ns
ity
Time [minutes]
ICP-MS: m/z 127 (127I)
ICP-MS: m/z 51 (51V)
ICP-MS: m/z 59 (59Co)
ICP-MS: m/z 63 (63Cu)
ICP-MS: m/z 75 (75As)
ICP-MS: m/z 79 (79Br)
Chapter 2 
72 
 
Figure 2.29:  LC-ICP-MS/ESI-MS results obtained for the extract of Aplidium sp. (SAF2004-
039); a) Selected ICP-MS and ESI-MS EICs; b) ESI mass spectra for retention times of 
interest (i) 6.73 min (ii) .7.90 and (iii) 13.00 min. 
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Early histochemical studies by Kennedy115 and later Barrington and Thorpe116 into the 
distribution of high levels of iodine in the organs of a number of tunicates, reported the 
occurance of monoiodotyrosine (2.44) and diiodotyrosine (2.45) in the endostyle, blood, tunic 
and gonads however, compounds 2.44 and 2.45 were not isolated in these studies.  A recent 
review by Gribble reports the detection of iodinated tyrosines in marine algae, spoges and 
gorgonians.117 
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The Aplidium sp. LC-ICP-MS trace relating to bromine (m/z 79) (figures 2.28 and 2.29 a)) had 
a single clearly distinct peak at TR 7.90 min.  Our first inspection of the ESI-MS for this 
retention time [Figure 2.29 b)(ii)] revealed a dominant mono-isotopic peak at m/z 320.1619 
which could not be the molecular ion for a compound containing one or more bromine atoms.  
After a closer analysis of the other peaks in the mass spectrum an isotopic pattern comprising 
three peaks at m/z 337.9022 (1); 339.9001 (2) and 341.8980 (1) was observed which we 
proposed corresponded to the [M+H]+ of a dibromo metabolite.  The best fit simulations 
obtained for the m/z 337.9022 was C9H10O3N79Br2 (∆ -0.04 mmu; [M+H]+) which was similar to 
the molecular formula established for 2.44 differing only in the presence of two bromine atoms 
instead of a single iodine atom.  Unfortunately, the intensity of this molecular ion peak was too 
low to obtain the MSMS spectrum and any fragmentation data.  However, some useful data 
was obtained through the ion mapping functionality.  The product ions mapped for the 
monoisotopic parent ions m/z 337.90 (79Br2) and 341.90 (81Br2) were m/z 292 (∆ 45.9 mu) and 
296 (∆ 45.9 mu) respectively which once again would suggest the presence of a carboxylic 
acid moiety in the parent ion and lead us to tentatively propose a 2,5-dibromotyrosine 
structure for 2.46.  There is no record of the isolation of 2.46 from a marine source in the 
database MarinLit,76 2.46 however the  monobromo analogue 2.47 has been reportedly 
detected in sponges, molluscs and gorgonians.117 
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A complex ESI-MS spectrum (Figures 2.29) was acquired for the third prominent peak 
(TR13.00 min) in the 127I   ICP-MS chromatogram  The extracted ion chromatograph which 
overlaid best with the elemental 127I peak was m/z 334.1411. However attempts at 
establishing the iodine containing molecular ion formula through calculated simulations all 
yielded mass values which differed significantly from the experimental mass (∆ mmu > 20) 
and no tentative structure could be proposed.   
 
 
2.5  Concluding remarks 
Although disappointed that we were unable to find evidence of metal-alkaloid chelation in the 
cohort of Algoa Bay ascidian extracts which we had selected for further study, we were able 
to conclusively show the value of LC-ICP-MS/ESI-MS to rapidly identify a plethora of 
iodinated and brominated metabolites in six i.e. nearly half of the 13 extracts screened. This 
discovery would suggest that brominated and/or iodinated tyrosine and tyramine metabolites 
are far more common in Algoa Bay ascidians than was previously known.  We also realised 
that the metal ion concentrations and their distribution in 25 different Algoa Bay ascidians, 
which we had obtained in our screening regime, provided a unique record of metal ion 
assimilation in these organisms.  Further statistical interrogation of the metal ion 
concentration data to identify amongst others possible patterns of metal ion concentration by 
different species in the same genus, and temporal and spatial differences in metal ion hyper-
accumulation by Algoa Bay ascidians are presented in the following Chapter. We return to our 
interest in metal ion chelation in ascidians by describing in Chapter 4 our approach to 
establishing the chelation of vanadium ion with the nucleosides which were also isolated from 
Aplidium monile from Algoa Bay. 
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Chapter Three: 
Trace Metal Concentration Analysis 
of Algoa Bay Ascidians 
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3.1 Metals in the marine environment 
Metals in the marine environment originate from either terrestrial sources through river inputs,  
atmospheric deposition, or hydrothermal sources.118  The persistence of a particular metal ion 
in the marine environment is related to its chemistry, natural abundance, and anthropogenic 
significance.118  Numerous metals have biological significance thus marine organisms, in 
common with terrestrial organisms, have developed mechanisms to acquire, retain and use 
metals from the surrounding environment, mostly in trace amounts, and a delicate balance of 
metals is often required in order for an organism to remain healthy.75  Investigating the levels 
of metals in marine organisms can thus not only establish the health of an organism but also 
the reef system as a whole. 
 
3.2 Metals and ascidians 
The discovery of high levels of vanadium in the ascidian Phallusia mamillata by Henze led to 
numerous investigations into the accumulation of vanadium in ascidians which are discussed 
in greater detail in Chapter 4.119,120   The ability of ascidians to not only tolerate but actively 
concentrate a range of metals was reviewed by Monniot in 1978.121  This review detailed high 
levels of metals including Sn, Mn, Ti, Cr, Fe, Nb and Ta within taxonomically and 
geographically diverse ascidian species.121  Since this report relatively few additional studies 
have investigated the accumulation of a wide range of metals within ascidians.  The 
investigations that reported other metals, apart from vanadium, often investigated metal 
concentrations within particular ascidian body parts such as the tunic, blood plasma, and 
branchial basket but did not quantify the total metal content of the ascidian species as a 
whole.122,123  The results of two recent investigations into the metal concentrations measured 
in whole specimens of different ascidian species are presented in Table 3.1 along with the 
limited values reported by Monniot.75,121,124  The first of these recent studies was conducted by 
Baker and co-workers and investigated the levels of vanadium, manganese and nickel in ten 
Antarctic ascidians.124  More recently Jaspars and co-workers reported the concentrations of 
sixteen transition metals in eleven ascidians from the Great Barrier Reef.75  In both these 
reports the ascidians investigated were found to accumulate metals in concentrations far 
greater than the surrounding sea water.75,124  The ability for ascidians to tolerate high 
concentrations of a wide range of metals could make them potentially good candidates for 
biomonitoring programs concerned with the early detection of metal pollutions in reef 
ecosystems.  
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3.3 Marine invertebrates and environmental monitoring  
The use of sessile marine organisms as bioindicators for environmental stresses such as 
metal pollution have long been considered to have a critical role in sustaining the health of 
reef ecosystems.  Rainbow and Philips proposed five criteria to identify marine study 
organisms suitable for a biomonitoring programme.  The marine organism chosen should be; 
first, capable of passively accumulating metals in high concentrations; second, sedentary; 
third, reasonably abundant in the site of interest; fourth, simple to identify and fifth; large 
enough to provide sufficient material for analysis.125  A good biomonitoring candidate would 
also be a species that is able to grow in healthy, nonpolluted areas (thus providing a point of 
reference) as well as being able to tolerate the variable environments characteristic of metal 
polluted sites.125  Following these principles some marine filter feeders have successfully 
become bio-indicators for metal pollution in their reef ecosystems.  The mussel Mytilus 
galloprovincialis was the bio-indicator species used to assess the metal pollution of the 
coastal waters off Galicia.126  A Mediterranean-based study of a number of potential sponge 
bioindicators established that the ability of Crambe crambe to accumulate copper and lead, 
the concentrations of which varied in a consistent manner with seasonal, spatial and temporal 
changes, making it a sound bio-indicator for these metals.127  An extensive 12 year study into 
the levels of a range of metals in the Mediterranean sponge Spongia officinalis also revealed 
spatial and temporal variation in metal concentrations which indicated an improvement in the 
health of the area since the establishment of a sewage plant which appeared to markedly 
reduce the concentration  of heavy metals over the study period.128 
 
There are only two reports of ascidians as good candidates for metal ion biomonitoring 
programmes.  The first report investigated the metal accumulation ability of two ascidians 
(Ciona intestinalis and Microcosumus sulcatus) common to the Saronicos gulf of the Aegean 
Sea.  From the high concentration of metals detected in these two species, the authors 
concluded that C. intestinalis could be used as an indicator for iron pollution and M. sulcatus 
as an indicator for selenium, chromium, zinc and cobalt pollution.129  The second report stated 
that the detection of elevated levels of vanadium, copper, lead and cadmium in the ascidians 
Microcosmus squamiger, Microcosmus exasperates, Herdmania pallida, Phallusia arabica, 
and Styela canopus from Thoothukudi on the South East Indian coast implied that these 
ascidians could be used as bioindicator species for metals in seawater.130  Metal 
accumulating ascidians are sessile, abundant, often found in large colonies, and capable of 
surviving in healthy and polluted waters which are all important criteria which satisfy Rainbow 
and Philips125 guidelines for establishing good biomonitoring agents.  However, these 
guidelines are based on the assumption that the marine invertebrates studied are passively 
accumulating metals which can therefore be directly related back to the health of the 
surrounding environment.125,131  Paradoxically, the investigations into metal 
hyperaccumulation in ascidians, at least for the most part, tend to conclude that the unusually 
high levels of trace metals in these organisms are brought about through mechanisms which 
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are far from passive.75,124,132  In particular, Wright et al.75 have provided a simplified overview 
of the active cellular mechanisms used by marine organisms to actively transfer metal ions 
across hydrophobic cell membranes against a concentration gradient via transfer ligands.  
The transfer of metal ions from transfer ligands to internal ligands within the cell generates a 
kinetic trap which prevents large scale expulsion of metal ions from the cell and enables 
hyperaccumulation of these ions within the cell.75   
 
Our current study was aimed at determining the concentrations of a 24 different metals in 25 
selected specimens from a unique collection of ascidians made from Algoa Bay in 2004 and 
2011 and to further explore the metal ion data thus obtained through statistical analysis in an 
attempt to establish if there were any statistically significant correlations between metal 
accumulation patterns and ascidian families (phylogenetic correlation), the reefs from which 
the ascidians were collected (spatial correlation) and the year in which the ascidians were 
collected (temporal correlation).  To the best of our knowledge this is the largest and most 
extensive investigation of metal concentrations in a group of different ascidians occurring in 
the same area. 
     
3.4 ICP-MS analysis on South African ascidians 
The ICP-MS total metal concentrations were measured for triplicate samples of the whole 
dried ascidian samples as well as crude organic extracts of each species.   The 24 different 
metals assayed were Li, Be, B, Rb, Sr, Mo, Cd, Sn, Sb, Cs, Ba, Pb, U, Al, V, Cr, Mn, Fe, Co, 
Ni, Cu, Zn, As, and Se (Section 2.2.4 details the theory of ICP-MS as a highly sensitive 
elemental analysis technique).  Due to the sensitivity of ICP-MS and to ensure accuracy to 
reflect only naturally occurring concentrations great care was taken to ensure that minimal 
contamination occurred during the preparation of ascidian samples for analysis.  All laboratory 
equipment used, including glassware, spatulas, falcon tubes, adaptors, etc. were acid washed 
using 10% nitric acid, and thoroughly rinsed with Millipore water.  When preparing the organic 
extracts, only HPLC grade methanol and dichloromethane were used.  
 
All of the species studied were compound ascidians therefore the samples prepared were all 
taken from the same colony.  For each ascidian species three representative samples 
(approximately 1.5 g wet weight) of the frozen colony were lyophilised, ground into a powder 
and stored at -20°C until digestion and total metal analysis.  These triplicate samples will be 
referred to as whole ascidian samples from this point on.  Further representative samples (at 
least 5 g wet weight) of the frozen ascidian species were used to prepare organic extracts 
using HPLC grade methanol and dichloromethane.  Extractions were carried out in the normal 
way excepting that all glassware and tools e.g. spatulas used were acid washed, an ice-water 
bath was used when sonicating the material, and when a rotary evaporator was needed to dry 
the extract, an acid washed splash head adaptor was used which was gently heated with a 
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heat gun to ensure that no water vapour within the shaft or adaptor could condense and run 
back into the sample flask causing contamination.  The crude ascidian extracts were stored at 
-20°C until digestion and ICP-MS analysis.  These ascidian extracts will be referred to as 
crude organic extracts from this point on.  The spent ascidian material remaining after the 
sequential extraction process was lyophilised and divided into three samples that were made 
available for total metal analysis as the need arose.  Throughout sample preparation, all 
masses were recorded to four decimal places to ensure accurate calculation of total metal 
concentrations.  
 
Digestions and total metal ICP-MS analyses were performed by the author with assistance 
from Dr Andrea Raab at the Marine Biodiscovery Centre (MBC) at the University of Aberdeen.  
Subsamples of approximately 100 mg of the triplicate whole ascidian samples and the crude 
organic extracts were made for each species for digestion.  These subsamples were digested 
in a microwave (CEM) with 1 mL of concentrated nitric acid and 2 mL of hydrogen peroxide.  
After digestion each sample was made up to 25 mL with Millipore water, and stored at 4°C 
until ICP-MS analysis.  Digests of five samples of reference material (whole egg, IAEA 140, 
TORT-2, DOLT-4 and DORM-3) were made following the same procedure.  Eight calibration 
standards were made incorporating all the metals investigated, at varying concentrations.  
Since high concentrations of iron and vanadium were expected in the ascidian samples the 
seventh and eighth calibration standards were doped with these metals to ensure accurate 
measurement at high concentrations.  Throughout the analysis 73Ge was used as the internal 
standard.    
 
Once the ICP-MS data were collected for all the samples, the metal concentrations obtained 
for the five reference samples were compared with those reported in the literature to ensure a 
reasonable recovery and accuracy.   
 
3.4.1 Results of metal concentration studies in Algoa Bay ascidians 
The total metal analysis results for the triplicate whole, dried ascidian samples are presented 
as an averaged value for each species in Tables 3.2 and 3.3, and Figure 3.1.  The results 
obtained for the organic extracts were used to determine which ascidian extracts to 
investigate using LC-ICP-MS/ESI-MS, the results of which are documented in Section 2.3.  
 
If Tables 3.2 and 3.3 are taken at face value it is not possible to identify any obvious patterns 
within the metal concentration data presented in these two tables.  Due to the vast difference 
in the metal concentrations across the different metals, a logarithmic scale is used in the bar 
chart in Figure 3.1 to try and provide a relative and quantifiable perspective.   
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Even with this acknowledgement of a widely varying sense of scale, it is easy to overlook 
certain metals, such as Be, Sn, Sb, Cs, and Co, which are found only at low concentrations (< 
1 ppm).  These “low concentration” metals may still be of some importance.  It is possible that 
the ascidians could still be considered to be bioaccumulating these “low concentration” metals 
as their concentrations within the ascidians may be significantly higher than the surrounding 
seawater concentrations.133  A measure of the degree to which the ascidians are 
accumulating the metal ions relative to the surrounding seawater would therefore be far more 
useful in any attempts to determine any patterns in the unique data set (the first of its kind 
from an African ascidian population) which we had in hand.  Unfortunately, at the time that the 
ascidian collections were made it was unbeknown to us that a metal ion analysis would be 
carried out several years later on these Algoa Bay ascidians and accordingly no seawater 
samples were collected from the relevant dive sites at the time of the collection. Investigations 
into the literature relating to metal concentrations in Algoa Bay yielded some results relating 
to metal concentrations in water samples collected within river estuaries134,135 at coastal sites 
near sewage outfalls136 as well as in Port Elizabeth Harbour.137  Although these reports are 
interesting, they do not include all 24 metals which were measured in this present study, and 
they are mostly from sites where the metal concentrations are expected to be very high, as 
opposed to those concentrations expected at the relatively pristine open water collection sites 
which are further off shore.  For these reasons, the oceanic metal concentrations (Tables 3.2 
and 3.3) used to determine the bioconcentration factors for the metals in the ascidians are 
those values reported by Nozaki133 in a review of the open water oceanic elemental 
distribution in the North Pacific.  Regrettably there have been no similar studies made in the 
Indian Ocean that we could access for our purposes. 
 
 
Bioconcentration Factor = [metal] in whole ascidian (ppm) 
[metal] in seawater133 (ppm) 
 
 
The bioconcentration factors calculated for each of the metal concentration measurements 
are presented in Figure 3.2. There are still vast differences in the calculated bioconcentration 
factors between different ions, with some concentrations for example of Li and B appearing to 
be only an order of magnitude higher than the general values reported for seawater, while 
other metals such as Al and Fe were concentrated by several orders of magnitude higher 
than seawater by some species (Figure 3.2).  However, as expected even though a 
logarithmic scale is still required to view the data, the use of a bioconcentration factor helps to 
establish which of the “low concentration” metals the ascidians are actively concentrating, for 
example Be, Cd, Sn and Co.  
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Figure 3.2: Metal bioconcentration factors (relative to oceanic concentrations97) of 25 Algoa Bay ascidians. Values are calculated from the average of the 
ICP-MS measurements after NOiH20 2 digestion of the representative triplicate samples of ground dried ascidians. 
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The magnitude and relative complexity of this data set made it difficult to observe clear 
patterns without further statistical analysis.  Although knowing the metal concentrations in a 
particular species of ascidian is interesting, what would be far more beneficial would be to be 
able to confidently identify patterns within these data which might, firstly for example, identify 
quantifiable differences between different collection sites possibly indicative of unknown 
localised areas of metal pollution.  Secondly, since our collection of ascidians was comprised 
of species collected in 2004 and 2011, it would also be interesting to establish if certain 
metals are more abundant in the ascidians relative to the year collected.  A third question that 
could be asked would be: are certain taxonomic groups i.e. families of ascidians accumulating 
a specific metal preferentially over others, and are groups of metals being concentrated 
together in different species from the same taxonomic families.  In an attempt to address 
these interesting questions the data set was investigated using multivariate statistical 
analyses.  
3.4.1.1  Multivariate analysis – Correlation matrix 
One approach to establishing patterns or reducing the dimensionality of a large data set with 
many variables is through principal component analysis (PCA).  In essence PCA identifies 
which variables differ most between the individual cases.138  In other words PCA re-expresses 
the data according to a set of factors where the greatest amount of variability is shown.  In 
this way the measured variables are grouped into the factors based on their correlations with 
each other (grouped into same factor) as well as the variance between them (grouped into 
different factors), thus it is expected that the majority of the data set may now be accounted 
for and explained using fewer factors, or principal components.138  Plotting the weightings of 
the principal components against each other will then help to show any patterns that can be 
used to explain the majority of the data set, and may further establish key trends that can help 
predict the results of a new set of measurements.  Therefore PCA can be used to establish 
relationships between cases and variables.138  In this present study the variables are the 
metal concentrations measured in the whole dry ascidian samples, which are the cases.  
Since PCA does not test anything, but rather identifies sources of grouping and variability in a 
data set, it is a good tool to use in exploring the metal concentration data which we had in 
hand.  In particular our aim was to establish if there are any patterns relating to metal ion 
concentrations at the different dive sites, over the two different years of collections, and within 
certain taxonomic families of ascidians. 
 
The first step was to establish if the data set was indeed appropriate for PCA.  The metal 
concentration data set certainly has multiple variables, but if there are no correlations 
between them, the variables cannot be grouped into factors as no relationship will be 
apparent.  On the other hand, if the variables are all strongly correlated to one another then 
there is no need for PCA analysis as there is probably only one underlying factor that can 
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explain the data set.138  In other words, PCA analysis will be useful for a data set which has 
correlating variables that can be grouped into factors as well as a level of variance between 
said variables so that patterns and trends may become apparent when the established factors 
are compared.  The best approach to use to determine if the data set is appropriate, is to 
create a correlation matrix of the variables.138  Table 3.4 is the correlation matrix obtained for 
the ascidian metal concentrations.  The numbers expressed in this matrix are the correlation 
coefficients (r values) calculated, and those that are marked red were shown to be significant 
with a probability (p value) of less than 0.05.  Negative values indicate an inverse correlation, 
for example the correlation between Pb and B is -0.59 which would imply that an ascidian with 
a relatively high concentration of Pb will have a low concentration of B and vice versa.  The 
correlation matrix obtained for the data shows a number of significant correlations (p < 0.05; 
marked in red) between metal concentrations, as well as a level of variance which satisfies 
the need for PCA to establish the underlying factors and patterns in the data.  Interestingly, 
vanadium and arsenic are not significantly correlated to any metals, and the accumulation of 
vanadium and arsenic in the ascidians appeared to be independent of any other metal. 
 
Although the calculated bioconcentration factors facilitated in visualising the degree to which 
the ascidians accumulate metals relative to the surrounding seawater, there was no 
difference in the correlation matrices (or the subsequence PCA) results obtained for the 
factored measurements compared to that of the non-factored measurements which would 
imply that the relationships between the metal concentrations within the ascidians are 
independent of the seawater concentrations.   
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3.4.1.2  Multivariate analysis – Principal component analysis 
Principal component analysis (PCA) was carried out on the ascidian metal concentration data 
set based on correlations.  Since PCA aims to establish variance in a data set, this analysis 
may give added unsubstantiated weight to variables with large measurement values, thus 
potentially missing patterns resulting from those measurements with lower values.138  In order 
to overcome this challenge, the original data set was standardised to give equal weighting 
and validity to all variables.  When PCA is performed on raw non-standardised data it is 
based on covariance as opposed to correlations, which is when the data set is standardised.  
The ascidian metal concentration data was indeed very varied, and even with the calculation 
of a bioconcentration factor, in an attempt to standardise the raw data, there were still vast 
differences between the metal concentration factors measured.  For this reason PCA was 
carried out based on correlations rather than covariance.   
 
Since 24 metals were measured the maximum number of factors that could be used to 
explain the data set was 24.  The eigenvalues of these PCA generated factors as well as the 
percentages of the data set which could be accounted for by each factor are recorded in 
Table 3.5.  Since our aim was to reduce the number factors required to explain the data set 
efficiently, the next step in our analysis was to decide how many of the PCA generated factors 
to retain, and how many to ignore.    
Figure 3.3: Scree plot of the principal components calculated for the ascidian metal 
concentration data.  Points are labelled with the percentage value of the data that can be 
explained by the related principal component.  
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A common method for deciding on the number of factors to retain is by plotting a scree plot 
(Figure 3.3).138  The points on the curve that appear before the break, or elbow of the curve, 
after which the curve levels out, are the factors that one would go forward with.139,140  
However, in this case there was not a clear break in the curve, and so it was difficult to decide 
which factors to ignore.  For this reason, Kaiser’s criterion was used to establish which 
principal components to continue with.  Kaiser’s criterion states that factors with an 
eigenvalue above 1 are significant.141   
Table 3.5:  PCA eigenvalues of correlation matrix and related statistics. Components 
highlighted in red are retained following Kaiser’s criterion. 
Eigenvalue 
% Total 
Variance 
Cumulative 
Eigenvalue 
Cumulative 
% 
1 7.850571 32.71071 7.85057 32.7107 
2 3.003319 12.51383 10.85389 45.2245 
3 1.944684 8.10285 12.79857 53.3274 
4 1.619947 6.74978 14.41852 60.0772 
5 1.388797 5.78665 15.80732 65.8638 
6 1.179509 4.91462 16.98683 70.7784 
7 1.010144 4.20893 17.99697 74.9874 
8 0.961153 4.00480 18.95812 78.9922 
9 0.852058 3.55024 19.81018 82.5424 
10 0.753396 3.13915 20.56358 85.6816 
11 0.693998 2.89166 21.25757 88.5732 
12 0.569398 2.37249 21.82697 90.9457 
13 0.486729 2.02804 22.31370 92.9738 
14 0.409946 1.70811 22.72365 94.6819 
15 0.314395 1.30998 23.03804 95.9918 
16 0.252131 1.05054 23.29017 97.0424 
17 0.247466 1.03111 23.53764 98.0735 
18 0.139915 0.58298 23.67756 98.6565 
19 0.124453 0.51855 23.80201 99.1750 
20 0.079414 0.33089 23.88142 99.5059 
21 0.063090 0.26288 23.94451 99.7688 
22 0.027368 0.11403 23.97188 99.8828 
23 0.016211 0.06755 23.98809 99.9504 
24 0.011908 0.04962 24.00000 100.0000 
 
Table 3.5 shows the eigenvalues of each factor along with the percentage of the variance that 
is explained by each factor.  With these data, one would continue with the first seven factors 
(highlighted red), which would have a cumulative percentage of 74.98% of the variance 
explained.  Normally seven components would be a large number of components to 
investigate and Table 3.5 shows that the eigenvalues of the components three to seven are 
fairly small in comparison to the first two components.  The third principal component, 
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although small, is on the elbow of the scree plot and incorporating it would explain over 50% 
of the data set, thus our most thorough statistical investigations of the data set focused on 
establishing patterns in the data that could be explained by the first three factors generated.   
 
The results of the PCA showed that the variables had been grouped into factors which 
displayed the most variance between each other and it was of interest to establish the 
weighting that each factor had on the metals measured.138  These variable factor loadings are 
shown in Table 3.6.  The higher the loading score of a metal the more emphasis it had on the 
particular factor.  An alternative view is that the factor within which a metal has its highest 
score will be the factor that best explains the results obtained for that metal variable.138  The 
PCA factor loading for each variable (Table 3.6) showed that eleven of the 24 metal variables 
had strong factor weightings (>0.50) in the first principal component, which accounted for 
32.71% of the variance in the total data set.  Thus, the concentrations of these eleven metals 
within the ascidian cases will influence the case weightings for the first principle component.   
Table 3.6: Factor loading scores of the metal variables obtained from principal component 
analysis.  Red font indicates strong weightings (>0.5). 
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 Factor 7 
Li -0.04 -0.12 -0.58 0.29 0.15 -0.08 -0.19 
Be -0.67 -0.12 -0.05 0.20 -0.09 0.33 0.11 
B 0.52 -0.11 -0.37 0.40 -0.14 -0.05 -0.31 
Rb -0.58 -0.57 -0.17 0.28 0.22 -0.06 0.00 
Sr -0.06 0.57 0.45 0.43 0.14 -0.10 0.29 
Mo 0.31 -0.53 0.34 0.03 -0.33 0.13 -0.21 
Cd -0.30 -0.32 0.43 -0.14 0.11 -0.46 0.01 
Sn -0.23 0.14 0.07 0.10 -0.70 -0.28 -0.05 
Sb -0.39 0.31 0.27 -0.17 -0.30 0.23 -0.39 
Cs -0.93 -0.05 -0.01 0.24 0.06 -0.05 0.03 
Ba -0.48 0.32 -0.30 0.46 -0.13 0.05 -0.07 
Pb -0.87 0.18 0.08 -0.24 -0.04 0.00 0.02 
U 0.28 0.58 0.43 0.52 -0.14 -0.14 0.08 
Al -0.88 0.04 -0.10 0.26 0.13 -0.14 0.08 
V 0.06 0.28 0.29 -0.02 0.43 0.48 -0.06 
Cr -0.85 -0.11 0.07 -0.03 -0.17 0.16 -0.13 
Mn -0.70 0.22 0.03 -0.29 0.09 0.11 -0.15 
Fe -0.93 0.14 -0.04 -0.01 0.14 -0.02 0.04 
Co -0.97 -0.08 0.08 0.00 0.08 0.01 -0.05 
Ni -0.76 -0.34 0.19 -0.08 -0.23 -0.17 0.01 
Cu -0.12 -0.69 0.06 0.30 -0.10 0.30 0.10 
Zn 0.24 -0.49 0.58 0.38 0.07 0.25 -0.10 
As -0.02 0.18 0.22 0.13 0.37 -0.26 -0.70 
Se 0.16 -0.55 0.23 -0.04 0.24 -0.35 0.08 
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Figure 3.4: Principal component analysis results displayed as case factor loading plots of 
principal component 1 against each of the other retained principal components 2 to 7.  Data 
points are labelled with abbreviated ascidian species names. 
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A visual representation of how the principal components are able to group the ascidian cases 
is shown in Figure 3.4 with a series of factor loading plots where cases are plotted based on 
their factor weightings for principal component one against each of the other retained principal 
components.  At this stage we concluded that these plots are “busy” and do not reveal any 
obvious grouping of the ascidian cases.  On investigation of the case factor loading plots 
generated from the principal component three against principal component one the Clavelina 
steenbrasensis (C. steen) samples appeared to be well separated from the other ascidians 
(Figure 3.4).  The metal variables with reasonable factor weightings for factor three are Li (-
0.58) and Zn (0.58).  Since C. steenbrasensis has a low score for principal component three, 
it is reasonable to state that the concentrations recorded for Zn maybe much lower than the 
other ascidians or the concentration of Li is higher in C. steenbrasensis compared to the other 
ascidians.  Revisiting the raw data in Tables 3.2 and 3.3 reveal that C. steenbrasensis has a 
zinc concentrations of 31.73 ppm which was not markedly lower that than of other ascidians.  
However, the lithium concentration was significantly larger (62.74 ppm) in C. steenbrasensis 
which is approximately 12 times higher than the Li concentrations recorded for the other 
ascidians in the study.  This high Li concentration explained why this species appeared to be 
well isolated from the rest of the data set in the factor plot of PC 1 vs PC 3.   
 
It was necessary for us at this point to evaluate the validity of the high lithium concentration 
obtained for C. steenbrasensis.  Consequently, on further investigation of the data set we 
established that the high concentrations of Li were measured in all of the three samples of C. 
steenbrasensis assayed and that the concentrations of the other metals measured were not 
unreasonably different from trends observed in other ascidian species in our data set, thus 
providing significant support for the validity of the result obtained.  It was also unclear why 
such a high concentration of lithium would be present in only one of the ascidian species 
especially since lithium has been shown to be a crucial trace metal in the development of 
ascidian embryos, with particular emphasis on the early development of the nervous system 
and larval tail.142  Biological investigations have shown that over exposure of ascidian eggs 
and blastomeres to lithium chloride resulted in clear development anomalies, emphasising the 
need for controlled regulation of the uptake of this trace metal.142   
 
In terms of the PCA results it was also of interest for us to see the effect which the high 
concentration of lithium in only one ascidian species had on the third principal component.  It 
would appear that the variance explained by the third principal component was dominated by 
the result of only one ascidian and the relationship between the concentrations of lithium in 
the remaining ascidians was not being reflected.  Since the PCA was based on correlations 
the effect of this unusual lithium measurement on the correlation analysis was investigated.  
The correlation between lithium and the other metals in the study was investigated further and 
in order to explain the method used to critically analyse these data the correlation between 
lithium and iron will be presented here as a representative example.   
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The regression analysis performed between lithium and iron showed that there was no 
correlation between the concentrations of these metals (r = 0.0307).  However, Figure 3.5 
illustrates the correlation and regression results in a simple scatter plot, and it is clear to see 
that the data points relating to the three C. steenbrasensis samples are distinct outliers which 
may be having an effect on the overall regression results.   
 
In order to determine whether these data points are influencing the correlation results, a 
residual analysis was performed, and the Cook’s distance of the all the data points were 
measured to determine the most prominent outliers.143,144  Cook’s distance judges the 
contribution of each data point towards the determination of the least squares estimate in 
linear regression.143,144  Data points which result in higher than average (for the data set 
tested) Cook’s distance values can be considered to be outliers that may have an adverse 
effect or influence on the regression analysis results.143,144  The residual analysis of lithium 
against iron using Cook’s distance to determine outliers clearly showed that the three data 
points corresponding to the C. steenbrasensis samples were outliers, with Cook’s distances 
of 1.86, 1.56 and 1.53 which were markedly larger than mean Cook’s distance of 0.007 
produced in this analysis.  
 
Figure 3.5(b) shows the regression analysis results of lithium against iron with the C. 
steenbrasensis lithium data points removed.  There is a dramatic difference in the regression 
analysis results, with a correlation coefficient of r = 0.7037 (shown by the solid red line) which 
has a significance within the confidence interval of p < 0.05 (red dashed lines).  With the 
influencing outliers removed the true relationship between the metals is now apparent.  It is 
important to note that the correlation and regression analyses of lithium against iron has been 
used here as an example to illustrate the dataset influencing outliers in the lithium data, 
however, lithium showed similar results against other metals, where the true correlation was 
only seen once the outliers were removed from the analysis.   
 
Since the PCA analysis is based on correlations, it was important that the true relationship 
between the metals was being investigated.  It was therefore fortuitous that these outliers in 
the lithium readings were revealed when investigating the case weightings in relation to the 
third principal component.  It was believed that lithium was not the only metal to have 
influencing data points that would possibly result in false correlation values, and therefore 
subsequently affect the results of the PCA.  Hence a systematic investigation of each of the 
metals was carried out using regression analysis and Cook’s distance of the residuals to 
determine the most prominent outliers in each of the metal variable data sets.  The regression 
analyses were then rerun with these outliers removed and if distinct changes in the r or p 
values calculated were seen then these outliers were deemed influencing data points.   
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The metals which contained influencing data points were Li, Be, Cd, and Sn.  These outliers 
are indicated in Tables 3.1 and 3.2 by asterisks.  The validity of the original readings is 
unclear however these data points were adjusted so that the PCA carried out would be based 
on the correlations that resulted from the majority of the readings, and not those skewed by 
unexplainable outliers.  Unfortunately, the calculations involved in PCA do not allow for 
missing data and PCA will exclude any cases with incomplete data sets from the analysis.138  
For this reason, simply removing the influencing data points was not the correct approach to 
take and the influencing data points were therefore adjusted to give the average value of the 
remaining data points in the set.  If, as in the case of Be, there was only one influencing data 
point (Pycnoclavella filamentosa sample 3), the influencing data point was adjusted to be the 
averaged value obtained for the two other samples assayed for that species.  
 
Once all the influencing data points where established and adjusted a new correlation matrix 
was made (Table 3.7).  This correlation matrix shows that the corrected metals i.e. Li, Be, Cd 
and Sn now have significantly stronger correlations to other metals than before they were 
corrected (shown in red in Table 3.7).  Strong and significant direct correlations were seen 
between Be and Cs (0.97), Fe and Al (0.94) and Cs and Al (0.94) indicating that these pairs of 
metal are commonly present together in elevated levels in the ascidians investigated.  
Interestingly, the correlation results for the outlier corrected data once again show that the 
concentration of vanadium and arsenic are not significantly correlated to concentrations of 
any other metals.  
Figure 3.6:  Scree plot of the principal components calculated for the ascidian metal 
concentration data where the influencing data points have been corrected.  Points are 
labelled with the percentage value of the data that can be explained by the related principal 
component. 
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Once again the next step in analysing this corrected data set was to establish the number of 
principal components to keep for further analysis.  The scree plot in Figure 3.6 was once 
again difficult to interpret with no clear elbow and thus Kaiser’s criterion (Table 3.8) was used 
as an alternative method to resolve this impasse.  Table 3.8 shows that the first seven 
components accounting for a cumulative 81.5% of the total variance in the data set have 
eigenvalues which are greater than or equal to one which through Kaiser’s criterion would 
deem them significant to explore further.141   
Table 3.8:  Eigenvalues of the correlation matrix and related statistics for the ascidian metal 
concentration data where the influencing data points have been corrected. Components 
highlighted in red are retained following Kaiser’s criterion. 
Eigenvalue 
% Total 
variance 
Cumulative 
eigenvalue 
Cumulative 
% 
1 9.13 38.04 9.13 38.04 
2 3.43 14.30 12.56 52.34 
3 2.06 8.57 14.62 60.91 
4 1.66 6.90 16.27 67.81 
5 1.19 4.98 17.47 72.78 
6 1.09 4.56 18.56 77.34 
7 1.00 4.17 19.56 81.51 
8 0.80 3.33 20.36 84.84 
9 0.74 3.09 21.10 87.93 
10 0.60 2.49 21.70 90.42 
11 0.47 1.97 22.17 92.39 
12 0.38 1.60 22.56 94.00 
13 0.32 1.34 22.88 95.33 
14 0.25 1.06 23.13 96.39 
15 0.22 0.90 23.35 97.29 
16 0.18 0.77 23.53 98.06 
17 0.15 0.61 23.68 98.67 
18 0.13 0.54 23.81 99.21 
19 0.06 0.25 23.87 99.47 
20 0.05 0.21 23.92 99.68 
21 0.03 0.14 23.96 99.82 
22 0.02 0.10 23.98 99.91 
23 0.01 0.05 23.99 99.96 
24 0.01 0.04 24.00 100.00 
 
 
Table 3.9 shows the factor coordinates generated from the PCA of the outlier corrected 
ascidian metal concentration data.   The values shown in red are the stronger factor weights 
for each metal variable.  Thus it was easy for us to see that the factors with the strongest 
weighting were factors 1 and 2 with thirteen metals and eight metals respectively showing 
strong weightings.  The only metal variables with reasonable weightings with factor 3 are Sr 
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(0.51) and Zn (0.52) which both had stronger weightings with factor two.  The other retained 
factors also only had one or two strong weightings across the variables and thus may not 
produce insightful results with further analyses.  Interestingly although factor 5 had a 
weighting of 0.71 for vanadium it would seem that only the results of this metal are explained 
by factor 5.  Since vanadium concentration was still not correlated with any of the other metal 
concentrations (Table 3.7) even after the influencing outliers were removed, it would appear 
that vanadium concentrations in ascidians are not related in any way to the concentration of 
any of the other metals in this study.  Chapter 4.1 will explore the vanadium concentrations of 
Algoa Bay ascidians in more detail. 
 
Table 3.9:  Factor coordinates of the outlier-corrected ascidian metal concentration data 
variables based on correlations.  Red font indicates strong weightings (>0.5). 
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 Factor 7 
Li -0.77 -0.32 -0.35 -0.25 -0.00 0.09 -0.11 
Be -0.95 -0.09 0.05 -0.16 0.00 -0.06 -0.08 
B 0.50 -0.13 -0.42 -0.41 -0.19 0.43 0.06 
Rb -0.62 -0.54 -0.23 -0.28 0.12 -0.11 0.04 
Sr -0.06 0.51 0.51 -0.48 -0.11 -0.24 0.02 
Mo 0.31 -0.64 0.42 0.10 -0.26 0.19 -0.05 
Cd 0.24 -0.72 0.48 0.07 -0.01 0.18 0.09 
Sn -0.58 0.03 0.35 0.17 -0.32 -0.26 0.13 
Sb -0.36 0.25 0.39 0.25 -0.10 0.44 -0.15 
Cs -0.95 -0.05 0.02 -0.22 -0.01 -0.05 0.03 
Ba -0.47 0.32 -0.16 -0.36 -0.26 0.32 -0.10 
Pb -0.85 0.18 0.13 0.27 0.01 0.02 -0.01 
U 0.29 0.50 0.48 -0.53 -0.22 -0.04 0.05 
Al -0.90 0.06 -0.10 -0.27 0.02 -0.08 0.13 
V 0.07 0.24 0.25 -0.12 0.71 0.02 -0.51 
Cr -0.85 -0.14 0.15 0.12 -0.08 0.18 -0.12 
Mn -0.65 0.20 0.08 0.27 0.15 0.29 0.03 
Fe -0.94 0.12 -0.05 -0.06 0.10 -0.07 0.04 
Co -0.96 -0.08 0.09 0.02 0.10 0.06 0.03 
Ni -0.75 -0.33 0.19 0.18 -0.10 -0.09 0.11 
Cu -0.12 -0.68 -0.10 -0.25 -0.06 0.06 -0.21 
Zn 0.23 -0.60 0.52 -0.38 0.11 0.00 -0.19 
As -0.00 0.14 0.22 -0.20 0.43 0.41 0.65 
Se 0.17 -0.52 0.02 -0.03 0.27 -0.28 0.33 
 
The results of the PCA of the outlier corrected metal concentration data were easier to 
interpret once displayed as a factor loading plots using the first two principal components 
(Figure 3.7-3.9).  Only the first two principal components established in the PCA will be used 
here to discuss the results because according to Table 3.9 these factors contained strong 
weightings for majority of the metal variables.  The factor loading plots showing the 
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relationship of the other seven retained components to each other did not result in clearly 
interpretable patterns and thus will not be presented here, but can be viewed in Appendix A. 
 
Plotting the case (ascidian samples) weightings for principal component 1 (PC 1) against 
principal component 2 (PC 2) with the ascidian samples displayed as icons based on their 
taxonomic families showed some level of grouping (Figure 3.7).  The grouping of ascidian 
families in the PC 1 vs PC 2 factor plot will be discussed briefly here.  The stolidobranch 
ascidian family Styelidae (blue circles) was only represented by two species in this 
investigation namely Botrylus sp. and Gynandrocarpa placenta.  The factor weighting of the 
data points relating to these species placed them quite distinctly apart from each other (Figure 
3.7).  This may be because, although they are in the same family, Botrylus sp. and 
Gynandrocarpa placenta are placed into separate subfamilies Botryllinae and Polyzoinae 
respectively.  This taxonomic distinction may result in differing metal concentrations however, 
analysis of a larger number of these stolidobranch ascidians would be necessary to properly 
establish any phylogenetically related metal concentration trends.  All of the other Algoa Bay 
ascidians included in this investigation belong to families within the suborder 
Aplousobranchia. 
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Figure 3.7: Principal component analysis results displayed as case factor loading plots of 
principal component 1 against principal component 2.  Data points are shown as different 
icons based on taxonomic families. 
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The families Clavelinidae (red squares) and Pycnoclavellidae (green diamonds) have recently 
been found, through phylogenetic relationships using mitochondrial DNA data to be 
taxonomically similar enough to be placed in the same family.145  However, in this analysis we 
allocated different icons to the two historically different genera and labelled them as the 
previous family synonyms to facilitate the observation of patterns.  Interestingly there was no 
clear grouping of the Clavelinidae and Pyconclavellidae (previous synonym) samples based 
on the metal ion data (Figure 3.7) which may be solely due to the fact that only three species 
were used to represent this family which was not a large enough number to give a true 
representative result.  
 
The family Didemnidae (pink triangles) appear to be grouping with high scores for both PC 1 
and PC 2.  Interestingly the 3 samples of Didemnum sp. 1 are all inconsistent with the other 
samples of this family, and are randomly scattered.  A point to note is that on analysing the 
metal correlation data for influencing outliers the samples of Didemnum sp.1 often appeared 
to have larger than average Cook’s distance values however, there were no significant 
changes in the regression analysis if these data points were removed, thus the correcting of 
the data obtained for Didemnum sp.1 was not warranted because these are not influencing 
outliers.  This does however help to explain why the factor scores for Didemnum sp. 1 were 
not consistent with the other didemnid samples.   
 
Within the family Holozoidae (black circles) the data relating to both Sigillina sp. and 
Hypodistoma vastum appear in a similar area of the scatter plot presented in Figure 3.7 whilst 
data relating to Distaplia skoogi is distinctly separated.  The random positioning of each of the 
triplicate data points relating to D. skoogi would suggest that there was variation in the metal 
content measured across this colony suggesting that this particular sample or genus of 
Holozoidae may be unusually inconsistent in terms of its metal content profile. 
 
The data points relating to ascidians within the Polycitoridae family (blue squares) all 
appeared relatively well grouped  together in the PC 1 vs PC 2 factor loading scatter plot 
(Figure 3.7).  However, these data points are not distinctly separated from the other families 
which once again may be due to the limited number of Polycitoridae species assayed 
impacting negatively on us being able to observe any interpretable patterns for this family.   
 
The data points corresponding to the Pseudodistomidae family are randomly scattered in 
Figure 3.7.  Additionally there appears to be distinct differences between the triplicate 
ascidian samples measured indicating inconsistency within the metal concentration fingerprint 
of these colonies of Pseudodistomidae species. 
 
The Polyclinidae family (red diamonds) seem to have an interesting pattern where the data 
obtained for the two species within the genus Aplidium are positioned fairly close to each 
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other in the scatter plot, whilst the Synoicum sp. data grouped further to the right and 
Aplidiposis tubiferus data points appear to be shifted to the left side of the PC 1 vs PC 2 factor 
loading scatter plot (Figure 3.7).  It is not clear why the Polyclinidae data was grouped in this 
way. 
 
The interpretation of these data was difficult as the samples investigated were representative 
of a relatively large number of ascidian families and in most cases the data were obtained 
from only three or four species per family meaning that statistically significant patterns of 
metal concentration within different families, if they existed, were not easily discerned.  The 
family Didemnidae contributed the greatest number of species to our data set and, with one 
notable exception (Didemnum sp.1) as discussed above, provided the clearest evidence of a 
possibly phylogenetic related trend in metal ion accumulation in Algoa Bay ascidians.  
 
Plotting the case weightings for principal component 1 vs principal component 2 with the 
cases grouped based on dive site (Figure 3.8) and based on year of collection (Figure 3.9) do 
not show any definitive patterns.  Plots generated for all the other factors are just as 
homogeneous, implying that neither the year nor dive site has an influence on the 
concentrations of metals concentrated in the ascidian species. 
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Figure 3.8: Principal component analysis results displayed as case factor loading plots of 
principal component 1 against principal component 2.  Data points are shown as different 
icons based on the dive sites from where ascidian samples were collected. 
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Figure 3.9:  Principal component analysis results displayed as case factor loading plots of 
principal component 1 against principal component 2.  Data points are shown as different 
icons based on the year of collection. 
 
The rationale behind displaying the PCA results based on collection location and year was 
because both of these variables would potentially indicate a change in the metal 
concentrations found in the surrounding seawater.  The homogenous nature of the data in 
factor loading scatter plots in Figures 3.8 and 3.9 indicated that the accumulation of different 
metals in this set of ascidian samples is not related to the collection location or year.  This 
suggests that the concentrations of the metals contained in the surrounding seawater are not 
necessarily a strong influencing factor of the metal concentration profile of ascidians.  This 
adds weight to the belief that ascidian species actively accumulate a variety of metals from 
the surrounding seawater and are not simply a sink for metals passively accumulated in filter 
feeding.  This observation also indicated that Algoa Bay ascidians could not be considered as 
suitable environmental metal biomonitoring organisms as there were no observed pattern 
which linked the site of collection to the metals accumulated by the ascidians  (the collection 
sites on the western periphery of  Algoa Bay were spread over an area > 20 km2).  The 
presence of elevated levels of a particular metal in an invertebrate does not warrant its use as 
a bioindicator and extensive long term studies on the temporal and spatial relationships of the 
metals in the environment and the invertebrate are necessary to confirm that the 
concentrations detected in the invertebrate are in fact directly related to the health of the 
surrounding reef.127,128,131   
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As a cautionary note, as was discussed with the interpretation of the PCA results in which we 
attempted to find a possible phylogenetic link between ascidian families and metal ion 
accumulation patterns, the absence of a possible spatial and temporal correlation with metal 
ion accumulation in Algoa Bay ascidians concluded from this study may be a reflection of the 
relatively small sample size and thus not truly representative.   
 
 
3.5 Concluding Remarks 
 
The initial purpose of the large scale collection of ascidians from Algoa Bay in 2004 was the 
discovery of new bioactive secondary metabolites with potential pharmaceutical applications 
and not to analyse the metal concentrations with an aim of possibly identifying a potential 
bioindicator candidate for the future environmental monitoring of Algoa Bay.  However, our 
later investigation of this unique collection of ascidians for bioactive metal – marine natural 
product complexes described in Chapter 2, coupled with the subsequent emergence of 
significant taxonomic data around this collection, provided, as a spin-off from the main goal of 
the project, an opportunity to acquire a dataset that afforded the concentrations of 24 different 
metals in 25 different Algoa Bay ascidian species.  Therefore, our goal described in this 
Chapter was to retrospectively critically evaluate this unique database to discern if there were 
any potential phylogenetic, temporal and spatial correlations between metal concentrations 
and selected Algoa Bay ascidians.  While we were unable to find any evidence to support 
temporal and spatial correlations between these selected Algoa Bay ascidian species and 
metal distribution, through the principal component analysis of the data which we had at hand 
we were able to provide some evidence to support a phylogenetic relationship between metal 
concentration and Algoa Bay ascidians.  This preliminary investigation could warrant a larger, 
more in depth future study to further support, or refute, this initial observation.   
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4.1  Vanadium in ascidians 
Since Henze’s 1911119 discovery of unusually high levels of vanadium together with an 
organic chromogen in the blood of the ascidian Phallusia mamillata, both chemists and 
biologists alike have been curious about the biological reason why, and the mechanism of 
how, particular ascidains are able to hyper-accumulate vanadium.119,120  Early investigations 
of the metal content of ascidians showed high levels of vanadium to be localised in 
vacuolated blood cells, termed vanadocytes, in the blood of phlebobranchs whereas the 
evolutionarily more advanced stolidobranchs preferentially accumulated iron in blood cells 
which were termed ferrocytes.146  The aplousobranchs which were believed to be positioned 
in between the two ascidian suborders in terms of evolutionary progress were found to 
concentrate either iron or vanadium.120,146,147  These findings, along with the fact that at the 
time vanadium was considered a rare metal, led many early investigators to falsely predict 
that vanadium was used in oxygen transportation in phlebobranch ascidians.  It was 
erroneously proposed that since Phlebobranchs, like other ascidians, are primitive chordates 
that understanding the transition from vanadium as an oxygen carrier over to iron could hold 
the key to discovering how respiration in higher order chorates evolved.120   
 
The blood of ascidians is made up of approximately nine to eleven variable blood cells that 
can be classified as either hemoblasts, leukocytes, lymphocytes, vacuolated cells, 
nephrocytes, or pigment cells depending on their morphology.148  It is the vacuolated cells 
that accumulate vanadium and they are commonly referred to a vanadocytes, however there 
are still further morphological differences as well as vanadium accumulating abilities that 
distinguish the vacuolated cells further into groups of morula cells, signet ring cells, 
compartment cells, and small compartment cells respectively.148  Interestingly, ascidian blood 
cells are actively amoeboid and are all able to leave the vascular system and penetrate the 
tunic therefore bearing little resemblance to the blood of higher order chordates such as 
vertebrates.149  The presence of a circulating biological fluid and the fact that oxovanadium 
can undergo redox reactions to take up or release oxygen, does not prove that vanadium 
within the blood of ascidians has the primary role of oxygen transportation.38,120,150  Ascidians 
are sessile and do not expend a great deal of energy.  Accordingly, the oxygen transfer 
directly from the ascidian’s branchial sac to the surrounding body parts during periods of filter 
feeding, when there is a constant water flow, is believed to be sufficient for respiration and 
cell function.132,150   However, there is some evidence that vanadium in the blood system may 
be involved in the release of oxygen for respiration during extended periods of anoxia.132,151  
These periods of oxygen deprivation may occur when ascidians tightly close their siphons 
during low tides especially when growing in intertidal regions.  Throughout this anoxic period, 
the branchial sac which is filled with seawater will act as an oxygen reservoir, however, as the 
partial pressure of oxygen in the trapped seawater decreases the need for oxygen to be 
transported around the body in a metal-bound form may arise.132,151  The biological 
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significance of high levels of vanadium in the blood of some ascidian species is therefore still 
questionable.38,120,132,151   
 
Like most transition metals, vanadium most commonly occurs in the marine environment as 
an oxyanion.  The majority of the vanadium in seawater will persist in the V(V) oxidation state 
as vanadate (HVO42-), however, in anoxic environments reduction may occur to produce 
unstable hydroxide species of vanadyl (VO2+) with vanadium in the V(IV) oxidation state.118  
The oxidation state of vanadium accumulated within ascidians appears to be related to 
phylogeny with phlebobranch ascidians concentrating the majority of vanadium in the V(III) 
oxidation state, in the form of aqua-sulphato ions [V(III)SO4(H2O)5]+, often alongside much 
lower concentrations (~10%) in the V(IV) state, whilst Aplousobranchia ascidians exclusively 
contain vanadium (IV) in the form of vanadyl (VO2+), and finally stolidobranch ascidians do not 
commonly contain elevated levels of vanadium.120,147   In the case of accumulation by both 
Aplousobranchia and Phlebobranchia ascidians vanadate present in seawater enters the 
ascidian’s branchial sac and is absorbed and reduced to the less stable V(IV) and/or V(III) for 
storage in the vanadocytes.148  A number of different blood cells have been found to house 
vanadium in varying concentrations and the term vanadocyte is a common name given to all 
vanadium containing blood cells.  Since V(III) is only stable under very acidic conditions 
numerous investigations have focused on determining the compounds or proteins present 
that are effective in reducing vanadate as well as chelating to, and thus stabilising and 
storing, V(III).38,120  This evidence led to a focussed search towards finding auxiliary 
compounds present in the blood of ascidians that were responsible for vanadium reduction 
and storage.38   
 
4.1.1 Tunichromes 
Kustin and co-workers152 established that green and yellow chromagens, which they called 
tunichromes, were contained in the vanadium rich ascidians Phallusia nigra (synonum Ascidia 
nigra) and Ciona instenalis.  Tunichromes were also found in the iron accumulating Molgula 
manhattensis and were shown to successfully reduce both metals.152,153  The early studies of 
tunichromes found them to be very unstable, highly reactive and either subject to 
decomposition on exposure to air and water, or strongly retained by a variety of solid phase 
chromatography packing materials.152,154  Furthermore, attempts to stabilise the tunichromes 
through acetylation before purification were unsuccessful.154  These setbacks led Kustin and 
co-workers to develop an unusual extraction and purification process where all stages of 
these two processes were carefully conducted with degassed solvents under inert, dry and 
anaerobic conditions.  As a result, some five years later, the definitive structures of the 
brightly coloured tunichromes from the vanadium rich blood of P. nigra were established as 
the hydrodopamine derived tripeptides, 4.1 - 4.3.155  Using the same anhydrous and 
anaerobic isolation protocols three other tunichromes (4.4 - 4.6) were isolated from the 
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vanadium rich blood of Phallusia mamillata.149  The basic structure of tunichromes 4.4 - 4.6 
differed from those isolated from P. nigra only by the saturation of the C-11 to C-12 bond.29,149  
A further two tunichromes containing only two dopamine residues, linked by either glycine 
(4.7) or leucine (4.8) were isolated from the iron rich stolidobranch Mogula manhattensis.156 
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The catechol and or pyrogallol moieties present in tunichromes provided strong evidence in 
support of the predicted involvement of tunichromes in the reduction and chelations of 
vanadium in phlebobranchs and iron in stolidobranchs.38,154 However, further investigations to 
test these predictions were initially impossible owing to the complicated isolation procedures 
and instability of tunichromes.  It was only after Kim et al. developed an isolation procedure 
where the tunichromes in the extracted ascidian blood were temporarily stabilised throughout 
the purification stage as tert-butyldimethylsilyl (TBDMS) and tert-butyloxycarbonyl (Boc) 
ethers (the ether protecting groups were subsequently removed after purification in the usual 
manner38,149,154) that this method allowed for the isolation of even trace amounts of 
tunichromes in numerous other ascidians as well as facilitating the production of synthetic 
tunichromes in large enough quantities for detailed metal reduction and chelation studies.38    
 
Subsequent studies on the purified tunichromes found that while tunichromes strongly chelate 
with vanadium and are able to reduce V(V) to V(IV) at biologically relevant conditions, they 
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cannot reduce vanadyl further to V(III) in aqueous solutions.38,120,157–159  There are also a 
number of other biologically common compounds including glutathione, cysteine, NADH, and 
NADPH which are capable of reducing V(V) to V(IV), clearly suggesting that tunichromes are 
not the only source of reducing agents available.120  The presence of tunichromes has been 
widely studied in a number of vanadium accumulating phlebobranchs as well as iron 
accumulating stolidobranchs, however no tunichromes have been reported for the vanadium 
rich aplousobranchs.38,120,160,161  The lack of tunichromes in aplousobranchs implies that either 
the primary biological role of tunichromes is not to reduce and concentrate metals such as 
iron and vanadium, or that aplousobranch ascidians have evolved a different mechanism for 
concentrating vanadium which does not require the presence of tunichromes.38 
 
The strongest piece of evidence against the role of tunichromes in vanadium accumulation 
and reduction in ascidians is that although both vanadium and tunichromes are concentrated 
in the blood of phlebobranch ascidians, studies have shown that majority of vanadium is 
stored as V(III) in the green/grey signet ring cells whilst tunichromes occur exclusively in the 
bright yellow green morula cells.162  This separation of V(III) and tunichromes between two 
different cells indicates that the primary biological role of tunichromes is not the production 
and maintenance of V(III) in the blood of phlebobranchs.  Although the biological role(s) of 
tunichrome in ascidians remain uncertain they have been shown to be involved in the 
crosslinking of fibres in the structural formation of the tunic, in defence mechanisms, and in 
wound healing.38,163   
 
4.1.2 Vanabins - Vanadium associated proteins involved in vanadate reduction 
After over 100 years of research into the accumulation of vanadium in ascidians it is only 
within the last decade that some headway has been made.  An important development made 
recently was Michibata and co-workers’ discovery of a series of vanadium binding proteins 
termed vanabins (Figure 4.1).164  To date five vanabins have been found with vanabins 1-4 
being present in the vanadocytes and vanabinP present in the blood plasma of Ascidia 
sydneiensis samea.120  The first vanabins were identified using anion exchange 
chromatography and atomic absorption spectroscopy.  All of the vanabins were found to be 
rich in cysteine and lysine residues and to have a molecular mass of between 10-20 
kDa.75,164,165  The positioning of 18 cysteine residues within the amino acid chains appeared 
to be well conserved for vanabins 1-4.120,165,166  Michibata’s group identified the genes which 
encoded vanabin 1 and 2 and through cloning and recombinant gene expression using E. coli 
they were able to conduct numerous studies into the properties of vanabins.167  The solution 
structure of vanabin 2 was subsequently determined using multidimensional NMR 
experiments.  Vanabins have a novel bow-shaped structure where four α-helices are 
stabilised by the disulphide bonds between the 18 cysteine residues (Figure 4.1).   
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Figure 4.1: The structure of vanabin 2 (Protein Data Bank ID: 1VF1)168,169 with the sulphur 
atoms (yellow) of the nine disulphide bridges enlarged for easy identification.  The areas 
within the red rectangles encompass sites targeted by Michibata and co-workers in directed 
mutagenesis experiments.148,170 
 
Vanabins 1 and 2 were shown to bind up to 20 vanadyl ions and through electron 
paramagnetic resonance studies as well as 15N HSQC NMR titration studies, it was 
established that the VO2+ ions were localised in a region of the protein where basic amino 
acids such as lysine and arginine were present.164,168  These experiments, along with recent 
site specific mutation studies, confirm that the amine functionalities on lysine and arginine 
residues are critical for metal binding whilst the highly conserved cysteine residues appear to 
have little association with vanadyl ions.164,168,171   
 
Generally, disulphide bonds are not commonly found in cytoplasmic proteins as the 
environment within the cells would result in the reduction of cysteine residues.168  However, 
the rare disulphide bond containing intracellular proteins such as thioredoxin and glutathione 
have been linked to redox processes.168  Michibata and coworkers therefore postulated that 
the role of the disulphide linkers between the 18 cysteines in vanabins 1-4 are involved in the 
reduction of vanadate.  Michibata and co-workers propose that the vanabin catalyse the 
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reduction of V(V) to V(IV) through a redox cascade; fuelled by the electron transfer when 
disulphide bonds are cleaved and then reform.148 Further evidence for the involvement of the 
disulphide linked cysteines in the formation of vanadyl has recently been established after site 
directed mutagenesis experiments on the cysteine residues of vanabin 2 effectively 
neutralised V(V) reduction.170  Vanabins are therefore involved in both the reduction of V(V) to 
V(IV) and the storage and transport of V(IV) within the vanadocyte.170  The presence of 
vanabins within phlebobranch ascidians is thought to be fairly ubiquitous, however, no 
evidence supporting the production of vanabin by vanadium rich aplousobranchs has been 
reported in the literature.164,170,172    
4.1.3  The role of cellular acidity and sulphates in the maintenance of V(III) 
Many early reports noted that a strongly acidic solution was present on lysis of ascidian blood 
cells and vanadium accumulation was often found in low pH conditions in ascidians.148,173,174  
Although the accumulated V(III) would be more stable under these acidic conditions, there are 
a number of conflicting reports providing contradictory pH values for the solution resulting 
from the lysis of ascidian blood cells and so it was difficult to determine if the reported pH 
values were the result of redox reactions or lysis of the ascidian blood cells.38,148   Michibata 
and co-workers used a microelectrode and non-invasive electron spin resonance (ESR) 
techniques on intact blood cells of three Ascidia species and were able to determine that the 
most acidic cells were indeed those that contained V(III).148  Vanadium accumulation has also 
commonly been reported in conjunction with high levels of sulphates.175–177  Through 
nonintrusive X-ray absorption spectroscopy (XAS) studies Frank et al. were able to determine 
that vanadium was predominantly coordinated as [V(III)SO4(H2O)4-5]+ in the signet ring cells of 
A. cerotodes.175–177  The acidity of the signet ring cells and the vanadium/sulphate interaction 
finally explains how such high concentrations of the unstable V(III) are maintained in 
phlebobranch ascidians.  How vanadium is reduced to the V(III) is unfortunately still unclear 
although it has been postulated that cysteine is involved in this process which is once again 
supported by the high levels of sulphur common in the blood cells of vanadium accumulating 
ascidians.148 
4.2 Presence of vanadium in Algoa Bay ascidians 
Chapter 3 describes the total metal analysis of twenty five carefully selected Algoa Bay 
ascidians.  The results described in this Chapter show that South African ascidian species, in 
common with ascidians elsewhere, are capable of bioaccumulating a variety of metals from 
the marine environment.  Notably, the PCA presented in Chater 3 revealed that dispite 
numerous correlations between the concentrations of metals investigated, none of the other 
metal concentrations correlated significantly with high concentrations of vanadium (Table 3.3).  
What this possibly means is that high levels of vanadium in an ascidian is not related to high 
or low levels of any of the other metals investigated which in turn may imply that the 
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mechanisms used in the accumulations of vanadium are distinct from those employed in the 
process of concentrating other metals.   
 
The introduction to this chapter detailed numerous successful investigations that have 
contributed towards a growing understanding of the accumulation and maintenance of 
vanadium within the blood of ascidians.  The most thoroughly studied ascidian suborder in 
terms of vanadium accumulation and reduction, and accordingly the best understood, is the 
suborder Phlebobranchia.120  Our interest however lies in the suborder Aplousobranchia 
which are abundantly represented on the reefs of Algoa Bay and relatively understudied when 
it comes to the process of vanadium accumulation.  What little is known about the vanadium 
chemistry of aplousobranchs ascidians is also distinctly different to that of the phlebobranchs 
i.e. aplousobranchs accumulate only V(IV) and not V(III), no vanadium reducing tunichromes 
have been found in the blood of aplousobranchs, and there is no current evidence towards 
the presence of the vanadium binding vanabins in aplousobranchs.120,147,148,160,171  These 
differences all add weight to Swinehart’s early prediction that the differences in vanadium 
oxidation state may suggest that aplousobranchs evolved to accumulate vanadium 
independently from phlebobranch ascidians potentially resulting in a completely different 
mechanism used for accumulation and even a distinctly different biological use for 
vanadium.173  It was therefore deemed necessary to explore the vanadium concentration 
results obtained for twenty five Algoa Bay ascidians (23 aplousobranchs and 2 
stolidobranchs).   
4.2.1 Total vanadium concentrations in 25 Algoa Bay ascidians 
The triplicate average vanadium concentrations measured for whole freeze dried ascidian 
samples as well as organic extracts (not in triplicate) of the corresponding 25 ascidians 
collected from Algoa Bay are shown in Figure 4.2.  Vanadium concentrations were 
determined using ICPMS after sample digestion with nitric acid, as detailed in Chapter 3.  The 
ascidian species with the highest concentration of vanadium were Eudistoma sp.1 (4658.4 
ppm), Atriolumn marinense (3531.4 ppm), Pseudodistoma sp.1 (1694.8 ppm), Polycitor sp. 
(388.3 ppm) and Hypodistoma vastum (194.6 ppm).   With the exception of Eudistoma none 
of the genera from the Algoa Bay collection which resulted in exceptionally high vanadium 
concentrations have been previously investigated.  Vanadium accumulation in ascidians 
belonging to the genus Eudistoma have been fairly well studied.  Levine reported a vanadium 
concentration of 471 ppm in the body of Eudistoma ritteri.  A pH of 1.5 was reported for the 
body tissue and tunic fluid of E. ritteri and believed to be the result of sulphuric acid present in 
the ascidian however proof that the acid was associated with the vanadium was not 
conculsive.174  Ciereszko et. al. found 200 ppm vanadium in E. olivaceum however the level 
of vanadium in E. capsulatum was below the detection limit.178  Swinehart et al. established 
the vanadium concentration of E. psammion, E. diaphanes, E. molle, and E. ritteri to be 130 
ppm, 25 ppm, 1000 ppm, and 320 ppm respectively.173  The oxidation state of vanadium 
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found in all of the Eudistoma species investigated by Swinehart et al. was V(IV) and these 
researchers noted that many of these species possessed acidic tunics.173  A recent study by 
Jaspars and co-workers of the metal ion content of an organic extract from E. gilboviride 
found a relatively low concentration of 19 ppm of vanadium.47 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2:  Concentrations in ppm (mg of metal per kg of organism or extract) of vanadium 
in 25 Algoa Bay ascidians. Values were obtained from NO3/H2O2 digests of either triplicated 
samples of whole dry ascidian (error bars indicate standard deviation) or single samples of 
CH2Cl2/MeOH extracts of ascidian and are displayed in grey and black respectively.    
Although all of the other ascidian species represented in Figure 4.2 exhibited markedly lower 
concentrations of vanadium (< 100 ppm) the oceanic concentration of vanadium is only 2.0 
ppb133 which means that even the ascidian with the lowest recorded concentration of 
vanadium, Synoicum sp. (2.1 ppm), is able to accumulate vanadium in concentrations that are 
a thousand times greater than that of the surrounding seawater.   
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This shows that even though only three of the ascidian species studied could be termed 
vanadium hyper-accumulators with vanadium concentrations above 1000 ppm, the 
concentrations of vanadium recorded in all of the ascidians studied were distinctly greater 
than that of the surrounding seawater.  Ascidians from the suborder Aplousobranchia have 
previously been found to contain high concentrations of vanadium.147  However ascidians 
belonging to the order Stolidobranchia are believed to have lost their ability to accumulate 
vanadium in their evolutionary development, however in our study the stolidobranch Botryllus 
sp. was found to contain vanadium at a concentration of 28.1 ppm which, although low, is 
certainly comparable to many of the vanadium accumulating aplousobranchs that formed part 
of our study (Figure 4.2).  This could imply that not all stolidobranchs have lost their ability to 
accumulate vanadium. 
 
The concentrations of vanadium found in the organic extracts of each ascidian species are 
also presented in Figure 4.2.  It was promising to see that for the most part species with high 
vanadium concentrations in the whole organism also had relatively high levels of vanadium in 
the organic extracts produced from these ascidians. This congruency may indicate the 
presence of organo-vanadium compounds in the extracts which prompted us to investigate 
the presence of these compounds in selected extracts with LC-ICP-MS/ESI-MS.  As 
mentioned previously in Chapter 2, the organic ascidian extracts chosen for LC-ICP-MS/ESI-
MS were selected based on the results obtained for all of the metals tested not only 
vanadium.  Figure 4.2 depicts the vanadium (m/z 51) ICP-MS traces obtained for all of the 
ascidian extracts selected for LC-ICP-MS/ESI-MS analysis.  It was very surprising that the 
51V-ICP-MS traces obtained for the ascidians with the greatest concentrations of vanadium, 
Eudistoma sp.1 (4658.4 ppm), Atriolumn marinense (3531.4 ppm), Pseudodistoma sp.1 
(1694.8 ppm) and Polycitor sp. (388.3 ppm) did not contain prominent vanadium peaks 
(Figure 4.3).  A possible explanation of this observation may be that the vanadium species 
present in the whole ascidian and organic extracts are highly polar compounds that elute 
early in the chromatography gradient and the vanadium signal would thus be obscured in the 
region of the ICP-MS trace that is dominated by noise from inorganic salts.  In the case of 
ascidians of the genus Eudistoma there are literature precedents which indicate a link 
between the presence of high levels of vanadium and an acidic, sulphur rich environment 
where vanadyl is present as a sulphate or hydroxyl anion.173,174   
 
Of further interest was that the vanadium (m/z 51) ICP-MS traces obtained for the other 
ascidians investigated resulted in fairly board peaks at two different retention times of 9.05 
and 10.30 minutes.  The presence of peaks at similar retention times may indicate the 
presence of a similar vanadium species across the ascidian extracts.  Unfortunately, no clear 
molecular ions of possible organo-vanadium complexes could be identified at the 
corresponding retention time in any of the ESI-MS spectra suggesting that these complexes if 
they did exist do not survive the LC-ICP-MS/ESI-MS protocols we had in place. 
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Figure 4.3: Vanadium (51V) LC-ICP-MS traces obtained for the MeOH/CH2Cl2 extracts of 
selected Algoa Bay ascidians.  Traces are vertically offset for clarity. 
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It became increasingly evident to us that our LC-ICP-MS/ESI-MS strategy was not going to 
provide us with evidence of organo-vanadium complexes in the Algoa Bay ascidians and we 
returned to the literature to explore vanadium complexation with various biomolecules.  Given 
our discovery of nucleoside metabolites in Aplidium monile through the inital NMR studies of 
the Algoa Bay extracts described in Chapter 2.3.2 and their isolation and identification 
discussed here in Section 4.4, our attention was drawn to a significant body of work around 
the complexation of vanadium with nucleosides.179–183 
 
4.3 Nucleosides as metal ion chelators  
Nucleosides consist of either a pyrimidine base in the case of cytidine (4.9), thymidine (4.10) 
and uridine (4.11), or a purine base in the case of guanosine (4.12), ionosine (4.13) and 
adenosine (4.14), attached to either five carbon ribose or deoxyribose sugars.184  Nucleosides 
form an integral part of the structure of the phosphorylated nucleotides which are the building 
blocks for RNA and DNA making them key components of all living cells.184  Not surprisingly 
the biochemical role of both natural and synthetic nucleosides and their analogues have been 
widely studied.  Numerous studies have successfully proven that nucleosides readily interact 
with metal cations including gold, ruthenium, lead, mercury, magnesium, calcium, strontium, 
barium, manganese, cobalt, nickel, zinc, and cadmium.185–188  Of interest to us in the context 
of this thesis, however, is the interaction between nucleosides and vanadium. 
 
N
N
NH2
O
O
OH OH
HO N
NH
O
O
O
OH
HO N
NH
O
O
O
OH OH
HO
O
OH OH
HO N
NHN
N
O
NH2
O
OH OH
HO N
NHN
N
O
O
OH OH
HO N
NN
N
NH2
4.9 4.10 4.11
4.12 4.13 4.14 .  
 
Chapter 4 
 
117 
4.3.1 Vanadium chelation by nucleosides 
The interaction of nucleosides and vanadium has been a topic of great interest to many 
researchers due to the ability of vanadium to inhibit ribonuclease activity by direct enzyme 
interaction via either the metal cation or  the nucleoside-vanadium complexes.181,189  Although 
nucleoside complexes with both vanadate and vanadyl ions are possible in biological 
systems, investigations into the stability and structure of nucleoside-vanadium complexes 
have only thus far been conducted for the vanadate ion.189–193  Nucleoside-vanadate 
investigations have used 51V NMR spectroscopy in combination with common nuclei NMR 
spectroscopy, circular dichroism and potentiometric analyses to successfully detect and 
characterise complexes.180,192,193  The uridine and adenosine based studies established that 
the major nucleoside-vanadate complex formed in biologically analogous systems was in a 
2:2 metal:ligand ratio.  Paradoxically, the minor 1:1 metal:ligand complex was shown to be the 
more potent inhibitor of ribonuclease.192,193  In the case of the adenosine-vanadate study the 
most stable complexes which formed were V2Ad2n- which were found to persist over the wide 
pH range of 3.5 to 10.0.  Between pH 5.5 and 8.0 almost 75% of the vanadate is bound in 
these complexes with the -2 charged state predominating.  Spectroscopic analysis of this 
dimeric structure revealed that vanadium was pentacoordinated with one of the two 
coordinated ribose vicinal oxygens from each adenosine moiety bridging the two vanadium 
atoms.192  The investigation into the uridine-vanadate counterpart yielded similar results with 
the V2Ur22- complex present as the major species.193  The exact geometry of these 
adenosine-vanadate and uridine-vanadate complexes were later established by X-ray crystal 
structure analysis.183,194   Figure 4.4 depicts a simplified representation of the structure 
established through X-ray crystallography of the 2:2 vanadate-adenosine complex.181,183  A 
great deal of research has been carried out to understand the chemical structure and 
properties of vanadate-nucleoside complexes and their role in the inhibition of ribonuclease 
and as a result these systems are now well understood.181  Studies into the interactions 
between nucleosides and vanadyl are unfortunately rare and usually qualitative in nature with 
limited information provided about the stability or structures of the complexes formed.190  The 
vanadyl accumulating aplousobranch ascidians dominated our study of Algoa Bay ascidians 
therefore providing us with the rationale to investigate the relatively little studied binding ability 
and stability of vandyl-nucleoside complexes. 
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Figure 4.4:  The structure of the major 2:2 vanadate-adenosine complex determined by X-ray 
crystallography.183  
 
4.3.2 The distribution of nucleosides and their derivatives in ascidians 
Nucleosides and their derivatives are commonly found in a vast array of marine organisms 
and a recent review by Peng and co-workers details the more unusual nucleosides 
discovered in the marine environment.184  The following discussion will focus only on those 
nucleosides isolated or detected in ascidians. 
 
The isolation of nucleosides and their derivatives are well documented in aplousobranch 
ascidians.184  Within the Didemnidae family the nucleosides thymidine (4.10) and uridine 
(4.11) have been isolated alongside 2’-deoxynucleosides (4.15-4.18) from Atriolum 
robustum,195 Didemnum psammatodes196 and Trididemnum cereum.197  The tubercidin 
derived 7-deaza-5’-deoxyadenosine nucleoside (4.19) was isolated with its brominated (4.20) 
and iodinated (4.21) analogues from Didemnum voeltzkowi,198 whilst the Okinawan didemnid 
Diplosoma sp. yielded a similar iodinated tubercidin-like nucleoside (4.22) which possessed 
an uncommon sugar unit.199   
 
Within the Polycitoridae family the only genus from which nucleosides have been isolated is 
Eudistoma.  The common nucleosides 4.12 and 4.14 were isolated from the Brazilian ascidian 
E. vannamei196 whilst 4.10 and 4.14 were isolated from a Micronesian Eudistoma species.200  
The new nucleoside derivative, 3-deazainosine (4.23) was isolated along with the known 
nucleosides 4.13-4.15 and 4.18 form the Egyptian ascidian E. laysani.201   
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The genus of ascidian which is most commonly reported to contain nucleosides is Aplidium  
belonging to the Polyclinidae family.31  Thymidine (4.10) was detected in the  Antarctic 
species A. falklandium, A. fuegiense, A. meridianum and A. millari.202  The nucleosides 4.10, 
4.11 and 4.14 were isolated from A. constellatum collected in the South China Sea.203  
Thymidine-5’-carboxylic acid (4.24) and 2’-deoxyuridine-5’-carboxylic acid (4.25) were 
isolated from the Mediterranean ascidian Aplidium fuscum and are the only nucleosides with 
a 5’-carboxylic acid functionality reported in the marine environment.184,204  The known 
nucleosides 4.10 and 4.11 and 2’-deoxynucleosides 4.15 and 4.17 as well as 7-deazainosine 
(4.26) were isolated form the South Australian ascidian A. pantherinum.205 
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From the chemical literature there appears to be a tenuous phylogenetic relationship between 
the presence of nucleosides in concentrations high enough to be detected and isolated from 
the general mix of primary metabolites.  Lopes and co-workers established a detection 
protocol using ESI-MSMS to screen ascidian extracts for common nucleosides 4.10-4.14.196  
They proposed that the protocol developed could be employed to use nucleosides as 
chemotaxonomic markers to identify specific ascidian species, however, regrettably they 
failed to provide any guidelines as to what the presence of a particular nucleoside of group of 
nucleosides in an ascidian species could mean in terms of phylogeny.196   
 
From the literature detailed above all of the ascidians with nucleoside isolates belong to the 
Aplousobranchia ascidian suborder which appears to be rich in nucleosides and their 
derivatives.  A recent study on the chemistry of Herdmania momus yielded the epimeric 
methylsulfinyladenosine nucleoside derivatives 4.27-4.30.206  This report along with the 
isolation of 4.11 from Botryllus schlosseri196 are the only reports of nucleosides and their 
derivatives being isolated from stolidobranch ascidians.184  Interestingly, there have not been 
any reports of nucleoside isolation from phlebobranch ascidians.184  This note on a 
phylogenetic relationship is based only on the published ascidian-nucleoside literature.  
However, nucleoside isolations may not regularly be reported as nucleosides are primary 
metabolites which form the building blocks of RNA and DNA and therefore are present in all 
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living organisms.  With this in mind, the number of ascidian studies where nucleosides have 
been detected or isolated may therefore be far greater than what has been detailed above.   
 
The presence of nucleosides in concentrations which are elevated enough for them to be 
detected and isolated using classical natural products techniques may allude to a secondary 
biological function of nucleosides within ascidians, unrelated to DNA and RNA production.  
Interestingly, cytidine (4.9) has never been reported as an ascidian isolate which is curious as 
if the nucleosides are only involved in primary metabolic processes involving RNA and DNA, 
all of the common nucleosides 4.9-4.14 would presumably be present and available for 
isolation.  This adds weight to the idea that the nucleosides isolated from ascidians are 
involved in a secondary biological process.  In an early report detailing the isolation of 2’-
deoxy-nucleosides from T. cereum, Dematté et al. argued that the nucleosides isolated were 
not artefacts produced through the breakdown of RNA and DNA during extraction and 
isolation.197 Dematté et al. firstly reiterated that on breaking down, the bonds between the 
deoxyriboses and the bases of DNA would cleave before the bonds in the phosphorous-
diesters thus the production of nucleosides at elevated levels detected in ascidians from DNA 
or the phosphorylated nucleotides is unlikely.197  Their second argument related to the fact 
that the uracil base is a component of RNA and as such would only be associated with a 
ribose sugar, thus, the isolation of 2’-deoxyuridine (4.15) cannot be due to the degradation of 
DNA.197  The same principle would apply with the isolation of 2’-deoxyinosine (4.17) as the 
hypoxanthine base is only associated with tRNA.184 
 
The elevated levels of nucleosides in ascidians may also indicate a role in the production of 
more complex secondary metabolites such as the inosine derived shimofuridins A-G (4.31-
4.37) form the Okinawan ascidian Aplidium multiplicatum207 and the adenosine derived 4.38 
and 4.39 from the Australian didemnid Atriolum robustum.195  These are the only reports of 
the isolation of complex secondary metabolites, which are clearly derived from nucleosides, 
from ascidian species.  Since the majority of the compounds, 4.15-4.26, are simple 
nucleoside derivatives which are commonly isolated alongside the nucleosides 4.10-4.14 this 
may provide evidence of a secondary biological function for this former cohort of compounds.  
The possibility of other biological functions for nucleosides in ascidians coupled with the 
previously discussed metal chelation ability and a paucity of nucleoside vanadyl complex 
studies of nucleosides prompted us to begin a preliminary investigation into the stability of 
nucleoside-vanadyl complexes. 
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4.4 Isolation and structure elucidation of nucleosides from Aplidium monile 
Aplidium monile Monniot, F., 200149 (Figure 4.5) is an aplousobranch ascidian belonging to 
the Polyclinidae family.49  This compound ascidian grows in soft, cushion shaped colonies 
which have an overall pink colour with paler zooid apertures arranged in botryllid-like irregular 
double rows.49  Colonies of Aplidium monile have been reported along the east coast of South 
Africa from Sodwana Bay to Algoa Bay.49,78  The sample of A. monile investigated in our 
study was collected, under the voucher code TIC2011-032, from a depth of 12 - 15 m at Bell 
Buoy Reef, Algoa Bay, South Africa, in November 2011.  The results obtained from the LC-
ESI-MS/ICP-MS screen of the extract of A. monile are documented in Chapter 2.3.2 along 
with the successful isolation of the diiodotyramine 2.33.  This section will detail the isolation 
and characterisation of a series of nucleosides form a larger scale extraction of A. monile.   
 
 
 
Figure 4.5: Aplidium monile (TIC2011-032) collected from Bell Bouy Reef, Algoa Bay, South 
Africa.  Photography provided by Dr S. Parker-Nance. 
 
Scheme 4.1 illustrates the chromatography protocol for the large scale (262.6 g wet mass of 
ascidian colony) methanol extract of A. monile.  The initial solid phase extraction with a C-18 
Sep-Pak® cartridge (Waters,10 g) yielded seven fractions reflecting the polarity of the solvent 
used to flush the cartridge (water, 10% acetonitrile(aq), 20% acetonitrile(aq), 40% acetonitrile(aq), 
60% acetonitrile(aq), 80% acetonitrile(aq), and 100% acetonitrile).  1H NMR spectra were 
acquired for each of the seven fractions and are reproduced in Figure 4.6.  The 1H NMR 
spectrum obtained for fraction two contained numerous peaks in the aromatic (H 7.0-8.5) and 
oxymethine (H 3.5-6.5)  regions of the spectrum and was thus chosen for further 
fractionation. Fraction two was subsequently subjected to several rounds of reversed-phase 
semi-preparative HPLC as detailed in Scheme 4.1 to yield the nucleosides 4.10, 4.11, 4.13, 
4.15, 4.17 and 4.40.  
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Figure 4.6: 1H NMR (600 MHz, MeOD) data obtained for fractions 1-7 after reversed phase 
fractionation of the methanol extract of A. monile. 
Fraction 1  
Fraction 2 
Fraction 3 
Fraction 4 
Fraction 5 
Fraction 6 
Fraction 7 
 9    8     7       6        5          4            3  2 ppm 
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The HRESIMS data obtained for compound 4.10 (m/z 243.0988) indicated a molecular 
formula of C10H15N2O5 ([M+H]+ calc., 243.0981, ∆ 0.7 mmu) which implied five degrees of 
unsaturation.  The characteristic broad bands at 3464 and 3403 cm-1 in the IR spectrum of 
4.10 revealed the presence of hydroxyl groups whilst the band at 3237 cm-1 was suggestive 
of an amide moiety.  The presence of bands at 1640 and 1619 cm-1 in the IR spectrum along 
with resonances at C152.5 and 166.6 in the 13C NMR spectrum suggested the presence of 
two carbonyl moieties which would account for two of the five degrees of unsaturation.  The 
deshielded resonances in the 13C spectrum (δC 111.5 and 138.2) and aromatic proton 
resonance [δH 7.83 (s)] suggested a highly substituted aromatic system.  Three bond gHMBC 
correlations from the aromatic proton [δH 7.83 (s)] to both carbonyl resonances (δC 152.5 and 
166.6) as well as the methyl proton shift (δH 1.88) with 3J HMBC correlations to the carbonyl 
resonance (δC 166.6) and the olefinic resonance (δC 138.2) established the structure of the 
thymine component of 4.10.  
 
Five deshielded resonances in the 13C NMR spectrum (δC 41.2, 62.6, 72.2, 86.3 and 88.8) of 
4.10 and the corresponding proton shifts [δH 2.23 (2H, m), 3.73 (1H, dd, J = 12.0, 3.6 Hz) and 
3.80 (1H, dd, J = 12.0, 3.1 Hz), 4.40 (1H, dt, J = 6.2, 3.3 Hz), 6.29 (1H, t, J = 6.7 Hz), and 
3.90 (1H, dt, J = 3.4, 3.5 Hz)] implied a sugar functionality.  Correlations observed in the two-
dimensional COSY NMR experiment from the deshielded proton resonance [δH 6.29 (1H, t, J 
= 6.7 Hz)] through to the methylene protons [δH 3.73 (1H, dd, J = 12.0, 3.6 Hz) and 3.80 (1H, 
dd, J = 12.0, 3.1 Hz)] indicated a contiguous five carbon chain with chemical shifts 
characteristic of a 2’-deoxyribose unit.  Three bond gHMBC correlations from the proton 
signal (H 6.29) to the carbonyl (δC 152.5) and aromatic (δC 138.2) resonances indicated that 
the 2’-deoxyribose moiety was connected to the base at C-1’ and unequivocally established 
4.10 as the nucleoside thymidine.  The structure elucidation of 4.10 gave us the first indication 
of the presence of a diverse array of related nucleosides in the A. monile extract. 
 
The structures of the other common nucleosides 4.11, 4.13, and 4.15 were determined 
through direct comparison of the 1H and 13C NMR data obtained with those published in the 
literature (Figures 4.7 and 4.8 and Table 4.1).  Standard two dimensional NMR experiments 
were used to confirm structures where necessary. 
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Figure 4.7:  1H (MeOD, 600 MHz) NMR spectra of the known nucleosides 4.10, 4.11, 4.13 
and 4.15 isolated from A. monile. 
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Figure 4.8: 13C (MeOD, 150 MHz) NMR spectra obtained from the known nucleosides 4.10, 
4.11, 4.13 and 4.15 isolated from A. monile. 
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The 1H and 13C NMR spectra acquired from the final fraction (fraction 31), afforded from the 
chromatography protocol depicted in Scheme 4.1 are reproduced in Figure 4.9.  On 
inspection of the 1H NMR peak integration data the consistency of the values obtained implied 
that these data related to a single compound and the elucidation of the structure of the 
suspected single compound using the spectroscopic techniques available to us (1D and 2D 
NMR and IR) was commenced.  The IR spectrum obtained for fraction 31 contained 
characteristic bands at 3438 and 1638 cm-1 indicative of hydroxyl and carbonyl moieties 
respectively.  The presence of mid-field resonances in the 1H NMR [δH 2.44(1H, ddd, 13.6, 
6.2, 3.3), 2.74 (1H, ddd, 13.6, 7.5, 6.2), 3.73 (1H, m), 3.74 (1H, m), 3.81 (1H, dd, 12.1, 3.4), 
3.85 (1H, dd, 12.3, 2.9), 4.04 (1H, dt, 3.4, 3.3), 4.10 (1H, dt, 3.1, 3.1), 4.29 (1H, dd, 4.9, 3.6), 
4.56 (1H, dt, 6.0, 2.9), 4.60 (1H, t, 5.5),  5.83 (1H, d, 5.8), and 6.45 (1H, t, 6.79)] and the 13C 
NMR spectra (δC 41.8, 63.2, 63.3, 72.3, 72.7, 75.5, 86.6, 87.4, 89.6, 90.3) supported the IR 
data by suggesting the presence of numerous oxymethine groups.  The two dimensional 
COSY NMR data (Figure 4.10 and Tables 4.2 and 4.3) were used to establish the presence of 
two ribose moieties in fraction 31, one of which was a 2’-dexoyribose. 
  
 
Figure 4.9: 1H (MeOD, 600 MHz) and 13C (MeOD, 150 MHz) NMR spectra obtained for the 
mixture of 4.17 and 4.40 from A. monile. 
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Figure 4.10: A region of the COSY spectrum (F1 = δ 2.0-7.5 ppm) obtained for fraction 31.  
The dashed lines indicate the correlations used to establish the presence of two distinct 
ribose moieties shown in the accompanying figure.  
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The presence of the ribose moieties along with the deshielded resonances in the 1H NMR 
spectrum [δH 7.95 (1H, s), 8.05 (1H, s) and 8.3 (1H, s)] and 13C NMR (δC 118.4, 126.1, 138.6, 
140.5, 147.3, 149.7, 152.6, 159.5 and 159.8) spectra implied that fraction 31 also contained 
heteroaromatic functionalities similar to those seen in the nucleosides 4.10, 4.11, 4.13 and 
4.15.  Thorough investigation of the two-dimensional NMR data obtained eventually 
established that fraction 31 was in fact an inseparable mixture of two compounds and did not 
contain a single compound as originally proposed. 
The 3J HMBC correlations (Table 4.2) between the aromatic proton resonance at 8.05 ppm 
and the carbonyl (δC 159.8) and heteroaromatic (δC 149.7) carbons as well correlations 
between the aromatic proton (δH 8.30) and quaternary aromatic carbons (δC 126.1 and 149.7) 
were indicative of a hypoxanthine base moiety such as that found in compound 4.13.  The 
gHMBC correlations between the proton at 6.45 ppm and the carbons at 140.5 and 149.7 
ppm connected the 2’-deoxyribose sugar to the hypoxanthine base establishing the structure 
to be 2’-deoxyinosine (4.17). The NMR data relating to 4.17 is presented in Table 4.2. 
The second compound in fraction 31 afforded 3 bond HMBC correlations between the 
aromatic resonance at δH 7.95 and the two carbonyl carbons at δC 152.6 and 159.5 in addition 
to a two bond correlation with the aromatic resonance at δC 118.4.  HMBC correlations were 
also observed between δH 5.83 and δC 138.6 and 152.6 (Table 4.3) confirming the position of 
the ribose sugar on the nitrogenous base.  These NMR data suggested that this compound 
was a C-5 substituted uridine derivative.  The chemical shift of C-5 (δC 118.4) indicated that 
the substituent at C-5 was an amine group thus prompting us to propose a 5-aminouridine 
structure (4.40) for the second compound in Fraction 31.  Further support for our structural 
assignment was provided by the 13C  NMR data reported for synthetic 5-aminouridine which 
correlates well with the data reported here for 4.40 isolated from A. monile.208  Compound 
4.40 has not previously been isolated form the marine environment184 
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Various attempts to separate compounds 4.17 and 4.40 with reversed phase semi-preprative 
and analytical HPLC were unsuccessful and only served to reduce the quantity of these 
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compounds available for further study.  All attempts to obtain reasonable high resolution mass 
spectral data on the inseparable mixture of 417 and 4.40 were unfortunately unsuccessful.   
Table 4.2: 1H (MeOD, 600 MHz), 13C (MeOD, 150 MHz) and 2D NMR data obtained for 4.17 
Position δC ppm 
δH ppm 
gHMBCa COSY (int., mult., J/Hz) 
1 
2  147.3  8.05 (1H, s)  C‐4, C‐6 
3 
4  149.7 
5  126.1 
6  159.8 
7 
8  140.5  8.3 (1H, s)  C‐4, C‐5 
9 
1'  86.6  6.45 (1H, t, 6.79)  C‐4, C‐8  H‐2'a, H‐2'b 
2'a  41.8  2.44 (1H, ddd, 13.6, 6.2, 3.3)  C‐1'  H‐1, H‐2'b, H‐3' 
2'b  2.74 (1H, ddd, 13.6, 7.5, 6.2)  H‐1', H‐2'a, H‐3' 
3'  72.7  4.56 (1H, dt, 6.0, 2.9)  H‐2'a, H‐2'b, H‐4' 
4'  89.6  4.04 (1H, dt, 3.4, 3.3)  C‐2'  H‐3', H‐5'a, H‐5'b 
5'a  63.2  3.73 (1H, m)  C‐3'  H‐4', H‐5'b 
5'b  3.81 (1H, dd, 12.1, 3.4)  C‐3'  H‐4', H‐5'a 
a HMBC correlations are from proton(s) stated to indicated carbons 
 
Table 4.3: 1H (MeOD, 600 MHz), 13C (MeOD, 150 MHz) and 2D NMR data obtained for 4.40 
Position δC ppm 
δH ppm 
gHMBCa COSY (int., mult., J/Hz) 
1 
2  152.6 
3 
4  159.5 
5  118.4 
6  138.6  7.95 (1H, s)  C‐2, C‐4, C‐5 
1'  90.3  5.83 (1H, d, 5.8)  C‐2, C‐6, C‐2'  H‐2' 
2'  75.5  4.60 (1H, t, 5.5)  C‐1'  H‐1', H‐3' 
3'  72.3  4.29 (1H, dd, 4.9, 3.6)  C‐5'  H‐2', H‐4' 
4'  87.4  4.10 (1H, dt, 3.1, 3.1)  H‐3', H‐5'a, H‐5'b 
5'a  63.3  3.74 (1H, m)  C‐3'  H‐4', H‐5'b 
5’b  3.85 (1H, dd, 12.3, 2.9)  C‐3'  H‐4', H‐5'a 
a HMBC correlations are from proton(s) stated to indicated carbons 
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4.5 Metal chelation studies using potentiometic titrations with commercially 
available nucleosides and vanadium 
In order to determine whether the nucleosides 4.10-4.14 were potentially involved in the 
accumulation and stabilisation of vanadyl (VO2+) in aplousobranch ascidians an investigation 
into the stability of nucleoside-vanadyl complexes will be described here.  Potentiometric 
experiments have successfully determined the organometallic complex speciation of 
oxovanadium (IV) or vanadyl across biological pH ranges as well as the relative stability of the 
complexes formed.209,210  Since little work has been done to establish the stability of 
nucleoside-vanadyl complexes within biological environments, a potentiometric study of the 
system was deemed necessary in order to gain a better understanding of the stability of such 
a system.  
 
When vanadyl (VO2+) is in aqueous solution it is susceptible to hydrolysis and may form 
insoluble species.  Figure 4.11 depicts a model, based on the vanadyl stability constants 
established by Henry et al.,211 showing the speciation products which would be present 
across the pH range of 2 to 14.  This model clearly illustrates that above pH 6 the majority of 
the free vanadyl will be present as insoluble hydroxides.  In order to establish if the 
nucleosides 4.10-4.14 are capable of forming stable complexes with vanadyl the protonation 
constants for each nucleoside would need to be established first.  The nucleoside protonation 
constants were determined using potentiometric titrations with a glass electrode and are 
presented in Table 4.4.   
 
Throughout the potentiometric study titrations were controlled using Tiamo 2.0 software 
following a method used successfully by Tshentu and co-workers.209,210  Nucleosides 4.10-
4.14 were purchased from Sigma-Aldrich.  Calibration of the glass electrode across a strong 
acid-base reaction used the Gran-method212 and the computer program GLEE213  to 
determine the standard potential Eo of the electrode.  All appropriate calculations were based 
on the ionic product of water (pKw) to be 13.76 at 25.0 ± 0.1 oC in 0.10 M sodium chloride.214  
The protonation constants for the nucleosides and oxovanadium(IV) complexes were 
determined by potentiometric titrations of approximately 25 mL solutions. All solutions were 
prepared using freshly boiled and degassed deionised milli-Q water to ensure the removal of 
dissolved oxygen and carbon dioxide. The ligand concentration of 1 mM was used and initial 
metal-to-ligand ratios of 1:1 were later changed to 1:10 to avoid precipitation. Titrations were 
performed over the pH range of 2 to 11 under a continuous flow of purified nitrogen using 0.1 
M hydrochloric acid (1 mL) and sodium hydroxide (0.1 M). The ionic strength of the titration 
solutions was kept constant at 0.10 M sodium chloride.  The data obtained from the 
potentiometric titrations of the nucleosides and the oxovanadium-nucleoside mixtures were 
used to calculate the protonation and stability constants.  
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Figure 4.11: Speciation distribution as a function of pH for aqueous vanadyl (VO2+) showing 
the hydroxyl products formed at certain pH values. Model created using the computer 
program HySS.215 
The computer program HYPERQUAD216 was used to calculate the concentration stability 
constants from the potentiometric titration data.  HYPERQUAD generates a model titration 
curve based on the concentrations of the species involved in the titration. This HYPERQUAD 
model works on the principal that for each chemical species MpLqHr, where M, L, and H 
represent metal, ligand and proton respectively, in the equilibrium solution there is a chemical 
constant that can be expressed as βpqr = [MpLqHr]/[M]p[L]q[H]r.216   HYPERQUAD will then fit 
the experimental data to the model and refine the protonation and/or stability constants of 
each chemical species.  Since this is an iterative refinement it is important that the initially 
predicted stability constant values entered produce a reasonable fit of the experimental data 
to the model.  For this reason the hydrolysis model of the oxidovanadium(IV) system (Figure 
4.11) was included in the model i.e. [VO(OH)3]- (logβ10-3 = -18.0) and [(VO)2(OH)5]- (logβ20-5 = 
-22.0), [VO(OH)]+ (logβ10-1 = -5.94) and [(VO)2(OH)2]2+ (logβ20-2 = -6.95).211   
 
The protonation constants obtained for the nucleosides 4.10-4.14 are shown in Table 4.4.  
From these results the pyrimidine based nucleosides 4.10 and 4.11 have two potential sites 
where protonation occurs across the pH range of 2-11.  The first of which is a hydroxyl group 
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on the sugar moiety and the other the N-3 position on the pyrimidine base.  The purine based 
nucleosides 4.12-4.14 also have two sites of potential protonation, once again a hydroxyl and 
the N-1 position on the purine base, whilst 4.12 and 4.14 contain a third protonation site due 
to the presence of an amine substituent on the purine base.  Establishing the protonation 
constants associated with these sites was necessary in order to determine if the nucleosides 
are capable of forming stable complexes with the vanadyl ion at a pH which is biologically 
relevant.  
 
 
 
 
Figure 4.12: Titration and fitted curves of a) guanosine (4.12) protonation and b) VO-
guanosine complexation systems. Experimental data points are shown as blue and red 
diamonds whilst the calculated model is shown by the dashed red line.  The other lines 
represent species and were not defined.  
The results obtained for the studies involving guanosine (4.12) shall be shown as a 
representative example.  Figure 4.12 depicts the experimental and calculated titration curves 
for the guanosine protonation studies [Figure 4.12 a)] alongside the titration curves for the 
vanadyl-guanosine studies [Figure 4.12 b)].  The curve in Figure 4.12 a) show that the 
experimental data (blue diamonds) are a very good fit to the calculated model (dashed red 
line) which established the protonation constants of guanosine to be logK 9.6, 2.30 and 8.87.  
The red diamonds observed over the end point of the titration curve represent data points that 
were excluded from the refinement and model calculation as these points are often found 
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unreliable as large shifts in pH occur even with small changes in titre volume at the end point 
of a titration.  Guanosine (4.12) protonation constants of logK 9.22 and 2.11, relating to 
protonation of the base, have been reported by Sigel et al.217 which are in line with the 
constants determined here (logK 9.6 and 2.30) however we were able to establish a third 
protonation constant for the hydroxyl of 4.12 with a logK 8.87 which has not been previously 
reported.   
 
With the protonation constants of guanosine determined the computer program HySS215 was 
used to simulated the species of guanosine that would be expected throughout a pH range of 
2 to 11 (Figure 4.13).  From this simulation one can see that at a high pH of 2 to 4 the 
nucleoside 4.12 would be present as either the protonated or neutral species.  The neutral 
guanosine species persists over the wides pH range of 3 to 8 after which deprotonation 
occurs (Figure 4.13). 
 
 
 
 
Figure 4.13: Species distribution as a function of pH simulated form the protonation constants 
determined for aqueous guanosine (4.12).  Model created using the computer program 
HySS.215 
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The first protonation constant determined for thymidine (4.10) logK 9.54 is similar to that 
established by Al-Flaijj et al.218 (logK 9.50) however no second protonation constant, relating 
to the hydroxyl, was reported in the literature for direct comparison with that obtained in our 
study (logK 10.78).  The protonation constants established for uridine (4.11), logK 9.12 and 
10.77 are reasonably similar to those obtained by Crans and co-workers193 (logK 9.0 and 
12.6).   
 
The only protonation constant determined for inosine (4.13) was logK 8.63 which was 
consisted with previous reports of logK 8.76217 and 8.65219 all other protonation constants 
relating to 4.13 were too high to be determined with the method employed here.  Finally the 
protonation constants obtained for adenosine (4.14) were logK 11.04 and 3.64 which were 
consistent with those determined by Crans and co-workers192 (logK 12.00 and 3.67). 
Unfortunately the constant relating to the amine substituent on the purine base of 4.14 was 
too large to be determined accurately in the pH range used. 
 
Once the protonation constants for the nucleoside ligands were determined potentiometric 
titrations investigating vanadyl-nuceoside complexation were carried out.  Analysis of the 
results obtained revealed that vanadyl-nucleoside system was complicated and conclusions 
drawn from the data would be limited.  From our results the nucleosides appear to associate 
with the vanadyl ion with varying stability constants.  In the theoretical model used in this 
analysis and reported in Table 4.4 the system relating to (1, 1, 0) it was assumed that the 
nucleoside ligand involved is not deprotonated at any site, whilst the (1, 1, 1) system assumes 
that the neutral nucleoside ligand binds to the vanadyl and takes up a proton in another site.  
This was assumed because the nucleoside species that would be available to complex the 
the vanadyl at the pH ranges studies were most likely not deprotonated (Figure 4.13).  
Unfortunately with the data at hand the protonation constants (logK) of the vanadyl-
nucleoside complexes were not determined for the (1, 1, 1) system as it is not clear which 
sites on the nucleoside were protonated during the complexation.  Due to the difficulty in 
determining protonation and stability constants for the vanadyl-nucleoside complexes formed 
no predictions can be made as to the structure of the complex, or even the nucleoside 
functionalities involved in the vanadyl complexation.  However, from the results in Table 4.4 a 
comparison can be made between the nucleosides based on their ability to associate with the 
vanadyl ion to form a stable complex.  The stability constants obtained from the vanadyl-
guanosine titration data [Figure 4.12 b)] are the largest (logβ 19.9 and 30.9) across the series 
and would imply that 4.12 is the most likely of the nucleosides to bind to vanadyl forming a 
stable complex.  It is however with some caution that any conclusions as to the nature of such 
systems or their presence in aplousobranch ascidians are made.  The results of the 
potentiometric studies are difficult to interpret and although it appears that complexation 
occurs, evidence towards even a basic structure of the systems involved were not apparent.  
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It must also be noted that further influencing factors would be involved in a biological system 
which have not been considered in this experiment. 
 
4.6 Conclusion  
The accumulation of vanadium by certain species of ascidians has long been of interest to 
biologists and chemists.  Although the recent discovery of a group of vanadium binding 
proteins, vanabins, in phlebobranch ascidians has helped to explain the presence of such 
large concentrations of vanadium in this suborder of ascidian, research towards 
understanding the mechanisms used by vanadium accumulating aplousobranchs is limited.  
The isolation of nucleosides 4.10, 4.11, 4.13, 4.15, 4.17 and 4.40 from the aplousobranch 
Aplidium monile prompted us to investigate the vanadyl binding properties of nucleosides 
commonly present in high quantities in ascidian extracts.  The results obtained from the 
potentiometric complexation studies with commercially available nucleosides and 
oxovanadium (IV) revealed that nucleosides are capable of binding to vanadyl ions in 
aqueous media with guanosine (4.12) appearing to form the most stable complex.  However, 
we concluded that the structure of the vanadyl-nucleoside complex is complicated and from 
the data obtained from the potentiometric experiments we were not able to shed any light on 
the structure of the complexes that clearly formed in solution nor establish exactly which 
nucleoside functional groups were involved in complexation with vanadyl. 
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Chapter Five: 
Atriolum marinense & Clavelina sp. - 
Isolation of a common styrene 
oligomer 
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5.1 Bioassay on HP-20 fractions 
In previous studies conducted by our research group, crude extracts of Clavelina sp. and 
Atriolum marinense were found to exhibit potent cytotoxicity towards oesophageal cancer 
cells in screening assays conducted at the University of Cape Town. Attempted isolation and 
identification of the compounds responsible for this activity were unfortunately unsuccessful, 
possibly because of the relatively low sensitivity of the NMR facilities (400 MHz) available at 
Rhodes University at that time.  Following the arrival of a 600 MHz NMR spectrometer at 
Rhodes University it was deemed appropriate to revisit these two ascidian species and 
attempt the isolation and characterisation of the metabolites responsible for the oesophageal 
cancer cell toxicity. 
 
 
a)  b)  
Figure 5.1: Colonies of (a) Atriolum marinense and (b) Clavelina sp.  both photographed in 
Algoa Bay, South Africa by Dr Shirley Parker-Nance. 
The ascidian, Atriolum marinense Kott, 200140,220 (Sub-order: Aplousobranchia, Family: 
Didemnidae) is cream to peach-orange in colour and has characteristic small, upright, flask 
shaped colonies which have a common apical cloacal opening (Figure 5.1a).40,220  Specimens 
of A. marinense were previously reported as Atriolum robustum34,40,220 but have subsequently 
been correctly described as a new and separate species by Kott, 2001.220  The genus 
Atriolum is a small genus of the family Didemnidae with currently only six species described 
worldwide.40  Atriolum marinense is the only species of this genus to be found outside of 
Australian waters, with a wide distribution including New Caledonia, South Africa and the 
Mozambique Channel.40  A. marinense is found throughout Algoa Bay, South Africa, occurring 
at depths of 12 to 24 m.40  For this investigation, a specimen of A. marinense was collected 
using SCUBA in November 2011 from the Algoa Bay dive site, known as Shy Shark reef. 
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The delicate blue ascidian commonly known as Lori Bell’s clavelina is a new species of 
Clavelina which shall be referred to as Clavelina sp. and is depicted in Figure 5.1(b).  
Clavelina sp. has also been found at depths between 17 and 24 m on low profile reefs off the 
South African coastal towns of Port Alfred and East London.78  The sample of Clavelina sp. 
investigated here was allocated the voucher code SAF2004-029 and was collected using 
SCUBA from a depth of 21 m at White Sands reef, Algoa Bay in 2004. 
 
Lyophilised samples of both species were sequentially extracted with equal volumes of 
methanol and dichloromethane. During this extraction process, the dichloromethane and 
methanol extracts were kept separate, and before HP-20 fractionation, the dichloromethane 
extract was concentrated under reduced pressure. This was necessary as dichloromethane is 
immiscible with water and if the solvent was not removed before the aqueous dilutions that 
are involved in cyclic loading (Section 5.3) the extract onto the HP-20 resin the organic 
metabolites would not be adsorbed by the resin.  Once all of the dichloromethane had been 
removed, the remaining solid extract was taken up in acetone and combined with the 
methanol extracts and cyclic loaded onto the HP-20 resin.  The HP-20 beads were washed 
thoroughly with water before being sequentially stripped with aqueous acetone mixtures of 
decreasing polarity (20%, 40%, 60%, 80% acetone/water and 100% acetone), to afford five 
fractions (Scheme 5.1).   
 
At the time this work was repeated in 2013 access to the oesophageal cancer screens was no 
longer available to us and subsamples of approximately 1 mg of each of the five HP-20 
fractions obtained for both ascidian species were instead assayed against breast cancer cells 
at concentrations of 50 μg/mL and 5 μg/mL.  In the assay the percentage viability of the 
breast cancer cells after exposure to the HP-20 fractions were measured and are illustrated in 
Figure 5.2.   
 
The results yielded from the fractions of A. marinense suggested that the 80% acetone(aq) 
fraction was the most cytotoxic with less than 50% cell viability even at the lower 
concentration of 5 μg/mL.  The other acetone(aq) fractions of A. marinense were only cytotoxic 
against the cells at a higher concentration of 50 μg/mL.  Interestingly and inexplicably, the 
HP-20 column wash (methanol/dichloromethane) of A. marinense appeared to promote the 
growth of the cancer cells at both concentrations assayed (Figure 5.2).    
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Figure 5.2:  Percentage viability of breast cancer cells on exposure to 50 μg/mL and 5 μg/mL 
of the acetone(aq) fractions of A. marinense and Clavelina sp. eluted from the respective HP-
20 columns (in each case the wash fraction was eluted using 1:1 methanol/dichloromethane). 
The HP-20 fractions obtained for the extract of Clavelina sp. were all markedly more cytotoxic 
than the A. marinense fractions in the breast cancer cell screens.  All of the Clavelina sp. 
fractions assayed showed cytotoxicity against the breast cancer cells even at the lower test 
concentration of 5 μg/mL.  The more non-polar HP-20 fractions of Clavelina sp. (60%, 80%, 
100% acetone(aq) and wash) appeared to be very active with less that 30% cell viability 
resulting from the assay with 5 μg/mL concentrations of the fractions.   
 
These promising bioassay results prompted further investigation of the most cytotoxic 
chromatography fractions from both species.  The 1H NMR spectra acquired for each of the 
five A. marinense and Clavelina sp. fractions eluted off of the HP-20 column are illustrated in 
Figures 5.3 and 5.4 respectively.  From these promising bioassay results the spectra obtained 
for the 80% acetone(aq)fraction of A. marinense and the 60%, 80%, 100% acetone, and wash 
fractions of Clavelina sp. were of greatest interest.  Unfortunately, with the exception for the 
100% acetone(aq)fractions of both ascidian species, the 1H NMR spectra produced by these 
particular fractions did not reveal the presence of major compounds with deshielded 
resonances (H > 4.5) characteristic of many bioactive secondary metabolites.   
 
At the outset we proposed that compounds responsible for the cytotoxicity were probably a 
very active minor compound(s) occurring in all the HP20 chromatography fractions making 
bioassay guided chromatography difficult.  The NMR data suggested that most active non 
polar fractions were dominated by what appeared to be structurally unremarkable fatty acid 
glycerides.  
 
Atriolum marinense 
HP-20 fractions 
Clavelina sp. 
HP-20 fractions 
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Figure 5.3: 1H NMR (600 MHz) spectra of the fractions of Atriolumn  marinense extract eluted 
from HP-20 resin; a) 20% acetone(aq)(MeOD); b) 40% acetone(aq)(MeOD); c) 60% 
acetone(aq)(MeOD); d) 80% acetone(aq)(CDCl3); e) 100% acetone (CDCl3); f) wash of 1:1 
methanol/dichloromethane (CDCl3). 
f) wash of 1:1 
   MeOH/DCM 
e) 100% 
    acetoneaq 
d) 80% 
    acetoneaq 
c) 60% 
    acetoneaq 
b) 40% 
    acetoneaq 
a) 20% 
    acetoneaq 
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Figure 5.4: 1H NMR (600 MHz) spectra of the fractions of Clavelina sp. extract eluted from 
HP-20 resin; a) 20% acetone(aq)(MeOD); b) 40% acetone(aq)(MeOD); c) 60% 
acetone(aq)(MeOD); d) 80% acetone(aq)(CDCl3); e) 100% acetone (CDCl3); f) wash of 1:1 
methanol/dichloromethane (CDCl3). 
8 7 6 5 4 3 2 1 ppm
f) wash of 1:1 
   MeOH/DCM 
e) 100% 
    acetoneaq 
d) 80% 
    acetoneaq 
c) 60% 
    acetoneaq 
b) 40% 
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    acetoneaq 
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5.2 Isolation and structure elucidation of a styrene oligomer 
Interestingly, the 100% acetone fractions of both species yielded 1H NMR spectra with very 
similar shifts in the aromatic region (H 7.0 – 7.4) implying a common compound in both 
ascidian extracts (Figure 5.5).  The 100% acetone fraction of A. marinense was initially 
purified through open column chromatography using propanediol-bonded silica (DIOL) as a 
stationary phase (Scheme 5.1).  Based on the 1H NMR spectra acquired for the fractions 
afforded from this chromatography, the first chromatography fraction was further purified 
through a series of normal phase HPLC separations as illustrated in Scheme 5.1 to yield the 
styrene trimer 5.1 (1.7 mg).     
 
 
 
Figure 5.5: 1H NMR (CDCl3 600 MHz) spectra of the 100% acetone fractions of a) Clavelina 
sp. and b) A. marinense eluted from the HP-20 fractionation of their crude extracts. 
The 1H and 13C NMR spectra acquired for 5.1 isolated from A. marinense are illustrated in 
Figure 5.6.  Through the analysis of the number and relative proportion of the 1H and 13C 
NMR resonances evident in these spectra a molecular formula of C24H24 was proposed for 
5.1, implying 13 double bond equivalences.  Regrettably, several attempts to confirm the 
molecular mass of 5.1 via high resolution mass spectrometry techniques such as LC-ESI-MS 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
b) 
a) 
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and GC-EI-MS were unsuccessful.  However eventual low resolution GC-EI-MS analysis 
yielded a molecular ion [M+] at m/z 312.1 which supported the molecular formula of C24H24 
established through NMR. 
 
The presence of two deshielded signals in the 13C NMR spectrum (δC 114.4 and 141.1) in 
addition to the olefinic proton resonances [δH 4.89 (s) and 5.15 (s)] in the 1H NMR spectrum of 
5.1 confirmed the presence of a terminal alkene, accounting for one of the degrees of 
unsaturation.  On further inspection of the aromatic regions of both the 1H and 13C NMR 
spectra, the remaining 12 double bond equivalences could be accounted for by three phenyl 
rings.  The aromatic envelope of the 13C NMR spectra of 5.1 contained three quaternary 
carbons (δC 142.4, 145.0 and 146.7) and nine aromatic methine carbons (δC 125.6, 126.1, 
126.4, 127.3, 127.7, 128.3, 128.26, 128.291 and 128.293) with the varying intensities of these 
resonances implying a level of chemical equivalence brought about by symmetry.  The 
corresponding region of the 1H NMR spectrum was, however, complicated by the presence of 
highly overlapped multiplets which hampered assignment of the relevant proton and carbon 
chemical shifts in subsequent 2D NMR experiments.  Accordingly, the Bruker simulation 
software, WIN-DAISY,81 was utilised to facilitate the assignment of these aromatic 
resonances.    
 
 
 
Figure 5.6: 1H (CDCl3, 600 MHz, bottom) and 13C (CDCl3, 150 MHz, top) NMR spectra 
obtained for 5.1. 
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Simulations and iterations produced via WIN-DAISY have successfully established the 
coupling constants and conformations of fluorine and phosphorous containing compounds 
whose 1H NMR spectra are complicated due to the additional splitting produced by these 
nuclei.221–223  The spectrum simulation aspect of WIN-DAISY calculates energy levels using 
the time-independent Schroedinger equation.81  For a fragment to be simulated, the total spin 
values, chemical and magnetic equivalences, in addition to fragment factorising are used to 
build up the Hamilton matrix.81  Fragment factorising helps to reduce the calculation time for 
simulations and iterations by splitting the large spin system into smaller fragments which are 
not interacting with each other through coupling.  The fragment factorising process leads to 
the running of a series of smaller, simpler simulations to produce the composite simulation of 
the total spin system.  To assist in identifying the structural fragments which produced the 
complicated pattern of peaks in the aromatic region (δH 7.00 – 7.35) of the 1H NMR spectrum, 
this region was processed by defining integrations, picking peaks, and determining multiplet 
couplings before loading the data into WIN-DAISY.  Through the use of the integration and 
multiplet data WIN-DAISY intuitively divided the aromatic region into four fragments.  The 
simplest of these fragments was a singlet resonating at δH 7.26 consistent with the CDCl3 
solvent peak.  The other three fragments each contained five spin systems divided into three 
groups i.e. each fragment possessed a C2 symmetry resulting in chemically equivalent 
protons.  With this information entered into WIN-DAISY a simulation was run to produce a 
spectrum of the complete spin system as well as subspectra corresponding to the factorised 
fragments.   
 
Once this simulation was completed, WIN-DAISY was used to perform a series of iterative 
calculations in order to establish a more accurate set of resonant frequencies, line widths and 
scalar coupling constants.81  Figure 5.7 depicts the aromatic region (6.95 – 7.40 ppm) of 
these iterated subspectra and the complete spin system alongside the original 1H NMR 
spectra obtained for 5.1.  The simulated spectrum of the complete aromatic spin system, 
along with the CDCl3 solvent is a good match to the original spectrum, and the subspectra of 
the individual fragments indicate the presence of three distinct aromatic systems which do not 
interact with each other via 1H scalar coupling.  There is a similarity in the subspectra in 
Figure 5.7(c) and (d) where the frequencies and scalar couplings were confirmed through the 
WIN-DAISY iterations to be δH 7.10 (2H, d, J = 7.6 Hz), 7.29 (2H, dd, J = 7.6, 7.4 Hz), and 
7.20 (1H, t, J = 7.4 Hz) and δH 7.03 (2H, d, J = 7.6 Hz), 7.20 (2H, dd, J = 7.6, 7.5 Hz), and 
7.13 (1H, t, J = 7.5 Hz) respectively which is indicative of two monosubstituted phenyl 
moieties.  The third subspectra seen in Figure 5.7(b) appears to be made up of a doublet 
integrating to four protons, and a complex multiplet integrating to a single proton.  This 
subspectra is markedly different from those relating to the two monosubsituted phenyl 
fragments.  Curiously, the observed coupling constants measured directly from the original 1H 
NMR spectrum were J = 4.1 Hz for both the doublet and the multiplet, which is unusually 
small for vicinal coupling in a planar aromatic system.80,224  However, inspection of the 
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frequencies and scalar couplings calculated through WIN-DAISY iteration of this fragment 
showed very different values viz. δH 7.31 (2H, J = 8.6 Hz), 7.31 (2H, J = 8.6, 8.2 Hz) and 7.27 
(1H, J = 8.2 Hz) which would once again indicate a monsubstituted phenyl moiety.  An 
explanation for the unusual and unexpected splitting pattern observed for the third phenyl 
group would be the occurrence of second order virtual coupling.  Second order coupling will 
occur when the difference in the chemical shifts of the proton nuclei (∆ν in Hz) are 
comparable in magnitude to the coupling constants between them (J in Hz).  That is to say 
that if ∆ν/J is smaller than five, second order coupling will begin to affect the appearance of 
the spectra, initially through the production of unsymetrical multiplets which appear to “lean” 
towards each other.80  The simulated spectra in Figure 5.7b) and c) illustrate slight leaning as 
a result of second order coupling effects, however, the splitting patterns expected for 
monosubstituted phenyl systems are still recognisable from these spectra.  As ∆ν/J becomes 
smaller the effect of second order coupling will be more prominent and can result in additional 
resonance peaks that cannot be explained by simple first order coupling rules.  Virtual 
coupling is when the lines produced through the effect of second order coupling suggests an 
apparent coupling of protons which are not actually vicinally coupled.80,225–228  To be more 
specific, second order virtual coupling will usually occur in a three spin system such as ABX, 
where spins B and X are coupled, the Jax is zero or near zero and the chemical shifts of A and 
B are not only very similar, but they are strongly coupled to each other, i.e. Jab > ∆νab.  Under 
these conditions spins A and B will act as a single unit, and will result in apparently false 
coupling constants and more complex splitting in spin X.80,225,226  Due to the dependence on a 
very small difference in the chemical shifts of two coupled protons, this second order coupling 
phenomenon is less likely to occur when the spectrum is measured with a higher frequency 
spectrometer as the resolution of chemical shifts (in Hz) is improved.226  The use of more 
powerful magnets with higher frequencies in modern NMR based organic structure elucidation 
has meant that virtual coupling is not as commonly observed or reported.229–233  Virtual 
coupling may also affect the 1H NMR spectra of heteronuclear systems for example in organic  
phosphines and phosphites.224,226,234  
 
In the present system, involving the third phenyl ring in 5.1, there are not three spins, as 
explained above, but rather five spins and therefore the ortho, meta, para terminology will be 
used instead.  In this phenyl system the ortho and meta proton resonances are not chemically 
equivalent, however they coincidently have near identical resonant frequencies, and so 
appear to be magnetically equivalent.  Further, these ortho and meta protons are strongly 
coupled to each other and as a result the four protons appear to act as one unit.  Virtual 
coupling of this 4H unit to the para proton produced the pentet (δH 7.27, 1H) and a doublet (δH 
7.31, 4H) seen in Figure 5.7a) and d), even though no actual coupling occurs between the 
ortho and para protons.  The observed coupling constant of 4.1 Hz is an average to the meta 
(J = 8.2 Hz) and para (J = 0 Hz) couplings.   
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Figure 5.7: Aromatic region (δH 6.95-7.40) of a) WIN-DAISY simulation of the complete spin 
system along with b), c) and d) the simulated subspectra of the three phenyl groups and e) 1H 
NMR (600 MHz, CDCl3) of 5.1.  
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Table 5.1: 1H (CDCl3, 600 MHz), 13C (CDCl3, 150 MHz) and 2D NMR data obtained for 5.1. 
 Position δC ppm 
δH ppm 
(int., mult., J/Hz) gHMBCa COSY 
1 114.4 5.15 (1H, s) C-2, C-3, C-1’ H-1b 
4.89 (1H, s) C-2, C-3 
H-1a, H-3a, H-
3b 
2 141.1 - - - 
3 43.4 2.84 (1H, dd, 14.2, 7.6) 
C-1, C-2, C-4, C-5, 
C-1’, C-1’’ H-1b, H-3b, H-4 
2.79 (1H, dd, 14.2, 7.2) 
C-1, C-2, C-4, C-5, 
C-1’, C-1’’ H-1b, H-3a, H-4 
4 43.6 2.68 (1H, dtd, 9.8, 7.3, 4.6) C-3 
H-3a, H-3b, H-
5a, H-5b 
5 37.3 2.02 (1H, m) C-6, C-1’’ 
H-4, H-5b, H-6a, 
H-6b  
1.88 (1H, dtd, 13.6, 9.8, 5.3) 
C-4, C-6, C-1’’, C-
1’’’ 
H-4, H-5a, H-6a, 
H-6b 
6 33.6 2.40 (1H, m) 
C-4, C-5, C-1’’’, C-
2’’’/6’’’ 
H-5a, H-5b, H-
6b 
2.34 (1H, m) 
C-4, C-5, C-1’’’, C-
2’’’/6’’’ 
H-5a, H-5b, H-
6a 
1’ 146.7 - - - 
2’/6’ 126.4 7.31 (2H, d, 4.1b 8.6c) C-2, C-4’ - 
3’/5’ 128.3 7.31(2H, d, 4.1b / 8.6c, 8.2c)  C-1’ H-4’ 
4’ 127.3 7.27 (1H, pent., 4.1b / 8.2c) - H-3’ 
1’’ 145.0 - - - 
2’’/6’’ 127.7 7.10 (2H, d, 7.6) C-4, C-4’’ H-3’’ 
3’’/5’’ 128.3 7.29 (2H, dd, 7.6, 7.4) C-1’’, C-3’’/5’’ H-2’’, H-4’’ 
4’’ 126.1 7.20 (1H, t, 7.4) C-2’’/6’’ H-3’’ 
1’’’ 142.4 - - - 
2’’’/6’’’ 128.3 7.03 (2H, d, 7.6) C-6, C-4’’’ H-3’’’ 
3’’’/5’’’ 128.2 7.20 (2H, dd, 7.6, 7.5) C-1’’’ C-3’’’/5’’’ H-2’’’, H-4’’’ 
4’’’ 125.6 7.13 (1H, t, 7.5) C-2’’’ H-3’’’ 
a HMBC correlations are from proton(s) stated to indicated carbons 
b Observed coupling constants 
c Calculated coupling constants 
 
 
 
Chapter 5 
 
154 
The use of WIN-DAISY confirmed that 5.1 consisted of three monosubstituted phenyl groups 
which accounted for 12 of the 13 degrees of unsaturation.  The ability to create simulations of 
the individual phenyl moieties allowed for the assignment of chemical shifts and coupling 
constants in this complicated region of the 1H NMR spectrum and greatly facilitated the 
subsequent interpretation of 2D NMR spectra.  Table 5.1 reports the chemical shifts and 
coupling constants established through WIN-DASIY simulations and iterations as well as the 
relevant apparent coupling constant values observed because of the effect of virtual coupling. 
 
Correlations observed in a two-dimensional COSY NMR experiment (Table 5.1) from the 
methylene protons [δH 2.34 (m) and 2.40 (m)] to the methylene protons [δH 2.79 (dd, J = 14.2, 
7.2 Hz) and 2.83 (dd, J = 14.2, 7.6 Hz)], as well as the long range COSY correlations 
between the latter methylene protons to the olefinic protons [δH 4.89 (s) and 5.15 (s)] 
indicated the presence of a contiguous six carbon chain with three substituents.   
 
The phenyl moieties established from the WIN-DAISY simulation were then positioned along 
this six carbon chain based on the 3J bond gHMBC correlations observed between ortho 
phenyl protons at δH 7.31, 7.10 and 7.03 and the carbon resonances at δC 141.1 (Cq), 43.6 
(CH) and 33.6 (CH2) respectively, placing the phenyl groups at positions 2, 4 and 6 of the 
carbon chain (Table 5.1 and Figure 5.8).  Compound 5.1 was therefore elucidated as a 
styrene trimer, 2,4,6-triphenyl-1-hexene.  Although this compound is a known synthetic 
compound, and oligomer commonly produced in the manufacturing and degradation of 
polystyrene plastics only the unassigned 13C NMR data has been previously reported,235 and 
this appears to be the first time that the 1H and 13 NMR data of 5.1 has been fully assigned.  
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Figure 5.8:  A region of the gHMBC spectrum (F1 = δ 4.5-7.6 ppm; F1 = δ 30-150 ppm) of the 
gHMBC spectrum (CDCl3; 600 MHz) of 5.1 illustrating the three bond 1H-13C coupling 
correlations.  The accompanying structure shows the key gHMBC and COSY correlations 
used to elucidate the structure of 5.1. 
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5.3 The possible origin of 2,4,6-triphenyl-1-hexene (5.1) 
 
The initial fractionation of the crude A. marinense and Clavelina sp. extracts utilised 
poly(styrene-divinylbezene) (PSDVB), a reverse-phase stationary phase also know by the 
trade name Diaion HP-20.  The isolation of a styrene oligomer from an extract that was in 
contact with a styrene based adsorption resin meant that the possibility that 5.1 was an 
artefact of the isolation process could not be ignored.  However, the use of HP-20 in the initial 
large scale fractionation of crude marine extracts has been standard practice in our research 
group for several years, and to date there have been no other cases where the styrene 
oligomer 5.1 was isolated during any of the chromatography procedures which utilised this 
resin.236    
 
The numerous cross-linkages in the polymeric structure of PSDVB make it a porous support 
onto which organic compounds of varying polarity are able to be adsorbed.  The absence of 
polar sites in PSDVB ensures the separation of even the most polar organic compounds 
without any threat of these metabolites irreversibly binding to the resin.237,238  PSDVB can be 
used successfully throughout a large pH range (pH 1-13), it is stable in most organic solvents 
and can withstand very ionic solutions allowing for a variety of applications.238   
 
The general technique employed to initially adsorb all the non-polar, semi-polar, and polar 
metabolites, from the crude extract onto the PSDVB resin, is known as cyclic loading and was 
first developed in 1996 by West and Northcote, during the fractionation of crude extracts of 
the New Zealand sponge Mycale hentscheli.238  A typical PSDVB chromatography column is 
depicted in Figure 5.9.  The PSDVB resin is initially primed by washing with water to remove 
any fine resin particles, followed by three column volumes of the polar, water miscible solvent 
(normally the solvent used in extraction, i.e. methanol or acetone).  In the process of cyclic 
loading (Figure 5.9) an acetone or methanol solution of the crude extract is initially loaded 
onto the column and allowed to pass slowly through the PSDVB resin, ensuring maximum 
interaction and therefore adsorption of the non-polar metabolites contained in the extract onto 
the PSDVB beads.238  The eluent is collected and diluted with water to approximately 50% of 
the original organic concentration and passed through the same column again, with 
metabolites of mid-polarity adhering to the PSDVB resin during this second loading.239  This 
process of dilution and re-loading is continued, allowing more polar metabolites to be 
sequentially adsorbed until the “organic” concentration of eluent collected has been diluted 
with water to 12.5% of the original extract.  At this stage, the eluent will often appear much 
paler than the crude extract loaded initially, indicating that majority of the compounds of 
interest have been adsorbed on the PSDVB resin beads.239  
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Figure 5.9:  PSDVB column chromatography illustrating the steps involved in the cycling 
loading of an organic extract. 
Once the PSDVB column has been loaded, it is washed with three column volumes of water 
to remove any inorganic salts (seawater contains ca. 3.5% sodium chloride).  The column is 
then eluted with aqueous acetone or methanol, in aliquots of decreasing polarity.239  This 
elution regime will result in the most polar metabolites eluted first and the least polar 
metabolites last.  Usually, the highest proportion or biologically active metabolites are found in 
the mid-polar fractions and the  sterols and fatty acids occur in the non-polar fractions with the 
organic salts, sugars and proteins emerging in the polar fractions.238    
 
The process of cyclic loading of the extract is time consuming and exposes the HP-20 beads 
to a large volume of solvents.  The two most common solvents used for cyclic loading are 
methanol and acetone, and so the effect of dichloromethane on the stability of the HP-20 
beads was of interest to us.  The initial extraction of A. marinense utilised both methanol, and 
dichloromethane, and although the dichloromethane extract was concentrated in vacuo 
before the process of cyclic loading onto the HP-20, there was still the possibility that some of 
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the dichloromethane remained in the extract and was loaded onto the HP-20 column.  In 
order to investigate whether the exposure to dichloromethane could result in the degradation 
of the HP-20 resin to produce the styrene oligomer 5.1 two experiments were carried out.   
 
The first experiment involved grinding a portion of HP-20 beads to form a fine powder, which 
was subsequently steeped in dichloromethane for 48 hours with intermittent periods of 
sonication in an attempt to disrupt the styrene based polymer and increase any effect which 
dichloromethane may have on degradation of the polystyrene.  The powder was then filtered, 
and the filtrate dried under reduced pressure and a 1H NMR spectrum acquired (Figure 
5.10b).  The 1H NMR spectrum produced was inconclusive and contained only very weak 
peaks, of a similar intensity to the satellite peaks produced by the solvent (CDCl3), which 
were not consistent with 5.1. 
     
The second experiment attempted to replicate the initial process of cyclic loading, without the 
presence of the ascidian extract.  The volumes of HP-20 resin, and solvent used in this 
experiment were the same as those used for the A. marinense extract.  All solvent used in 
extraction and fractionation of A. marinense were HPLC grade, thus the same level of purity 
of the solvents was used throughout this experiment.  Since the ascidian was extracted with 
both methanol and dichloromethane, it is unclear how much dichloromethane may have still 
been present in this crude extract, after concentration, a 50 mL portion of dichloromethane 
was added to the methanol (500 mL) and then loaded onto the HP-20 resin.  This solvent 
mixture was cyclic loaded onto the HP-20 column over the course of a week to ensure that 
the HP-20 was exposed to the methanol/acetone/dichloromethane mixture for an extended 
time.  The HP-20 beads where then washed with 100% acetone as this was the solvent 
system within which the styrene oligomer 5.1 appeared.  The eluent produced was 
concentrated in vacuo and analysed by 1H (Figure 5.10c) and 13C NMR.  Although there is 
some noise in the aromatic regions of both the 1H and 13C NMR spectra, there were no 
distinct resonances that were consistent with corresponding resonances in the 1H NMR 
spectrum of the 100% acetone HP-20 fraction of A. marinense.   
 
The results of the two experiments indicated that exposure of HP-20 resin to dichloromethane 
did not produce any significant amounts of the styrene oligomer 5.1.  However, it is still 
unlikely that 5.1 could be considered to be present in the ascidian, and unequivocally not a 
product of the chromatographic medium.  Fortuitously, a portion of the crude extract of A. 
marinense that had not been exposed to HP-20 resin was still available for 1H NMR analysis 
(Figure 5.10d). However, although signals were evident in the aromatic region of the 1H NMR 
spectrum from this extract they were not directly comparable with those observed in the 1H 
NMR spectrum of 5.1 and the direct comparisons were deemed inconclusive. 
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Figure 5.10: 1H NMR (600 MHz) spectra of (a) compound 5.1 isolated from A. marinense; (b) 
HP-20 powder exposed to dichloromethane; (c) HP-20 exposed to the cyclic loading process 
without A. marinense extract; and (d) crude extract of A. marinense prior to HP-20 
fractionation. 
 
5.4 The presence of styrene oligomers in the marine environment 
Polystyrene, a plastic polymer manufactured from styrene, is widely used in modern society 
appearing in numerous forms including building materials, packaging, containers, and 
disposable cutlery.240  Along with other plastics, polystyrene is often not correctly disposed of 
and is known to accumulate in and pollute coastal waters.  In 2012 there was an estimated 
280 million tonnes of plastic goods manufactured worldwide and whilst there are promising 
policies in place to encourage correct disposal and recycling of plastic products, only 130 
million tonnes was reported to be correctly disposed in landfills.241,242   Within South Africa243 
and the world, there is a wealth of research dedicated to establishing the extent of coastal 
a)
b)
c)
d)
2.53.03.54.04.55.05.56.06.57.07.5 ppm
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and marine pollution caused by plastic waste as well as developing strategies to combat this 
growing threat.243–249  Bulk plastic marine pollution has been shown to have many adverse 
effects to marine ecosystems where they can persist for centuries and may be ingested by, or 
entangle wildlife.241,248     
 
The oligomers of bulk plastics such as the styrene monomer (5.2), dimer (5.3) and trimer (5.1) 
are known to have toxic effects on biological systems where they may mimic hormonal activity 
however the polystyrene polymer is regarded as inert and of no direct threat.250,251  This is a 
somewhat naïve belief as bulk polystyrene resins has been found to contain levels of 
unreacted styrene oligomers which would be released slowly from the plastic materials.  
Possibly the most well-known example is the potentially carcinogenic effects of oligomers 
released from polystyrene food containers which have been found interfere with estrogenic 
biological pathways.250,251  This contamination of unreacted oligomers in bulk polystyrene is a 
possible route for these monomer, dimers and trimers to enter the marine environment.252  
 
5.2 5.3  
 
Another likely route is through the degradation of plastic waste pollution.  The synthetic 
polymer structure of plastics ensures that they are durable materials which will degrade over 
long periods of time, or under fairly harsh physical conditions.  However, in the marine 
environment these lightweight, floating plastics are exposed to high levels of sunlight, and 
wave action which facilitates fragmentation to produce microplastics.248,253  Microplastics are 
classified as pieces of plastic debris with a diameter <1 mm, and may enter the marine 
environment through atmospheric and general marine degradation process, as well as a more 
direct route from sewage waste waters that contain microbeads, a common abrasive additive 
to cosmetics such as exfoliating face washes.253,254  In recent years there has been a 
significant  research focus on the occurrence and influence of microplastics in the marine 
environment, including the consideration of environmental and ecological effects due to harm 
caused not only by the microplastic particles, but also the potentially toxic compounds that 
can be adsorbed onto the particles and subsequently passively migrated through the 
ecosystem.252,254,255  Microplastics have been found to contaminate shorelines,244,256 plankton 
samples248,257 and deep sea sediments258 especially in the waters around Europe and Asia.  
Microplastics have also been found to be ingested by a number of animals through various 
feeding mechanisms, including seabirds, fish, mussels, amphipods, lugworms, barnacles, 
polycheates, echinoderms, and bryzoans.244,246,248,249,253,254,259,260 The current research into 
microplastics appears to be mostly general in focus and is not focussed on any individual 
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polymer or oligomer, however in the case of the laboratory studies into the ingestion of 
microplastics by the mussel Mytilus edulis the microplastic beads used were polystyrene.259 
Since there is evidence to show that fragmented plastic debris is wide spread in the marine 
environment, and may be ingested by various marine biota, it is reasonable to suggest that 
the oligomers derived from plastic debris, like polystyrene, may persist in the marine 
environment as well.252  
 
The presence of styrene oligomers in the marine environment has been investigated by Saido 
and coworkers.261–265   These studies have assessed the presence of styrene monomer, 
dimer, and trimers in sea water and sand samples from numerous locations along the 
coastlines of the North-West Pacific Ocean263,264 and more recently the coastlines along the 
North-East Pacifiic ocean including Hawaii.265  In their studies Saido and coworkers detected 
5.1-5.3 using selective ion monitoring gas chromatography-mass spectrometry (SIM-GC-
MS).263–265  All three oligomers were found at costal locations throughout the north Pacific, 
with the styrene trimer  (5.1) commonly being detected in the highest concentrations out of 
the three oligomers.263–265 
 
5.5 Conclusion 
Although there was not enough of 5.1 available for cytotoxic evaluation against breast cancer 
cells it is highly unlikely that this relatively simple aromatic compound, found in only the 100% 
acetone fraction from the HP-20 column chromatography, was responsible for the cytotoxicity 
of the A. marinense and Clavelina sp. extracts.  Despite the tenuous possibility that the 
styrene oligomer, 5.1, isolated from A. marinense and Clavelina sp. may be a marine pollutant 
concentrated by the filter feeding ascidians it is more likely that this compound is an isolation 
artefact arising from elution of HP-20 polystyrene resin with copious volumes of solvent.  
However, since we cannot clearly show the presence of 5.1 in the crude extracts, or establish 
unequivocally that 5.1 is an artefact of isolation, the origin of this compound is still unknown.  
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Chapter Six: 
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6.1 General Experimental Procedures 
6.1.1 Analytical 
NMR spectra were acquired using standard pulse sequences on Bruker Avance 400 MHz and 
600 MHz Avance II spectrometers. Chemical shifts are reported in ppm and referenced to 
residual solvent resonances (CDCl3 δH 7.26, δC 77.0, CD3OD δH 3.34 δC 49.9, DMSO (d-6) δH 
2.50 δC 39.5).  Coupling constants are reported directly from the NMR spectra unless 
otherwise stated and corresponding coupling constants have not been matched.  Infra-red 
spectra were recorded on a Perkin-Elmer Spectrum 2000 FT-IR spectrometer and Digilab 
FTS 3100 Excalibur HE Series with compounds as films (neat) on NaCl discs.  Mass 
spectrometry of isolated compounds were performed on a Waters API Q-TOF Ultima 
instrument using electron-spray ionisation (ESI) or in the case of GC-EI-MS an Agilent 6890N 
GC and Agilent 5975B MS were used in electron ionisation (EI) positive mode, at the 
University of Stellenbosch Central Analytical Facility.  
 
6.1.2  Chromatography involved in the isolation of ascidian metabolites 
General laboratory solvents were distilled from glass before use. Analytical normal phase thin 
layer chromatography was performed on DC-Plastikfolien Kieselgel 60 F254 plates.  Plates 
were viewed under UV light (254 nm) and developed by spraying with 10% H2SO4 in MeOH 
followed by heating.  HP-20 beads used were manufactured by Diaion and supplied by 
Supelco.  Open column chromatography was performed using Discovery® DSC-DIOL 
supplied by Supelco, and flash chromatography was performed using Kieselgel 60 (230-400 
mesh) silica gel. Normal phase DIOL semipreparative HPLC separations were performed on 
a Machery-Nagel VP 250/10 Nucleosil 100-7 OH column using an Agilent 1100 Series quad 
pump and an Agilent 1100 diode array detector.  Reversed-phase semi-preparative HPLC 
separations were performed on a Phenomenex Onyx Monolithic Semi-PREP C-18 column 
using an Agilent 1100 Series quad pump and an Agilent 1100 diode array detector, or Waters 
1500-Series isocratic pump with Waters 2414 Refractive Index Detector.  
 
6.2 Chapter Two Experimental 
6.2.1 MarinLit database survey 
The marine chemical literature database, MarinLit76, was used to establish the chemistry 
associated with the genera of ascidians common to South Africa.  Ascidian genera were 
entered into MarinLit using all known synonyms or previous taxonomic classifications.  The 
resulting literature was classified as either “MNP isolation papers” when initial isolation and 
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elucidation of ascidian marine natural products (MNP) were reported, or “non-MNP isolation 
papers” when subsequent studies or reviews on the clinical, biological, ecological, synthetic, 
or stereochemistry or absolute configurations of ascidian metabolites were documented.  The 
isolated natural products observed from the MarinLit genera searches were classed into two 
subsets, namely “nitrogenous compounds” and “non-nitrogenous compounds”. 
 
6.2.2 1H-15N HMBC NMR Screening Protocol 
Small representative samples (~ 2 g wet mass) of each of the 20 selected colonial ascidians 
were lyophilised and subsequently crushed to form a fine powder.  Each of the powdered 
ascidian specimens were sequentially extracted with 100% MeOH followed by 100% CH2Cl2.  
Samples were concentrated in vacuo and subsamples of approximately 20 mg were made in 
DMSO (d6) for 1H-15N HMBC NMR experiments.   Standard common nuclei gHMBC pulse 
program was used (Bruker Topspin hmbcgplpndqf81)  excepting that CNST2 was changed to 
90 Hz and the first and third gradient parameters were corrected to 70% and 50.1% 
respectively.81  A wide sweep width of 650 ppm was set and centred at O2= 200 ppm.        
 
 
6.2.3 Preparation of samples for total metal analysis and screening for organometallics and 
metal chelates using LC-ICP-MS/ESI-MS 
All glassware and laboratory equipment used in the preparation of samples and extracts for 
metal analysis and LC-ICP-MS/ESI-MS screening were acid washed using 10% HNO3 and 
subsequently rinsed using MilliPore® water.  HPLC grade solvents were used and to prevent 
contamination solvents and samples were covered at all times.  Where possible the transfer 
of samples and solvents was carried out without the use of pipettes in an attempt to minimise 
contamination.  
 
For each of the 25 ascidian species three representative samples (each containing all tissues, 
etc.) of least 1.5 g fresh weight were taken and placed in separate acid-washed and pre-
weighed falcon tubes and lyophilised.  The weights of the dried triplicate samples were 
recorded and the falcon tubes sealed and stored at -20ºC until total metal analysis.  
 
Extracts of each species of ascidian (~15 g wet mass) were made using HPLC grade MeOH 
and CH2CH2.  Extractions were carried out in the normal way excepting that all glassware and 
tools used were acid washed and an iced water bath was used when sonicating the material.  
On concentration the extracts to dryness using a rotary evaporator an acid washed splash 
head adaptor was used which was further heated using a heat gun on a low setting to ensure 
that no water vapour within the shaft or adaptor condensed and contaminated the extract.  
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The crude ascidian extracts were stored at -20°C until digestion and ICP-MS analysis or LC-
ICP-MS/ESI-MS screening.   
 
The spent ascidian material remaining after the sequential extraction process was lyophilised 
and distributed between three separate acid-washed and pre-weighed falcon tubes and these 
samples were made available for total metal analysis is the need arose. 
 
Four control samples were prepared by extracting the equivalent weight of Millipore water 
instead of organism and otherwise treat as if extracting an organism.  Control samples were 
kept at -20ºC until further analysis. 
 
6.2.4 Total Metal Concentration Analysis (ICP-MS) 
Digestions of each of the dried ascidian samples (100 mg) and the organic extracts (50 mg) 
were carried out by adding conc. HNO3 (1 mL, Fluka TraceSELECT® >69.5%) and leaving 
overnight before adding a solution of H2O2 (2 mL, Fluka puriss. p.a. ≥30%) and microwaving 
(CEM, 5 min at 50°C, 5 min at 75°C and 30 min at 95°C).  After digestion each sample was 
made up to 25 mL with Millipore water, and stored at 4°C until ICP-MS analysis.  Reference 
digests made were whole egg, IAEA 140, TORT-2, DOLT-4 and DORM-3.  Eight calibration 
standards were made incorporating all the metals investigated, at varying concentrations.  
Since high concentrations of iron and vanadium were expected in the ascidian samples the 
seventh and eighth calibration standards were doped with these metals to ensure accurate 
measurement at high concentrations.   
 
ICP-MS analysis of samples and standards were carried out on an Agilent 8800 triple quad 
ICP-MS, with micro-flow PFA nebuliser and Pt cones.  Selected metals detected were Li, Be, 
B, Rb, Sr, Mo, Cd, Sn, Sb, Cs, Ba, Pb, U, Al, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, and Se.  The 
ICP-MS data for each metal were standardised to the signal for 73Ge (internal standard). 
 
6.2.5 Speciation Analysis (LC-ICP-MS/ESI-MS) 
Methanolic solutions of the organic extracts of 13 ascidian species (50 mg/µL) were entered 
into speciation studies using an Agilent 1100 series HPLC with in-line degasser, quaternary 
pump, autosampler, column compartment, and single wavelength UV detector for LC-ICP-
MS/ESI-MS analyses.  Chromatography was carried out by injecting 100 µL of sample onto 
an analytical C18 Waters SunFire column with a solvent flow rate of 1 mL/min and gradient 
profile of 100% H20 to 100% MeOH over 20 mins.  HPLC solvents which were used for 
chromatography with made up with 0.1% formic acid (FA).  After passing through the UV 
detector a passive splitter directed approximately 80-85% of the eluent flow to the ESI-MS 
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and 15-20% of the eluent flow to the ICP-MS.  ESI-MS was performed on a Thermo Orbitrap 
high resolution electrospray ionisation mass spectrometer whilst ICP-MS was performed on 
an Agilent 8800 triple quad ICP-MS, with micro-flow PFA nebuliser and Pt cones, and 7% O2 
reaction gas.  Elements detected were V (m/z 51), Mn (m/z 55) Fe (m/z 57), Co (m/z 59), Cu 
(m/z 63), Zn (m/z 66), As (m/z 75), Se (m/z 77), Br (m/z 79), Mo (m/z 95) and I (m/z 127).   
 
6.2.6 Extraction and isolation of Distaplia skoogi metabolites 
The colony of Distaplia skoogi Michaelsen, 1934 was collected from a depth of 25m at the 
White Sands Reef, Algoa Bay, South Africa (34:00.436S, 25:43.296E), on 15 July 2004 and 
identified by Dr. S. Parker-Nance. The voucher specimen (SAF2004-030) preserved in 5% 
buffered formalin is kept at the South African Institute for Aquatic Biodiversity (SAIAB), 
Grahamstown, South Africa.  Samples of D. skoogi were frozen immediately after collection in 
the field and kept at –18 °C until extracted. 
 
The frozen ascidian colony (309.41 g wet mass) was lyophilised and then sequentially 
extracted with 100% MeOH followed by 100% CH2Cl2.  The combined organic extracts were 
concentrated in vacuo and then subjected to liquid-liquid partitioning between EtOAc and 
H2O.  The combined EtOAc fractions were concentrated in vacuo to yield 1.11 g of extract.  A 
350 mg aliquot of the partitioned extract was purified further with normal phase HPLC (40% 
EtOAc/hexane) on a semi-preparative DIOL column to afford four fractions (Scheme 2.1).  
Fraction 2 was subjected to normal phase DIOL HPLC (60% CH2Cl2/hexane) followed by 
further normal phase DIOL HPLC (20% CH2Cl2/hexane) purification to yield 3.0 mg of 3,6-
dibromoindole (2.29) and 2.2 mg of 6-bromo-3-chloroindloe (2.30).  Fraction 3 was further 
purified using a small DIOL plug (10% EtOAc/hexane), and recrystallisation from hexane to 
afford 2.4 mg of 6-bromo-2-oxindole (2.28) as colourless needles (Scheme 2.1). 
 
 
N
H
Br
2.28
O
 
 
6-Bromo-2-oxindole (2.28): Colourless needles (hexane); mp 216 - 219 °C; IR (film) νmax 
3435, 1643, 1096 cm-1; 1H and 13C NMR data see Table 2.2; ESIMS m/z 215 [(M+H)+] (10), 
214 (100), 213 (10), 212 (97); HRESIMS m/z 211.9710 (calcd for C8H7NO79Br [(M+H)+], 
211.9711, ∆ 0.1 mmu).  
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N
H
Br
Br
2.29  
 
3,6-Dibromoindole (2.29):   Colourless oil; IR (film) νmax 3445, 1422, 1265, 1106, 895, 736 
cm-1; 1H and 13C NMR data see Table 2.3; EIMS m/z 276 [(M-H)-] (48), 274 (100), 272 (49); 
HRESIMS m/z 271.8719 (calcd for C8H4N79Br2 [(M-H)-], 271.8710, ∆ 0.9 mmu).  
 
 
N
H
Br
Cl
2.30  
 
6-Bromo-3-chloroindole (2.30):   Colourless oil; IR (film) νmax 3445, 3055, 1265, 895, 737 
cm-1; 1H and 13C NMR data see Table 2.3; ESIMS m/z 232 [(M-H)-] (28), 230 (100), 228 (78); 
HRESIMS m/z 227.9215 (calcd for C8H4N79Br 35Cl [(M-H)-], 227.9216, ∆ 0.1 mmu).  
 
6.2.6.1 Bioassay of 2.28 – 2.30 
 
MDA-MB-231 breast cancer cells (ATCC HTB-26) were cultured in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 5% (v/v) heat-inactivated FCS, 1 mM L-glutamine, 100 
U/mL penicillin, 100 µg/mL streptomycin and 12.5 µg/mL amphotericin (PSA) at 37°C in a 
humidified 9% CO2 incubator.  The effect of the compounds on cell proliferation was 
assessed using the MTT assay (Roche) as previously described.55,103  Cells were seeded at a 
density of 6000 cells per well into 96-well plates and incubated overnight, followed by 
treatment with a range of concentrations (0, 0.5, 5, 50, 250 and 500 µM) of the compounds or 
dimethyl sulphoxide (DMSO) vehicle control (0.02% v/v DMSO) for 96 hours and absorbance 
at 595 nm recorded using a Powerwave spectrophotometer (BioTek). The half maximal 
inhibitory concentration (IC50) for each compound was calculated relative to the vehicle-
treated control from a dose response curve (log concentration versus absorbance at 595 nm) 
using non-linear regression with GraphPad Prism 4 (GraphPad Inc.). Paclitaxel was included 
as a positive control (IC50 of 100 nM). All treatments were conducted in triplicate on each of 
the two plates.55,103 
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6.2.7 Extraction and isolation of 2.33 from Aplidium monile 
The ascidian Aplidium monile Monniot, F., 2001 was collected by SCUBA from a depth of 12 - 
15 m at Bell Buoy dive site (33° 58.998’ S 25° 41.622’ E), Algoa Bay, South Africa, in 
November 2011.  The voucher specimen (TIC2011-032) preserved in 5% buffered formalin is 
kept at the South African Institute for Aquatic Biodiversity (SAIAB), Grahamstown, South 
Africa.  The sample of A. monile was frozen immediately after collection in the field and kept 
at –18 °C until extracted. 
 
The small scale MeOH/CH2Cl2 extraction of A. monlie (23.90 g) prepared for the metal 
analysis and LC-ICP-MS/ESI-MS screen was partitioned between CH2Cl2 and 70% aq. 
MeOH.  The 676.0 mg MeOH partition was fractionated using a C-18 Sep-Pak® cartridge 
(Waters,10 g) and a step wise gradient to produce seven fractions (water, 10% MeCNaq, 20% 
MeCNaq, 40% MeCNaq, 60% MeCNaq, 80% MeCNaq, and 100% MeCN) (Scheme 4.1 and 
Figure 4.6).  The fourth fraction yielded 5.0 mg of 2.33. 
 
 
I
I
O
NH2
2.33  
 
3,5-diido-4-methoxyphenethylamine (2.33): White amorphous solid; 1H and 13C NMR data 
see Table 2.4; HRESIMS m/z 403.9000 (calcd for C9H11NOI2 [(M+H)+], 403.9003 ∆ 0.3 mmu).   
 
 
6.3 Chapter Three Experimental 
The procedure used to obtain the total metal analysis results using ICP-MS has been 
discussed in section 6.2.4 of this chapter.  All statistical analyses were carried out using 
established tests within the Statistica 10 software package. 
 
 
6.4 Chapter Four Experimental 
The procedure used to obtain the total vanadium content of the Algoa Bay ascidians using 
ICP-MS has been discussed in section 6.2.4 of this chapter. 
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6.4.1 Isolation and elucidation of nucleosides from Aplidium monile 
The ascidian Aplidium monile Monniot, F., 2001 was collected by SCUBA from a depth of 12 - 
15 m at Bell Buoy dive site (33° 58.998’ S 25° 41.622’ E), Algoa Bay, South Africa, in 
November 2011.  The voucher specimen (TIC2011-032) preserved in 5% buffered formalin is 
kept at the South African Institute for Aquatic Biodiversity (SAIAB), Grahamstown, South 
Africa.  The sample of A. monile was frozen immediately after collection in the field and kept 
at –18 °C until extracted. 
 
The larger scale extraction of A. monile (262.6 g wet mass) involved the sequential extraction 
with MeOH followed by CH2Cl2.  Extractives of each solvent system were kept separate and 
concentrated to dryness under reduced pressure.  Subsamples of the MeOH extract (~1 g) 
were fractionated using a C-18 Sep-Pak® cartridge (Waters,10 g) and a step wise gradient to 
produce seven fractions (water, 10% MeCNaq, 20% MeCNaq, 40% MeCNaq, 60% MeCNaq, 
80% MeCNaq, and 100% MeCN) (Scheme 4.1 and Figure 4.6).  As discussed in section 6.2.7 
of this chapter, the fourth fraction yielded 2,5-diiodotyrame 2.33.  The second fraction (10% 
MeCNaq) was further purified using RP-HPLC with a Luna C18 column and an isocratic 
solvent system of 10% MeCN/H2O (3 mL/min) to produce fractions 8-14.  Fraction 12 was 
thymidine (4.10).   
 
RP-HPLC using a C18 column and 10% MeOH/H2O (4 mL/min) of fraction 11 produced 
fractions 15-22 where fractions 18 and 20 were nucleosides 4.11 and 4.13 respectively.  
Further RP-HPLC (C18, 5% MeOH/H2O, 4 mL/min) of fraction 19 yielded 4.15.  RP-HPLC 
(C18, 10% MeOH/H2O, 3 mL/min) of fraction 21 yielded fractions 29-31.  Fraction 31 was an 
inseparable mixture of 4.17 and 4.40.  
 
 
 
N
NH
O
O
O
OH
HO
4.10  
 
Thymidine (4.10): white amorphous solid;  IR (film) νmax 3464, 3403, 3237, 1692, 1640, 1619, 
1474, 1421, 1266, 1092, 1054 cm-1; 1H and 13C NMR data see Table 4.1; HRESIMS m/z 
243.0988 (calcd. for C10H15N2O5 [(M+H)+], 243.0981, ∆ 0.7 mmu). 
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N
NH
O
O
O
OH OH
HO
4.11  
 
Uridine (4.11): white amorphous solid;  IR (film) νmax 3545, 3469, 3416, 1699, 1640, 1617, 
1472, 1421, 1266, 1089, 1053 cm-1; 1H and 13C NMR data see Table 4.1; HRESIMS m/z 
245.0796 (calcd. for C9H13N2O6 [(M+H)+], 245.0774, ∆ 2.2 mmu). 
 
O
OH OH
HO N
NHN
N
O
4.13  
 
Inosine (4.13): white amorphous solid; IR (film) νmax 3436, 3057, 1639, 1465, 1421, 1266, 
1160, 1093, 1053 cm-1; 1H and 13C NMR data see Table 4.1; LRESIMS m/z 269.8. 
 
 
N
NH
O
O
O
OH
HO
4.15  
 
2’-deoxyuridine (4.15): white amorphous solid; IR (film) νmax 3438, 3055, 1709, 1638, 1421, 
1269, 1155, 1101, 1056 cm-1; 1H and 13C NMR data see Table 4.1; HRESIMS m/z 229.0844 
(calcd. for C9H13N2O5 [(M+H)+], 229.0824, ∆ 2.0 mmu).  
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OH
HO N
NHN
N
O
4.17  
 
2’-deoxyinosine (4.17): white amorphous solid; IR (film) νmax 3438, 1638, 1534, 1475, 1416, 
1121, 1083 cm-1; 1H and 13C NMR data see Table 4.2. 
 
N
NH
O
O
O
OH
HO
4.40
OH
H2N
 
 
5-aminouridine (4.40): white amorphous solid; IR (film) νmax 3438, 1638, 1534, 1475, 1416, 
1121, 1083 cm-1; 1H and 13C NMR data see Table 4.3. 
 
6.4.2 Potentiometric Studies 
The commercially available nucleosides 4.10-4.14 were purchased from Sigma-Aldrich The 
protonation and stability constants for the nucleosides and oxidovanadium(IV) complexes 
were determined by potentiometric titration of approximately 25 mL solutions.  Tiamo 2.0 
software was used to control all titrations which were performed using a Metrohm 794 Basic 
Titrino.  All solutions were prepared using freshly boiled and degassed deionised milli-Q water 
to ensure the removal of dissolved oxygen and carbon dioxide. The ligand concentration was 
1 mM and metal-to-ligand ratios of 1:1 and 1:10 were used. Titrations were performed over 
the pH range of 2-11 under a continuous flow of purified nitrogen using 0.1 M HCl (1 mL) and 
sodium hydroxide (0.1 M). The ionic strength of the titration solutions was kept constant at 
0.10 M sodium chloride. Titrations were controlled using Tiamo software, and the titration rate 
used was 0.01 ml/min and the pausing time was 60 s. The glass electrode was calibrated for 
a strong acid-base reaction by the Gran-method212 using the program GLEE213 to determine 
the standard potential Eo. The ionic product of water (pKw) of 13.76 at 25.0±0.1 oC in 0.10 M 
NaCl was used in all calculations.214 The hydrolysis model of a oxidovanadium(IV) system 
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was included in the model; [VO(OH)3]- (logβ10-3 = -18.0) and [(VO)2(OH)5]- (logβ20-5 = -22.0), 
[VO(OH)]+ (logβ10-1 = -5.94) and [(VO)2(OH)2]2+ (logβ20-2 = -6.95).211 The concentration stability 
constants βpqr = [MpLqHr]/[M]p[L]q[H]r were calculated by using the computer program 
HYPERQUAD.216   
 
Thymidine (4.10): Protonation constants established as logK 9.54 and 10.78.  Stability 
constant(s) for the nucleoside-vanadyl complexation study determined as logβ 13.6 for the 
(1,1,0) model. 
 
 
Figure 6.1:  Titration and fitted curves of aqueous thymidine protonation study 
 
 
Figure 6.2: Titration and fitted curves of aqueous thymidine-vanadyl complexation study. 
y
0 0.4 0.8 1.2
titre volume
3
5
7
9
pH
0 0.4 0.8 1.2
titre volume
-0.2
0
0.2
W
ei
gh
te
d 
re
si
du
al
s
y p
0 0.4 0.8 1.2 1.6
titre volume
0 0.4 0.8 1.2 1.6
titre volume
y
0 0.4 0.8 1.2 1.6
titre volume
0
10
20
30
40
50
60
70
80
90
100
%
 fo
rm
at
io
n 
re
la
tiv
e 
to
 T
hy
0 0.4 0.8 1.2 1.6
titre volume
0 0.4 0.8 1.2 1.6
titre volume
3
5
7
9
pH
0 0.4 0.8 1.2 1.6
titre volume
-0.2
0
0.2
W
ei
gh
te
d 
re
si
du
al
s 0 0.4 0.8 1.2 1.6
titre volume
0 0.4 0.8 1.2 1.6
titre volume
0 0.4 0.8 1.2 1.6
titre volume
0 0.4 0.8 1.2 1.6
titre volume
0 0.4 0.8 1.2 1.6
titre volume
0
10
20
30
40
50
60
70
80
90
100
%
 fo
rm
at
io
n 
re
la
tiv
e 
to
 V
O
0 0.4 0.8 1.2 1.6
titre volume
Chapter 6 
 
173 
 
Uridine (4.11): Protonation constants established as logK 9.12 and 10.77.  Stability 
constant(s) for the nucleoside-vanadyl complexation study determined as logβ 10.9 for the 
(1,1,0) model and logβ 13.9 for the (1,1,1) model. 
 
 
 
Figure 6.3: Titration and fitted curves of aqueous uridine protonation study 
 
 
 
Figure 6.4: Titration and fitted curves of aqueous uridine-vanadyl complexation study. 
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Guanosine (4.12): Protonation constants established as logK 9.6, 8.87 and 2.30.  Stability 
constant(s) for the nucleoside-vanadyl complexation study determined as logβ 19.9 for the 
(1,1,0) model and logβ 30.9 for the (1,1,1) model. 
 
 
 
Figure 6.5: Titration and fitted curves of aqueous guanosine protonation study 
 
 
 
Figure 6.6: Titration and fitted curves of aqueous guanosine-vanadyl complexation study. 
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Inosine (4.13): Protonation constant established as logK 8.63.  Stability constant(s) for the 
nucleoside-vanadyl complexation study determined as logβ 12.2 for the (1,1,0) model and 
logβ 17.8 for the (1,1,1) model. 
 
 
 
Figure 6.7: Titration and fitted curves of aqueous inosine protonation study 
 
 
 
Figure 6.8: Titration and fitted curves of aqueous inosine-vanadyl complexation study. 
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Adenosine (4.14): Protonation constants established as logK 11.04 and 3.65.  Stability 
constant(s) for the nucleoside-vanadyl complexation study determined as logβ 10.8 for the 
(1,1,0) model and logβ 16.2 for the (1,1,1) model. 
 
 
 
Figure 6.9: Titration and fitted curves of aqueous adenosine protonation study 
 
 
 
Figure 6.10: Titration and fitted curves of aqueous adenosine-vanadyl complexation study. 
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6.5 Chapter Five Experimental 
6.5.1 Animal material 
Atriolum marinense Kott, 2001 (TIC2011-025) was collected using SCUBA in November 2011 
from the Algoa Bay dive site, known as Shy Shark reef (25°41'34.14"E) and stored at -20°C 
until lyophilisation and extraction.  Clavelina sp. (SAF2004-029) was collected from a depth of 
21 m at White Sands reef (25°42'34.38"E), Algoa Bay, South Africa and kept at -20°C until 
lyophilisation and extraction. 
6.5.2 Bioassay 
Lyophilised samples of Atriolum marinense (132 g wet mass to 31 g dry mass) and Clavelina 
sp. (157 g wet mass to 39 g dry mass) were each sequentially extracted with MeOH and 
CH2Cl2.  The CH2Cl2 extractives were concentrated to dryness under reduced pressure and 
redissolved in their respective MeOH extracts before being cyclic loaded onto HP-20 resin.  
The HP-20 resin was washed with with water to remove inorganic salts and then stripped with 
aqueous Me2CO mixtures of decreasing polarity (20%, 40%, 60%, 80% Me2CO/H2O and 
100% Me2CO) to afford five fractions per ascidian species (Figure 5.2).  Fractions were 
concentrated in vacuo. HPLC grade solvents were used throughout. 
 
Subsamples of 1 mg of each of the 5 HP-20 fractions of the two ascidian extracts were 
submitted into a biological assay against breast cancer cell line MDA-MB-231 (see section 
6.2.6 of this chapter).  The percentage viability of the cancer cells was determined after 
exposure to 5 µg/mL and 50 µg/mL of each fraction.  
6.5.3 Isolation of 5.1 from Atriolum marinense 
The fifth fraction (100% Me2CO) obtained from the HP-20 fractionation of the extract of A. 
marinense was further purified by DIOL HPLC with 20% EtOAc/hexane followed by DIOL 
HPLC with 16.6% EtOAc/hexane and finally by DIOL HPLC with 10% DCM/hexane to yield 
the styrene trimer 5.1.  The Bruker software WIN-DAISY was used to establish the structure 
of 5.1.  
5.1  
Styrene trimer (5.1): colourless oil; 1H and 13C NMR data see Table 5.1; EIMS m/z (rel. int.) 
312.1 [M+] (10), 207.0 (46), 117.0 (74), 91.0 (100).  
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6.5.4 Attempts to establish if 5.1 is an artefact of HP-20 fractionation 
A portion 5 g of HP-20 beads were ground into a fine powder and steeped in CH2Cl2 for 48 
hours with periods of sonication.  The powder was then filtered and the filtrate dried under 
reduced pressure and a 1H NMR spectrum acquired. 
 
The second experiment replicated the initial process of cyclic loading on to HP-20 resin, 
without the presence of the ascidian extract.  A volume of 250 mL of HP-20 resin was 
subjected to the process of cyclic loading using HPLC grade solvents.  The 500 mL of MeOH 
was doped with 50 mL of CH2Cl2 prior to cycling loading.  The solvent mixture was cyclic 
loaded onto the HP-20 resin over the course of a week.  The HP-20 column was then striped 
with 100% acetone.  The eluent collected was concentrated to dryness under reduced 
pressure and analysed using 1H NMR. 
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Appendix A: 
Principal component analysis (PCA) 
factor loading plots obtained from the 
total metal analysis data of 25 Algoa 
Bay ascidians 
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Appendix A1: Factor loading plots with case labels relating to taxonomic families 
The factor loading plots presented in this appendix relate to the principal component analysis 
conducted on the metal concentration data obtained for 25 species of Algoa Bay ascidians 
and discussed in detail in Chapter 3.  Each data point relates to an ascidian species and 
clustering of data plots within a particular area of the plot indicates similar factor scores 
between ascidian relating to the metals which predominate within them.  In the case of 
Appendix A1 the ascidian species are labelled according to their taxonomic families in an 
attempt to establish any phylogenetic relationships between ascidian species and metal 
concentrations.  
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Appendix A1 continued 
 
 
Appendix A2: Factor loading plots with case labels relating to collection site 
The factor loading plots presented in this appendix relate to the principal component analysis 
conducted on the metal concentration data obtained for 25 species of Algoa Bay ascidians 
and discussed in detail in Chapter 3.  Each data point relates to an ascidian species and 
clustering of data plots within a particular area of the plot indicates similar factor scores 
between ascidian relating to the metals which predominate within them.  In the case of 
Appendix A2 the ascidian species are labelled according to their collection sites in an attempt 
to establish any spatial relationships between collection site and metal concentrations.  
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Appendix A2 continued 
 
 
 
 
 
 
  
-10 -8 -6 -4 -2 0 2 4 6
Principal component 1: 38.04%
-4
-3
-2
-1
0
1
2
3
P
rin
ci
pa
l c
om
po
ne
nt
 4
: 6
.9
0%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-10 -8 -6 -4 -2 0 2 4 6
Principal component 1: 38.04%
-3
-2
-1
0
1
2
3
4
P
rin
ci
pa
l c
om
po
ne
nt
 5
: 4
.9
8%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-10 -8 -6 -4 -2 0 2 4 6
Principal component 1: 38.04%
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
P
rin
ci
pa
l c
om
po
ne
nt
 6
: 4
.5
6%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-10 -8 -6 -4 -2 0 2 4 6
Principal component 1: 38.04%
-3
-2
-1
0
1
2
3
4
5
P
rin
ci
pa
l c
om
po
ne
nt
 7
: 4
.1
7%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
Appendix A 
 
187 
Appendix A2 continued 
 
 
 
 
 
  
-7 -6 -5 -4 -3 -2 -1 0 1 2 3 4
Principal component 2: 14.30%
-3
-2
-1
0
1
2
3
4
P
rin
ci
pa
l c
om
po
ne
nt
 3
: 8
.5
7%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-7 -6 -5 -4 -3 -2 -1 0 1 2 3 4
Principal component 2: 14.30%
-4
-3
-2
-1
0
1
2
3
P
rin
ci
pa
l c
om
po
ne
nt
 4
: 6
.9
0%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-7 -6 -5 -4 -3 -2 -1 0 1 2 3 4
Principal component 2: 14.30%
-3
-2
-1
0
1
2
3
4
P
rin
ci
pa
l c
om
po
ne
nt
 5
: 4
.9
8%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-7 -6 -5 -4 -3 -2 -1 0 1 2 3 4
Principal component 2: 14.30%
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
P
rin
ci
pa
l c
om
po
ne
nt
 6
: 4
.5
6%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
Appendix A 
 
188 
Appendix A2 contintued 
 
 
 
 
 
 
 
  
-7 -6 -5 -4 -3 -2 -1 0 1 2 3 4
Principal component 2: 14.30%
-3
-2
-1
0
1
2
3
4
5
P
rin
ci
pa
l c
om
po
ne
nt
 7
: 4
.1
7%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-3 -2 -1 0 1 2 3 4
Principal component 3: 8.57%
-4
-3
-2
-1
0
1
2
3
P
rin
ci
pa
l c
om
po
ne
nt
 4
: 6
.9
0%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-3 -2 -1 0 1 2 3 4
Principal component 3: 8.57%
-3
-2
-1
0
1
2
3
4
P
rin
ci
pa
l c
om
po
ne
nt
 5
: 4
.9
8%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-3 -2 -1 0 1 2 3 4
Principal component 3: 8.57%
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
P
rin
ci
pa
l c
om
po
ne
nt
 6
: 4
.5
6%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
Appendix A 
 
189 
Appendix A2 continued 
 
 
 
 
  
-3 -2 -1 0 1 2 3 4
Principal component 3: 8.57%
-3
-2
-1
0
1
2
3
4
5
P
rin
ci
pa
l c
om
po
ne
nt
 7
: 4
.1
7%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-4 -3 -2 -1 0 1 2 3
Principal component 4: 6.90%
-3
-2
-1
0
1
2
3
4
P
rin
ci
pa
l c
om
po
ne
nt
 5
: 4
.9
8%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-4 -3 -2 -1 0 1 2 3
Principal component 4: 6.90%
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
P
rin
ci
pa
l c
om
po
ne
nt
 6
: 4
.5
6%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-4 -3 -2 -1 0 1 2 3
Principal component 4: 6.90%
-3
-2
-1
0
1
2
3
4
5
P
rin
ci
pa
l c
om
po
ne
nt
 7
: 4
.1
7%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
Appendix A 
 
190 
Appendix A2 continued 
 
 
 
 
 
 
 
 
  
-3 -2 -1 0 1 2 3 4
Principal component 5: 4.98%
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
P
rin
ci
pa
l c
om
po
ne
nt
 6
: 4
.5
6%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-3 -2 -1 0 1 2 3 4
Principal component 5: 4.98%
-3
-2
-1
0
1
2
3
4
5
P
rin
ci
pa
l c
om
po
ne
nt
 7
: 4
.1
7%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
-2.5 -2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5 2.0 2.5 3.0
Principal component 6: 4.56%
-3
-2
-1
0
1
2
3
4
5
P
rin
ci
pa
l c
om
po
ne
nt
 7
: 4
.1
7%
Roman Rock; Shy Shark; Bell Bouy; Haarlem Reef; White Sands
Appendix A 
 
191 
Appendix A3: Factor loading plots with case labels relating to collection year 
The factor loading plots presented in this appendix relate to the principal component analysis 
conducted on the metal concentration data obtained for 25 species of Algoa Bay ascidians 
and discussed in detail in Chapter 3.  Each data point relates to an ascidian species and 
clustering of data plots within a particular area of the plot indicates similar factor scores 
between ascidian relating to the metals which predominate within them.  In the case of 
Appendix A3 the ascidian species are labelled according to their year of collection in an 
attempt to establish any temporal relationships between collection year and metal 
concentrations.  
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